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ABSTRACT 
 
 Stereoselective Diels-Alder cycloaddition is a very important methodology in the 
synthesis of chiral organic compounds. In this thesis, the selectivity was achieved by 
means of a chiral auxiliary or by the use of chiral Lewis acid complex. 
 Diastereoselective Diels-Alder cycloaddition was achieved by reacting a 1,3-
butadiene bearing 2,3,4,6-tetraacetyl glucosyl as chiral auxiliary with PTAD. Total facial 
selectivity was obtained in this process. The cycloadduct obtained was converted in the 
known (-)-1-azafagomine, and in (+)-5-epi-1-azafagomine. Two new 1-N-phenyl 
carboxamide derivatives of 1-azafagomine were obtained by partial reductive cleavage 
of the phenyltriazolidinone moiety. The inhibitory potency of these new compounds 
towards - and -glucosidases was evaluated, and with the compound related to (-)-1-
azafagomine showing the best inhibitory activity against -glucosidase. The biological 
mechanism of action of both enantiomers in yeast α-glucosidase was studied by 
molecular docking methodologies using the homologue Saccharomyces cerevisiae 
enzyme. The efficient packing of the aromatic ring of the N-phenyl carboxamide moiety 
into a hydrophobic subsite (pocket) in the enzyme’s active site seems to be responsible 
for the improved binding affinity. 
 This process was very efficient in terms of facial discrimination; however a long 
sequence of reactions were needed to obtain the final products, due to the additional 
steps required to introduce and remove the chiral auxiliary. As an alternative, a shorter 
synthetic strategy was devised using a Diels-Alder cycloaddition catalysed by a 
bimetallic complex of Mg and Zn tethered to BINOL (LACASA-DA). 
 Combination of a D-erythrose 1,3-butadiene with maleimides and achiral 2H-
azirine 3-carboxylate in a LACASA-DA cycloadditions gave in most cases total facial 
selectivity. In the case of cycloadduct obtained from 2H-azirine, both enantiomers were 
obtained depending of the chirality of BINOL. The (R)-cycloadduct, obtained with (S)-
BINOL, is a precursor of neuraminic acid and D-swainsonine analogues.  
 Moreover, LACASA-DA methodology also gave excellent enantioselectivities 
(>99 %) with achiral reagents, such as 2,4-pentadienol (diene) and t-butyl 2H-azirine 3-
carboxylate or DEAD (dienophiles). Both enantiomeric forms of cycloadducts were 
obtained only by changing BINOL stereochemistry. Cycloadducts obtained from 2H-
 viii 
azirine were easily converted in two sets of polihydroxylated pipecolic acid derivatives, 
after 3 steps. 
 All new compounds were fully characterized by the usual spectroscopic 
technics (1H NMR and 13C NMR and IR), analytical techniques (mass spectrometry) 
and physical properties (optical rotation). The absolute stereochemistry of 
stereocentres included in the molecules was determined by X-ray crystallography, in 
cases where single crystals could be obtained, or by combination of coupling constants 
(J) in the 1H NMR data with dihedral angles determined by molecular dynamics studies 
for the oils. 
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RESUMO 
 
 A reação de Diels-Alder estereosseletiva é uma metodologia muito importante 
na síntese de compostos orgânicos quirais. Neste trabalho, a seletividade foi 
conseguida utilizando um auxiliar quiral ou um ácido de Lewis quiral. 
 A reação de Diels-Alder diastereosseletiva entre um dieno contendo o 2,3,4,6-
tetra-acetilglucopiranosilo como auxiliar quiral e o PTAD, originou o aducto 
correspondente com total seletividade facial. O cicloaducto obtido foi convertido em 
aza-açucares conhecidos: (-)-1-azafagomina e (+)-5-epi-1-azafagomina. A clivagem 
redutiva parcial da unidade de feniltriazolidinona originou dois novos derivados N-fenil-
carboxamida da 1-azafagomina. Estes novos compostos foram avaliados quanto à sua 
atividade inibitória face às enzimas - e -glucosidases. O composto relacionado com 
a (-)-1-azafagomina exibiu a melhor atividade inibitória face à -glucosidase. O 
mecanismo biológico de acção de ambos os enantiómeros na -glucosidase (baker’s 
yeast) foi estudado por metodologias de “docking” molecular utilizando a enzima 
homóloga Saccharomyces cerevisiae. O acondicionamento eficiente do anel aromático 
da unidade N-fenil carboxamida numa bolsa hidrofóbica presente no local activo da 
enzima parece ser responsável pelo aumento da inibição. 
 Esta metodologia mostrou-se muito eficiente em termos de discriminação facial, 
no entanto, era necessário uma longa sequência reacional para se obter os produtos 
finais, devido aos passos adicionais necessários para introduzir e remover o auxiliar 
quiral. Assim, enveredou-se por um processo mais curto que usa a cicloadição de 
Diels-Alder catalisada por um complexo bimetálico de Mg e Zn ligado ao BINOL 
(LACASA-DA). 
 A combinação de um dieno derivado da D-eritrose, com maleimidas e uma 
azirina não quiral, a 2H-azirina 3-carboxilato de t-butilo, usando a estratégia LACASA-
DA gerou, na maioria dos casos, total seletividade facial. No caso do cicloaducto 
obtido a partir da azirina, foram obtidos ambos os enantiómeros dependendo da 
quiralidade do BINOL. O cicloaducto (R) obtido com o (S)-BINOL, é um precursor de 
análogos do ácido neuramínico e da D-swainsonina. 
 Adicionalmente, a metodologia LACASA-DA também originou produtos com 
excelentes enantiosseletividades (>99 %) usando reagentes não quirais, tais como, o 
2,4-pentadienol (dieno) e a 2H-azirina 3-carboxilato de t-butilo ou o azodicarboxilato de 
dietilo (DEAD) (dienófilos). Ambas as formas enantioméricas dos cicloaductos foram 
 x 
obtidas apenas alterando a estereoquímica do BINOL. Os cicloaductos obtidos a partir 
da 2H-azirina foram facilmente convertidos, em dois conjuntos de derivados 
polihidroxilados do ácido pipecólico, em apenas três passos reacionais. 
 Todos os compostos foram caracterizados pelas técnicas espetroscópicas 
usuais (1H e 13C RMN, e IV), técnicas analíticas (espetrometria de massa) e 
propriedades físicas (rotação ótica). A estereoquímica absoluta dos estereocentros 
incluídos nos produtos foram determinados por cristalografia de raio-X, nos casos em 
que os cristais puderam ser obtidos, ou por correlação das constantes de acoplamento 
(J) dos espetros de RMN de protão com os ângulos diedros determinados por estudos 
de dinâmica molecular, para os óleos. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
xi 
GENERAL INDEX 
 
AGRADECIMENTOS .................................................................................................................... v 
ABSTRACT .................................................................................................................................. vii 
RESUMO ....................................................................................................................................... ix 
GENERAL INDEX ......................................................................................................................... xi 
FIGURES INDEX ........................................................................................................................ xiii 
SCHEMES INDEX ........................................................................................................................ xv 
TABLES INDEX .......................................................................................................................... xvii 
SYMBOLS AND ABBREVIATIONS LIST .................................................................................... xix 
THESIS SUMMARY .................................................................................................................. xxiii 
 
 
Chapter 1 - Introduction 
 
1.  Enantioselective Diels-Alder cycloadditions in the synthesis of important 
chiral synthons using (R)-/(S)-BINOL ligands ................................................................. 3 
1.1 Titanium-BINOL catalysts ...................................................................... 4 
1.2 Boron-BINOL catalysts ........................................................................ 25 
1.3 Aluminium-BINOL catalysts ................................................................. 28 
1.4 Zinc-Magnesium-BINOL catalysts ....................................................... 31 
1.5 Indium-BINOL catalysts ....................................................................... 34 
1.6 Lanthanide/Transition metals-BINOL catalysts (Sc, Yb) ..................... 36 
2.  Conclusions ................................................................................................ 42 
3.  References ................................................................................................. 42 
 
 
Chapter 2 - Results and discussion as a compilation of articles 
2.1 Advances in the Synthesis of Homochiral (-)-1-Azafagomine and (+)-5-epi-1-
Azafagomine. 1-N-Phenyl Carboxamide Derivatives of both Enantiomers of 1 
Azafagomine: Leads for the Synthesis of Active α-Glycosidase Inhibitors. .................. 53 
  
xii 
2.2 Diastereoselectivity in Diels–Alder Cycloadditions of Erythrose Benzylidene-acetal 
1,3-Butadienes with Maleimides ................................................................................... 81 
 
2.3 Asymmetric Diels-Alder Cycloadditions of D-Erythrose 1,3-Butadienes to Achiral t-
Butyl 2H-Azirine 3-Carboxylate ..................................................................................... 93 
 
2.4 Enantioselective Diels-Alder Cycloadditions in the Synthesis of Two Enantiomeric 
Sets of Homochiral Polihydroxylated Pipecolic Acid Derivatives. ............................... 111 
 
 
Chapter 3 - Overview of Results 
Overview of Results .................................................................................................... 131 
 
 
Chapter 4 - Conclusions and future prospects 
1.  Conclusions .............................................................................................. 139 
2.  Future Prospects ...................................................................................... 141 
  
 
 
 
 
 
 
 
 
 
 
 xiii 
FIGURES INDEX 
 
Figure 1 BINOL enantiomers. ........................................................................................ 3 
Figure 2 Structure of a known anthracyclinone aglycone. ............................................. 5 
Figure 3 Structure of antibiotics indanomycin 18 and erythromycin 19. ........................ 8 
Figure 4 Structure of indole alkaloids (-)-ibogamine 28 and (-)-ibogaine 30. ............... 10 
Figure 5 Examples of steroids with cis-decalin unities. ................................................ 11 
Figure 6 Structure of octalindione, streptovaricin U and 5-(3-furyl)-8-
methyloctahydroindolizine. ........................................................................................... 14 
Figure 7 Proposed TS model of the HDA reaction of diene 48 with aldehydes catalysed 
by (R)-BINOL-Ti(Oi-Pr)4. ............................................................................................... 17 
Figure 8 Structure of cyathin A3. .................................................................................. 19 
Figure 9 Selected cyathane diterpenes. ...................................................................... 20 
Figure 10 Dispongins A 69 and B 70 and their enantiomers. ...................................... 22 
Figure 11 1,5-Anhydro-D-fructose and its metabolite (-)-bissetone 74. ....................... 24 
Figure 12 Structure of alkaloid peduncularine 103. ..................................................... 30 
Figure 13 Structure of Penostatin F. ............................................................................ 33 
Figure 14 Assumed transition state. ............................................................................ 37 
Figure 15 Structure of dendrobatid alkaloid 251F. ....................................................... 39 
Figure 16 Structure of some relevant gibberellins. ...................................................... 40 
Figure 17 Transition state proposed for reaction of imine 129 and different 
dienophiles.a ................................................................................................................. 42 
Figure 18 Structures of D-swainsonine and aza-D-swainsonine. ............................... 142 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
xv 
SCHEMES INDEX 
 
Scheme 1 Asymmetric DA reaction of methyl acrylate 1 and cyclopentadiene 2. ......... 4 
Scheme 2 DA cycloaddition of naphthoquinone 7 with diene 4b catalysed by BINOL-Ti 
complex. ......................................................................................................................... 6 
Scheme 3 Alkoxy-ligand exchange reaction between MS and BINOL-TiCl2 complex. .. 7 
Scheme 4 Synthesis of monosaccharides and lactone portion of mevinolin 17a and 
compactin 17b from precursor ent-15a. .......................................................................... 8 
Scheme 5 Synthesis of calcitriol precursor (-)-25. ......................................................... 9 
Scheme 6 DA cycloaddition of benzoquinone (26) and diene 27 in the synthesis of the 
cycloadduct 29, precursor of (-)-ibogamine. ................................................................. 10 
Scheme 7 Epimerization of cis-decalone monoketal 33a to the corresponding trans-
fused ketone 35. ........................................................................................................... 13 
Scheme 8 Synthesis of Fluostatin C (36) and E (40). .................................................. 13 
Scheme 9 Synthesis of colombiasin A precursor 44. ................................................... 14 
Scheme 10 One-step synthesis of (R)-(+)-Kavain and (S)-(+)-dihydrokavain. ............ 19 
Scheme 11 Synthesis of cyathin A3 precursor 59. ....................................................... 20 
Scheme 12 Synthesis of 73 and ent-73. ...................................................................... 23 
Scheme 13 Synthesis of diospongins A and B. ........................................................... 23 
Scheme 14 The synthesis of (-)-bissetone and O-protected epimer of bissetone from 
ent-77............................................................................................................................ 25 
Scheme 15 Enantioselective DA cycloaddition of cyclopentadiene 2 and methacrolein 
5 catalysed by the diborate complex 79. ...................................................................... 25 
Scheme 16 Synthesis of (-)-anabasine. ....................................................................... 26 
Scheme 17 Asymmetric synthesis of (+)-coniine. ........................................................ 27 
Scheme 18 Formation of the chiral BLA-87 promoter. ................................................. 27 
Scheme 19 Asymmetric aza-Diels-Alder cycloadditions catalysed by BLA-87. ........... 28 
Scheme 20 HDA reaction leading to a key 1-methylcarbapenem intermediate 98. ... 29 
Scheme 21 Aluminium tethered Diels-Alder reaction between diene 99 and dienophile 
100. ............................................................................................................................... 30 
Scheme 22 Enantioselective DA reactions with N-hydroxy-N-phenylacrylamide 104. 31 
Scheme 23 Asymmetric synthesis of cycloadducts 109 using Zn(II)-(S)-BINOL 
complex. ....................................................................................................................... 32 
Scheme 24 BINOL-zinc complex catalysis of aza-Diels-Alder reaction between imine 
110 and Danishefsky’s diene 71. .................................................................................. 32 
  
xvi 
Scheme 25 LACASA-DA reaction of 112 with 1 using a multinuclear Lewis acid (R)-
BINOL catalyst. ............................................................................................................. 33 
Scheme 26 Catalytic enantioselective DA reaction in ionic liquid via a chiral In(III) 
complex. ....................................................................................................................... 36 
Scheme 27 Preparation of chiral Yb or Sc catalysts. ................................................... 36 
Scheme 28 Synthesis of enantiomers 124 and 125 under the same chiral source and 
in the presence/absence of PAA. ................................................................................. 38 
Scheme 29 Catalytic enantioselective inverse electron-demand DA reaction of vinyl 
ethers and sulphides 126 with 3-CMP 127. .................................................................. 39 
Scheme 30 Synthesis of two enantiomeric sets of homochiral polihydroxylated 
pipecolic acid derivatives. ........................................................................................... 135 
Scheme 31 Conversion of cycloadduct 2.3-4a in neuraminic acid analogue. ............ 141 
Scheme 32 FGT of cycloadduct to D-swainsonine analogue. .................................... 142 
 
 
 
 
 
  
  
xvii 
TABLES INDEX 
 
Table 1 DA cycloaddition of 1,3-dienol derivatives 4 with methacroleine 5 in the 
presence of (R)-BINOL:TiCl2(Oi-Pr)2 complex. ............................................................... 5 
Table 2 DA reaction of naphthoquinones 10 and dienes 4 catalysed by the BINOL-TiCl2 
system. ........................................................................................................................... 6 
Table 3 HDA reaction catalysed by the BINOL:TiCl2(Oi-Pr)2 system. ............................ 7 
Table 4 Enantioselective DA reactions of quinone monoketal 31 with various dienes 
catalysed by (S)-BINOL:TiCl2(Oi-Pr)2, MS 4Å. ............................................................. 11 
Table 5 Enantioselective DA reactions of quinone monoketal 32 with various dienes 
catalysed by (S)-BINOL:TiCl2(OiPr)2, MS 4Å. ............................................................... 12 
Table 6 Asymmetric synthesis of 2,5-disubstituted dihydropyrones 47 catalysed by 
[(R)-BINOL]2-Ti(Oi-Pr)4 complex. .................................................................................. 15 
Table 7 Asymmetric HDA reaction of aldehydes with diene 48. ................................... 16 
Table 8 Asymmetric HDA reaction of pyruvates with diene 48. ................................... 17 
Table 9 HDA reaction of Brassard’s diene 54 with aldehydes catalysed by (R)-BINOL-
Ti(Oi-Pr)2:55. ................................................................................................................. 18 
Table 10 Asymmetric DA cycloaddition between aza-chalcones 68 and 
cyclopentadiene 3. ........................................................................................................ 21 
Table 11 Enantioselective HDA reaction between triene 75 and ethyl glyoxylate 76. .. 24 
Table 12 Aza-Diels-Alder reaction catalysed by the (R)-BINOL/B(OPh)3 system. ....... 26 
Table 13 Selectivity of the Diels-Alder reaction catalysed by the Et2AlCl/diol system. . 28 
Table 14 Hetero Diels-Alder reaction catalysed by the aluminium-BINOL system. ..... 29 
Table 15 Reaction of N-alkoxyacrylamides 106 with cyclopentadiene 2 catalysed by 
(R)-BINOL-Zn system. .................................................................................................. 31 
Table 16 Enantioselective HDA reactions of Danishefsky’s diene 71 and aldehydes by 
catalysis of BINOL-Mg complexes. ............................................................................... 34 
Table 17 Diels-Alder reaction of open-chain 1,3-dienes with 2-methacroleine 5 and 2-
bromoacrolein 116 catalysed by chiral (S)-BINOL-In(III) complex. ............................... 35 
Table 18 Results of DA reaction catalysed by chiral Yb catalyst with PAA additive. ... 37 
Table 19 Effect of additive in DA reaction of imine 129 and cyclopentadiene 2. .......... 40 
Table 20 Asymmetric synthesis of tetrahydroquinolines derivatives 131. .................... 41 
Table 22 Ki Values (µM) for the inhibition of - and -glucosidases for compounds 2.1-
22 and other relative azasugars. ................................................................................ 133 
Table 22 Comparison of the facial selectivities achieved in thermal and catalysed 
cycloadditions of D-erythrose benzylidene-acetal 1,3-butadienes with maleimides. .. 134 
  
xviii 
Table 23 Comparison of the facial selectivities achieved in thermal and catalysed 
cycloadditions of D-erythrose benzylidene-acetal 1,3-butadienes and t-butyl 2H-azirine 
3-carboxylate. ............................................................................................................. 135 
 
 
 
 
  
  
xix 
SYMBOLS AND ABBREVIATIONS LIST 
 
δ chemical shift (in ppm) 
νmax maximum wavelength (in cm-1) 
ABG 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide 
Ac acetyl group 
Ad adamantyl group 
aq. aqueous 
Ar aromatic group 
bd broad duplet 
BINOL 1,1′-bi(2-naphthol) 
BLA Bronsted acid-assisted chiral Lewis Acid 
Bn benzyl group 
Boc t-butyloxycarbonyl group 
bs broad singlet 
Bu butyl group 
t-Bu t-butyl group 
Bz benzyl group 
cat. catalyst 
conc. concentration 
13C NMR Carbon Nuclear Magnetic Resonance 
cod 1,5-cyclooctadiene 
Cy cyclohexyl group 
d doublet 
∆ reflux 
DA Diels-Alder 
DBU 1,8-diazabicyclo[5.4.0]undec-7-ene 
DCM dichloromethane 
dd doublet of doublets 
ddd doublet of doublet of doublets 
dm doublet of multiplets 
DEAD diethyl azodicarboxylate 
DMAP 4-(dimethylamino)pyridine 
DMSO dimethylsulfoxide 
DPP 2,6-diphenylpyridine 
dq doublet of quartets 
  
xx 
dr diasteriomeric ratio 
dt doublet of triplets 
DTBMP 2,6-di-t-butyl-4-methylpyridine 
DTBP 2,6-di-t-butylpyridine 
ee enantiomeric excess 
ent enantiomer 
eq. equivalent 
Et ethyl group 
EtOAc ethyl acetate 
exc. excess 
FGT Functional Group Transformation 
HDA Hetero Diels-Alder reaction 
1H NMR Proton Nuclear Magnetic Resonance 
HMBC Heteronuclear Multiple Bond Correlation 
HMPA Hexamethylphosphoramide 
HMQC Heteronuclear Multiple Quantum Correlation 
HRMS High Resolution Mass Spectrometry 
IR Infrared 
Ki inhibition constant 
J coupling constant (in Hertz) 
LACASA-DA Diels-Alder cycloaddition based on a Lewis Acid-Catalysed reaction 
of a “Self-Assembled” complex 
lit. literature 
m multiplet 
M mol/dm3 
Me methyl group 
MOM methoxymethyl ether group 
Ms methanesulfonyl or mesyl group 
MS molecular sieves 
Naph naphthyl group 
NMO N-methylmorpholine N-oxide 
NOE Nuclear Overhauser Effect 
mp melting point 
PAA 3-phenylacetylacetone 
PE petroleum ether 
Ph phenyl group 
  
xxi 
PLC Preparative Liquid Chromatography 
i-Pr isopropyl group 
PTAD 4-phenyl-1,2,4-triazoline-3,5-dione 
pyr pyridine 
q quartet 
rt room temperature 
s singlet 
sat. saturated 
t triplet 
TBAF tetra-n-butylammonium fluoride 
TBS t-butyldimethylsilyl group 
TFA trifluoracetic acid 
THF tetrahydrofuran 
TLC Thin Layer Chromatography 
TMS trimethylsilyl group 
Tr triphenylmethyl or trityl 
p-TsOH p-toluenesulfonic acid 
VAPOL 2,2′-diphenyl-(4-biphenanthrol) 
 
 
  
 
 
 
 xxiii 
THESIS SUMMARY 
 
 The present dissertation is divided in four chapters and a brief description of 
each chapter is here depicted. 
 
 Chapter 1 is a brief introduction covering the reports of BINOL chiral ligands 
attached to any metals as catalysts in enantioselective Diels-Alder cycloaddition, 
focusing in the synthesis of chiral synthons leading to biologically important 
compounds. 
 
 Chapter 2 comprises a compilation of the articles published or submitted to 
international scientific journals, obtained during this dissertation. Each article is 
presented as a sub-chapter and the formatting presented does not correspond to the 
format of the journal where it was published or submitted. This second chapter is 
organized as follows: 
 2.1. “Advances in the Synthesis of Homochiral (-)-1-Azafagomine and (+)-5-epi-
1-Azafagomine. 1-N-Phenyl Carboxamide Derivatives of both Enantiomers of 1-
Azafagomine: Leads for the Synthesis of Active -Glycosidase Inhibitors”, J. Org. 
Chem. 2011, 76, 9584-9592. 
 2.2. “Diastereoselectivity in Diels–Alder Cycloadditions of Erythrose 
Benzylidene-acetal 1,3-Butadienes with Maleimides”, Synlett 2012, 23, 1765-1768. 
 2.3. “Asymmetric Diels-Alder Cycloadditions of D-Erythrose 1,3-Butadienes to 
Achiral t-Butyl 2H-Azirine 3-Carboxylate” Tetrahedron: Asymmetry 2013, 24, 1063-
1068. 
 2.4. “Enantioselective Diels-Alder Cycloadditions in the Synthesis of Two 
Enantiomeric Sets of Homochiral Polihydroxylated Pipecolic Acid Derivatives.”, 
submitted to Org. Lett. 2013. 
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 Chapter 3 presents a general overview of results presented in Chapter 2. 
 
 Chapter 4 presents the conclusions of the research reported in this dissertation, 
as well as considerations for future work. 
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Introduction
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
Chapter 1 
 
 
3 
1. Enantioselective Diels-Alder cycloadditions in the synthesis of important 
chiral synthons using (R)-/(S)-BINOL ligands 
 The Diels-Alder (DA) cycloaddition is one of the most important synthetic 
reactions to build up six-membered ring compounds. Four contiguous stereogenic 
centres are created in a single step. The stereochemistry control of these reactions is 
defined by 1) the preference of endo vs exo transition state or vice-versa, being the 
endo kinetics generally the favouring approach, and 2) the facial discrimination. If either 
the facial discrimination and the endo/exo diastereomery are excellent, homochiral 
products will be generated.1 
 It has been long known that coordination of metals attached to any of the 
reagents allows lowering the transition states energetics so much that reactions can 
often occur below 0 ºC. If metals used as catalyst are attached to chiral ligands, these 
complexes may be able to promote both catalysis and induce facial discrimination, 
leading to homochiral products.2 
 Since 1990 the enantiomeric atropoisomers of 1,1’-binaphtyl-2,2’-diol (BINOL) 
(Figure 1) have become widely popular as ligands in enantioselective oxidation, 
reduction, and C-C or C-X (X = N, O) bond forming reactions, including DA 
cycloaddition.3 
 
 
Figure 1 BINOL enantiomers. 
 
 In what enantioselective Diels-Alder reaction concerns at a first stage aluminium 
and boron dominates, but recently the focus has been shifted to transition-metal 
catalysts.4 
 This review is based on BINOL chiral ligands attached to any metals whenever 
used in enantioselective DA cycloaddition having in view the synthesis of chiral 
synthons leading to biologically relevant molecules. 
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1.1 Titanium-BINOL catalysts 
 The earlier studies in asymmetric DA reaction using BINOL-Ti complexes were 
reported by Reetz5 and Seebach6 using BINOL-TiCl2 and BINOL-Ti(Oi-Pr)2, 
respectively. Seebach obtained the most promising result so far. It is represented in 
Scheme 1: methyl acrylate 1 was combined with cyclopentadiene 2 in the presence of 
(R)-BINOL-TiCl2(Oi-Pr)2 complex. The cycloadduct 3 was formed in 77 % yield and 50 
% of enantiomeric excesse (ee). 
 
 
Scheme 1 Asymmetric DA reaction of methyl acrylate 1 and cyclopentadiene 2. 
 
 
 Mikami and Nakai7,8 extended these first results on enantioselective DA reaction 
with BINOL, in which the key to the success was the use of the Ti-complex prepared in 
situ from Ti(Oi-Pr)2X2 and (R)-BINOL in the presence of MS 4Å. The presence of MS 
facilitated the alkoxy-ligand exchange reaction, which is essential for the in situ 
preparation of the chiral catalyst. The reaction of 1,3-dienol derivatives 4 to 
methacroleine 5 afforded the endo-cycloadducts 6 in high endo ratio and good ee (71-
86 %) (Table 1).  
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Table 1 DA cycloaddition of 1,3-dienol derivatives 4 with methacroleine 5 in the presence of 
(R)-BINOL:TiCl2(Oi-Pr)2 complex. 
 
Entry R solvent T (ºC), t (h) yield (%) endo/exo ee (%) 
1 4a, CONMe2 CH2Cl2 0 ºC, 58h 82 99.6/0.4 86 
2 4a, CONMe2 toluene 0 ºC, 48h 80 99.4/0.6 85 
3 4b, CH3 CH2Cl2 -30 ºC, 5h 43 87/13 71 
4 4c, COCH3 toluene rt, 18h 81 98/2 80 
 
 
 The results achieved encouraged further application of this methodology to 
naphthoquinone. This resulted to be one of the most efficient entry to the asymmetric 
synthesis of anthracyclinone aglycones (Figure 2).9 
 
 
Figure 2 Structure of a known anthracyclinone aglycone. 
 
 
 The reaction of naphthoquinone 7 with diene 4b catalysed by (R)-BINOL-TiCl2 
provided the chiral adduct 8 with complete endo-selectivity and a good facial 
discrimination. Carbonyl groups in compound 8 were stereoselectively reduced with 
LiAlH4 leading to derivative 9. Derivatization of 9 with (S)-MTPA allowed determination 
of the optical purity of 8 to be 85 % ee (Scheme 2). Adduct 8 is a synthetic intermediate 
in the synthesis of tetracycline antibiotics. 
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Scheme 2 DA cycloaddition of naphthoquinone 7 with diene 4b catalysed by BINOL-Ti 
complex. 
 
 
 Later, Mikami10 reported a full account of an enantioselective DA reaction of 
naphthoquinones 10 and methyl glyoxylate 11 with 1,3-dienol ethers and esters 
catalysed by the chiral BINOL-TiCl2 complex (Mikami’s catalyst) (Table 2). 
 
 
 
 The asymmetric catalytic Diels-Alder reaction of juglone (10a) with butadienyl 
acetate 4d was catalysed by BINOL-TiCl2 complex prepared in situ in the presence of 
MS 4Å. Cycloadduct 12a was obtained with complete endo-selectivity, but with very 
low ee, 9 % (Table 2, entry 1) as determined in (R)-MTPA ester derivative of the more 
stable derivative 13. The low enantioselectivity in this case is in marked contrast with 
the ee (85 %) obtained with naphthoquinone 10b and diene 4b under the same 
reaction conditions. These results suggested that the free hydroxyl group in 10a might 
be binding to titanium, displacing chloride as outlined in Scheme 3 and be responsible 
for the low ee observed. 
Table 2 DA reaction of naphthoquinones 10 and dienes 4 catalysed by the BINOL-TiCl2 system. 
 
Entry MS 4Å R1 R2 yield (%) ee (%) 
1 yes 10a, OH 4d, COMe __ 9 
2 removed 10a, OH 4d, COMe 86 96 
3 yes 10b, H 4b, Me __ 85 
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Scheme 3 Alkoxy-ligand exchange reaction between MS and BINOL-TiCl2 complex. 
 
 
 To prevent this undesired reaction, a MS-free BINOL-titanium complex was 
obtained by MS centrifugation followed by decantation. Removal of isopropanol under 
reduced pressure gave BINOL-Ti complex as a solid. DA reaction of juglone 10a and 
diene 4d in the presence of Ms-free catalyst afforded adduct 12a in high yield (86 %) 
and high optical purity (96 %). This adduct provides an efficient approach to the 
asymmetric synthesis of anthracycline and tetracycline antibiotics. 
 It was found that the use of MS-free catalyst also improved the endo- and 
enantioselectivity in the hetero Diels-Alder (HDA) reactions of glyoxylate 11 with 
methoxydienes 14. The reaction proceeded smoothly to give the endo-adduct 15 with 
high facial selectivity (Table 3). 
 
Table 3 HDA reaction catalysed by the BINOL:TiCl2(Oi-Pr)2 system. 
 
Entry MS 4Å R1 R2 yield (%) 15 (ee) 16 (ee) 
1 yes H H 77 78 (94) 22 (>90) 
2 removed H H 78 88 (96) 12 (>90) 
3 yes H Me 63 97 (90) 3 
4 removed H Me 58 >98 (93) <2 
5 yes Me Me 18 98 (88) 2 
6 removed Me Me 32 >98 (>95) <2 
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 Applying the same reaction conditions, but in the presence of (S)-BINOL-TiCl2 
complex, was obtained ent-15a, a useful intermediate in the synthesis of 
monosaccharides,11 and the lactone portion in mevinolin 17a, compactin 17b, 
coenzyme A redutase inhibitors (Scheme 4).12 
 
 
Scheme 4 Synthesis of monosaccharides and lactone portion of mevinolin 17a and compactin 
17b from precursor ent-15a. 
 
 
 Moreover, the Diels-Alder cycloadducts 15b and 15c could be part of the 
antibiotic indanomycin 18 (X-14547A) (left-wing portion)13,14 and of the macrolide 
antibiotic erythromycins 19 (C1-C5 portion) (Figure 3).15 
 
 
Figure 3 Structure of antibiotics indanomycin 18 and erythromycin 19. 
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 Posner16 studied the stereo-control of DA cycloadditions with 2-pyrone dienes 
with the aim of obtaining useful and versatile bicyclic lactone adducts 20 (Scheme 5). 
Such bicyclic adducts could be converted into various biologically active compounds, 
e.g. calcitriol 21 (1,25-dihydroxyvitamin D3) (Scheme 5) and 21 analogues.17  
 Calcitriol 21 has been known for a long time to be hormonally active in 
regulating calcium and phosphorus homeostasis in humans.18 
 Commercially available methyl 2-pyrone-3-carboxylate 22 reacted with 1-
naphtylmethyl vinyl ether 23 and vinyl silyl ether 24 in the presence of (R)-
BINOL:TiCl2(Oi-Pr)2 mixture, affording the corresponding cycloadducts 20 with good 
yields (59-83 %) and high enantioselectivities (92-93 %). These adducts were 
converted in 5 or 4 steps into calcitriol intermediate (-)-25 depending on the dienophile 
used (23 or 24) (Scheme 5). 
 
 
 
Scheme 5 Synthesis of calcitriol precursor (-)-25. 
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 Later, White19,20 described a high enantioselective cycloaddition of 
benzoquinone (26) to diene 27 in the presence of the Mikami’s catalyst (Scheme 6). 
The cycloadduct was obtained in 65 % yield and 87 % ee. It is a useful chiral synthon 
in the synthesis of the indole alkaloid (-)-ibogamine 28.21,22 
 
 
 
 Cycloadduct 29 was transformed into (-)-ibogamine 28 after eight steps, in 10 % 
overall yield (Scheme 6). 
 (-)-Ibogamine (28) and its congener (-)-ibogaine (30) have attracted much 
attention due to the evident property of reducing heroin and cocaine addiction (Figure 
4).23  
 
 
 
 Corey24 was able to obtain excellent yields and ee of cycloadducts from DA 
reaction of quinones monoketals 31 and 32 with simple carbon open-chain dienes 
catalysed by (S)-BINOL:TiCl2(Oi-Pr)2 system in the presence of MS 4Å (Table 4 and 
Table 5). This method provided for decades a powerful synthon for construction of 
functionalized cis-decalin systems, part of steroid skeletons (Figure 5).25 
Scheme 6 DA cycloaddition of benzoquinone (26) and diene 27 in the synthesis of the 
cycloadduct 29, precursor of (-)-ibogamine. 
 
Figure 4 Structure of indole alkaloids (-)-ibogamine 28 and (-)-ibogaine 30. 
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Figure 5 Examples of steroids with cis-decalin unities. 
 
 
 Enantioselectivities (81-84 % ee) were found to be somewhat lower for 
butadiene, 2,3-dimethylbutadiene and isoprene than for (E)-1,3-pentadiene (98 %). As 
usual reaction with isoprene suffers from another drawback, a poor regioselectivity 
(53:47) (Table 4). 
 
Table 4 Enantioselective DA reactions of quinone monoketal 31 with various dienes catalysed 
by (S)-BINOL:TiCl2(Oi-Pr)2, MS 4Å. 
 
Entry diene yield (%) ee (%) 
1 a 97 98 
2 b 91 81 
3 88 84 
4 91 84, 72c 
a endo/exo ratio >98:2. b Reaction at -20 ºC for 72h. c Mixture of regio-isomers (53:47). 
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 Higher ee were obtained for products of reactions occurring under the same 
conditions with bulkier neopentyl ketals dienophiles 32, instead of ethylene ketals 31 
(Table 5). 
 
Table 5 Enantioselective DA reactions of quinone monoketal 32 with various dienes catalysed 
by (S)-BINOL:TiCl2(OiPr)2, MS 4Å. 
(S)-BINOL:TiCl2(Oi-Pr)2
(5 mol %)
O O
O
Me Me
Me
diene
MS 4Å
CH2Cl2, rt, 16h
O O
O
Me Me
Me
H
H R
32 34  
Entry diene yield (%) ee (%) 
1 a 90 99 
2  90 99 
3 b 95 95 
4 95 90 
5 91 96, 91c 
a endo/exo ratio >99:1. b Reaction at -20 ºC for 72h. c Mixture of regio-isomers (56:44). 
 
 
 Isoprene afforded a mixture of regio-isomers as in previous cases. The cis-
decalin precursors 33 and 34 can be successfully epimerized to the trans-isomer 35 
with sodium methoxide (see Scheme 7 as an example). Aromatization was avoided in 
the epimerization process due to the quinone ketal moiety in the molecule. The 1,4-
quinone would naturally led to aromatization during the process. 
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Scheme 7 Epimerization of cis-decalone monoketal 33a to the corresponding trans-fused 
ketone 35. 
 
 
 Fluostatin C (36) is a member of a larger family of fluostatins, it exhibits 
antibiotic and antitumor activities.26 Enantioselective DA cycloaddition catalysed by 
BINOL-Ti complex was applied to the synthesis of fluostatin C precursor 37.27  
 The cycloaddition step occurs between diene 38 and quinoneketal 39 in the 
presence of (R)-BINOL:TiCl2(Oi-Pr)2 leading to the adduct 37 in 93 % yield and 65 % 
ee. The cycloadduct was submitted to several chemical transformations (11 steps) to 
achieve fluostatin C (36) in 3.3 % overall yield. Fluostatin C afforded fluostatin E (40) in 
90 % yield by treatment with aqueous HCl (Scheme 8). 
 
 
Scheme 8 Synthesis of Fluostatin C (36) and E (40). 
 
 
 The first step of a total synthesis of terpenoid (-)-colombiasin A 41 is the DA 
cycloaddition catalysed by (S)-BINOL:TiCl2(Oi-Pr)2 (Scheme 9). Nicolaou28 combined a 
Danishefsky-type diene 42 with quinone 43 under the mentioned catalysis giving 
cycloadduct 44, which was transformed in situ into 45 with 70 % yield and 94 % ee. 
After 9 steps, colombiasin A 41 was obtained in 4 % overall yield. The cycloaddition 
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between diene 42 and quinone 43 under Mikami’s catalyst having (R)-BINOL as chiral 
inductor led to ent-44 with the same ee. 
 
 
Scheme 9 Synthesis of colombiasin A precursor 44. 
 
 
 Danishefsky-type diene 46 has been used to synthesise useful synthons of 
alkaloids, such as octalindione,29 the naphthoquinone core of streptovaricin U,30 and 5-
(3-furyl)-8-methyloctahydroindolizine31 (Figure 6). 
 
                      
 
Figure 6 Structure of octalindione, streptovaricin U and 5-(3-furyl)-8-methyloctahydroindolizine. 
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 The key products, 2,5-disubstituted dihydropyrones in its chiral form (47), were 
obtained from trans-1-methoxy-2-methyl-3-trimethylsilyloxybuta-1,3-diene (46) and 
aldehydes in the presence of [(R)-BINOL]2:Ti(Oi-Pr)4.32 This catalytic system proved to 
be very effective with a wide range of aldehydes, affording the corresponding products 
47 in moderate to high yields and with high ee values (Table 6). 
 
Table 6 Asymmetric synthesis of 2,5-disubstituted dihydropyrones 47 catalysed by [(R)-
BINOL]2-Ti(Oi-Pr)4 complex. 
 
Entrya aldehyde yield (%) ee (%) 
1 benzaldehyde 86 99 
2 2-chlorobenzaldehyde 99 90 
3 2,4-dichlorobenzaldehyde 70 94 
4 3-nitrobenzaldehyde 85 98 
5 4-methoxybenzaldehyde 84 90 
6 1-naphthaldehyde 40 97 
7 4-fluorobenzaldehyde 73 94 
8 4-cyanobenzaldehyde 95 92 
9 2-pyridinecarboxaldehyde 99 98 
10 2-furaldehyde 99 97 
11 n-hexanal 41 87 
a Reactions were carried out at 0 ºC in THF using 5 mol % [(R)-BINOL]2-Ti(Oi-Pr)4 complex, in the 
presence of MS 4Å, over 48h. 
 
 
 Other related compounds (2,6-disubstituted dihydropyrones) also important 
intermediates in organic synthesis, were achieved firstly by Huang33 and then by 
Yang.34 Yang reported an HDA cycloaddition between diene 48 and different aldehydes 
catalysed by (R)-BINOL:Ti(Oi-Pr)4. A range of aromatic, hetero-aromatic, conjugated 
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and aliphatic aldehydes were used, affording the respective products 49 in moderate to 
high yields (up to 99 %) and excellent enantioselectivities (up to 99 %) (Table 7). 
 
Table 7 Asymmetric HDA reaction of aldehydes with diene 48. 
 
Entrya substrate yield (%) ee (%) 
1 benzaldehyde 70 99 
2 3-methylbenzaldehyde 73 >99 
3 3-chlorobenzaldehyde 83 98 
4 1-naphthaldehyde 78 >99 
5 4-phenylbenzaldehyde 93 98 
6 4-cyanobenzaldehyde 86 94 
7 4-nitrobenzaldehyde 99 >99 
8 4-methoxybenzaldehyde 83 >99  
9 3-pyridinecarboxaldehyde 65 98 
10 (E)-cinnamaldehyde 64 92 
11 propionaldehyde 88 94  
12 n-hexanal 77 91 
a Reactions were carried out in the presence of MS 4Å, toluene and with 20 mol % catalyst loading (R)-
BINOL:Ti(Oi-Pr)4 at 0 ºC for 48h.  
 
 
 A possible mechanism for asymmetric induction in this catalytic system is 
outlined as in Figure 7. When the (R)-BINOL-Ti(Oi-Pr)4 complex is used as the catalyst, 
the steric hindrance of the binaphthyl moiety shields the si face of the aldehyde, while 
the re face is available to accept the attacking diene to give the products as expected.  
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Figure 7 Proposed TS model of the HDA reaction of diene 48 with aldehydes catalysed by (R)-
BINOL-Ti(Oi-Pr)4. 
 
 
 Some pyruvates were also explored as dienophiles under the same reaction 
conditions. The results obtained were not as good. When the reactions of pyruvates 
were carried out in the presence of 10 mol % of [(R)-BINOL]2:Ti(Oi-Pr)4, 2,2,6-
trisubstituted dihydropyrones 50 were obtained in good yields (76-85 %) and high ee 
values (94-99 %) (Table 8).34 
 
Table 8 Asymmetric HDA reaction of pyruvates with diene 48. 
OMe
TBSO
48
O
O
O
R
O
O
O
O
R
50
*
 
Entrya substrate yield (%) ee (%) 
1 ethyl pyruvate 85 99 
2  methyl pyruvate 82 94 
3 isopropyl pyruvate 76 96 
a Reactions were carried out in THF with 10 mol % catalyst loading [(R)-BINOL]2:Ti(Oi-Pr)4 at 0 ºC for 72h. 
 
 
 Combination of propionaldehyde and diene 48 in the presence of 20 mol % of 
(R)-BINOL:Ti(Oi-Pr)4 catalyst gave in one step the (S)-(-)-hepialone 49 compound in 88 
% yield with 94 % ee (Table 7, entry 11). As expected, its enantiomer, (R)-(+)-
hepialone, a male moth sex pheromone isolated from Hepialus hecta L. and Hepialus 
californicus Bdv,35 was obtained in the same yield and ee by replacing (R)-BINOL for 
(S)-BINOL in the reaction conditions.  
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 ,-Unsaturated -lactones are key structural subunits of numerous natural and 
unnatural products with a wide range of biological activities.36 Some of these 
compounds: kavain 51 and dihydrokavain 52 were isolated from kava plant Piper 
methysticum (Piperaceae). Kava root is commonly available in dietary supplements 
due to their anxiolytic and soporific properties. Analgesic, anaesthetic, antifungal, 
antithrombotic, anticonvulsive, and muscle-relaxing properties have also been 
reported.37 
 Feng38 reported an efficient asymmetric HDA reaction leading to ,-
unsaturated -lactone derivatives 53 in moderate-to-good yields (46-79 %) with high 
enantioselectivities (81-88 %) by combining Brassard’s diene 54 and aldehydes with 
(R)-BINOL:Ti(Oi-Pr)4 and 4-picolyl chloride hydrochloride 55 as additive (Table 9). 
 
Table 9 HDA reaction of Brassard’s diene 54 with aldehydes catalysed by (R)-BINOL-Ti(Oi-
Pr)2:55. 
 
Entrya Aldehyde yield (%) ee (%) 
1  74 83 
2  46 82 
3  79 84 
4  72 88 
5 54 83 
6 65 81 
7  79 85 
8b  56 87
c 
a Reactions were carried out in toluene at 28 ºC for 115h in the presence of 15 mol % of (R)-BINOL:Ti(Oi-
Pr)4:55. b Performed at 0 ºC. c The absolute configuration was determined to be R by comparison with 
literature data.39 
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 Kavain 51 and dihydrokavain 52 were obtained in one step by HDA 
cycloaddition of Brassard’s diene 54 with cinnamaldehyde and 3-
phenylpropionaldehyde, respectively (Scheme 10). (R)-(+)-Kavain (51) was obtained in 
56 % yield with 70 % ee, and purified by recrystallization to give homochiral (R)-(+)-
kavain. (S)-(+)-dihydrokavain (52) was obtained in 57 % yield and 84 % ee.38 
 
 
Scheme 10 One-step synthesis of (R)-(+)-Kavain and (S)-(+)-dihydrokavain. 
 
 
 Recently, Ward40 described a total synthesis of (-)-cyathin A3 (56), that includes 
an enantioselective DA cycloaddition as key step. The chiral induction was produced 
by a modified Mikami’s catalyst. Cyathin A3 (56), belon to the diterpenoids’ family, can 
be isolated from various mushrooms and related basidiomycetes (Figure 8). Diverse 
biological activities has been noted, namely that certain cyathanes can stimulate the 
production of nerve growth factor (NGF), important to the survival of neuronal cells.41,42 
 
 
Figure 8 Structure of cyathin A3. 
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 The synthesis of cyathin A3 (56) was achieved by a DA cycloaddition between 
2,5-dimethyl-1,4-benzoquinone 57 and 2,4-bis(trimethylsilyloxy)-1,3-pentadiene 58 
catalysed by Mikami’s catalyst [(R)-BINOL-TiCl2] modified by addition of Mg powder 
and silica gel (SiO2). Mg powder added to remove HCl, and SiO2 may preferentially 
absorb diene polimers as decomposition products or improve catalyst performance by 
immobilizing it in the SiO2 surface.43 The cycloadduct 59 was obtained in 90 % yield 
and 93 % ee in dienophile one gram scale. After 28 steps, cyathin A3 56 was achieved 
in 0.65 % overall yield from cycloadduct 59 (Scheme 11). 
 
Scheme 11 Synthesis of cyathin A3 precursor 59.  
 
 
 Once cyathin A3 56 is easily transformed into allocyathin B3 (60), neoallocyathin 
A4 (61), cyathin B3 (62), cyathin C3 (63), and allocyathin B2 (64), this route also 
constitutes a formal synthesis for these natural products.44,45,46 In the other hand, 
cyathatriol (the 14--alcohol derivative of 56)45 has been proposed47 as a (bio)synthetic 
precursor of the erinacines (e.g., 65 and 66)46, which are xylose-conjugated terpenoids 
possessing a cyathane core (Figure 9). 
 
Figure 9 Selected cyathane diterpenes. 
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 Yu48 showed that BINOL-titanium complex also catalysed asymmetric Diels-
Alder reactions of aza-chalcones 67 with cyclopentadiene 2 in the presence of 
hexamethylphosphoramide (HMPA) (80 mol %). Products 68 were obtained in 
moderate-to-good yields and with up to 87 % ee (Table 10). Other Lewis base additives 
such as quinine, imidazole, DMAP, Et3N and quinoline proved to be less efficient than 
HMPA. Aza-chalcones have been reported to display a wide variety of biological 
activities and are valuable intermediates for Diels–Alder reactions.49 Moreover, the DA 
reaction of aza-chalcones and cyclopentadiene 2 has been used in many studies as a 
benchmark reaction.50 
 
Table 10 Asymmetric DA cycloaddition between aza-chalcones 68 and cyclopentadiene 3. 
 
Entry R yield (%) ee (%) 
1 >99 52 
2 91 87 
3 53 70 
4 76 72 
5 49 79 
 
 
 In 2009, Kumaraswamy and co-workers51 reported an enantioselective route to 
the synthesis of diospongins A 69 and B 70 and their enantiomers using catalytic 
hetero Diels-Alder cycloaddition as the first step.  
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 Diospongins A 69 and B 70 were isolated from the rhizomes of Discorea 
spongiosa. They had shown interesting antiosteoporotic activity,52 and are leads in the 
discovery of potent and novel antiosteoporotic agents (Figure 10). 
 
 
Figure 10 Dispongins A 69 and B 70 and their enantiomers. 
 
 
 Despite their structural similarity, diospongins A and B exhibit remarkable 
differences in their biological profile. Diospongin B (70) displays a potent inhibitory 
activity on bone resorption induced by parathyroid hormone, while diospongin A 69 did 
not show any activity. 
 The enantioselective hetero Diels-Alder reaction between Danishefsky’s diene 
(71) and furfuraldehyde (72) using 10 mol % of (S)-BINOL/Ti(Oi-Pr)4 catalyst gave 
dihydropyranone 73 in 60 % yield and 96 % ee. Recrystallization of the product 
resulted in 99.9 % enantiomeric excess. Dihydropyranone 73 and its enantiomeric form 
ent-73 were obtained depending on the chiral nature of BINOL. After recrystallization 
ent-73 was obtained in >99 % ee (Scheme 12). 
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Scheme 12 Synthesis of 73 and ent-73. 
 
 
 Adduct 73 was converted in diospongin B (70) in 8 steps with 56 % overall yield 
(Scheme 13). Further, diospongin B was transformed into diospongin A (69) in 79 % in 
2 steps. By the same sequence, ent-73 was converted into ent-70 in 62 % yield, and 
ent-70 into ent-69 in 79 % yield. 
 
 
Scheme 13 Synthesis of diospongins A and B. 
 
 
 Kwiatkowski et al 53 recently reported a new approach for the synthesis of 
bissetone 74 and its stereoisomers. Bissetone 74 is one of the metabolites of 1,5-
anhydro-D-fructose, it showed antimicrobial activity, and can be isolated from 
Gorgonian soft coral Briareum polyanthes (Figure 11).54 
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Figure 11 1,5-Anhydro-D-fructose and its metabolite (-)-bissetone 74. 
 
 
 The key reaction in the synthesis of (-)-bissetone (74) is a highly 
enantioselective hetero Diels-Alder cycloaddition between triene 75 and ethyl 
glyoxylate 76 catalysed by a BINOL-Ti complex. Cycloadduct 77 was obtained in high 
yield and 90 % ee. Optimization of the reaction conditions showed that 2 mol % of 
[BINOL]2:Ti complex in toluene gave the highest enantioselectivity (93 %), and good 
yield (80 %) (Table 11). 
 
Table 11 Enantioselective HDA reaction between triene 75 and ethyl glyoxylate 76. 
 
Entry cat. mol % solvent T (ºC) t (h) yield (%) ee (%) 
1 (R)-BINOL:Ti(Oi-Pr)4 (1:1) 5 CH2Cl2 0 4 89 90 
2 (R)-BINOL:Ti(Oi-Pr)4 (2:1) 2 toluene 0 15 80 93 
 
 
 In the synthesis of natural (-)-bissetone 74, a titanium catalyst based on (S)-
BINOL was used to obtain cycloadduct ent-77. This adduct was then transformed in 
five steps into (-)-bissetone 74 in 54 % overall yield, and its O-protected epimer 78 with 
53 % yield for R = Tr and 48 % yield for R = Bz (Scheme 14). 
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Scheme 14 The synthesis of (-)-bissetone and O-protected epimer of bissetone from ent-77. 
 
 
1.2 Boron-BINOL catalysts 
 Chiral boron complexes have been explored as promoters of asymmetric Diels-
Alder reactions. Kaufmann55 reported the synthesis and X-ray of a C3-symmetric 
tetradecacyclic diborate complex 79, which efficiently catalysed the Diels-Alder reaction 
between methacrolein 5 and cyclopentadiene 2 (Scheme 15). The catalyst was 
prepared by mixing (S)-BINOL (3 eq.) and bromoborane-dimethyl sulphide complex (2 
eq.). 
 
 
Scheme 15 Enantioselective DA cycloaddition of cyclopentadiene 2 and methacrolein 5 
catalysed by the diborate complex 79. 
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 Yamamoto56,57 used a chiral boron complex generated in situ by mixing an 
equimolar amount of BINOL and triphenyl borate in CH2Cl2. This catalyst was used in 
the presence of MS 4Å in an aza-Diels-Alder reaction of imines 80 with Danishefsky’s 
diene 71. Cyclodducts 81 were obtained in moderate to good yields (45-89 %), and 
high enantiomeric purity (74-90 % ee) (Table 12). 
 
Table 12 Aza-Diels-Alder reaction catalysed by the (R)-BINOL/B(OPh)3 system. 
 
Entrya R1 yield (%) ee (%) 
1 Ph (a) 75 82 
2 3-pyridyl (b) 71 90 
3 Cyclohexanyl 45 76 
4 3,5-(MeO)2C6H4 89 74 
5 2-naphthyl 83 84 
a Conditions: CH2Cl2, catalyst (1 eq.), and diene (1.2 eq.), -78 ºC, 5h. 
 
 
 Either (R)- and (S)-81 were obtained as products by changing the chirality of the 
BINOL ligand. The methodology was applied to the synthesis of piperidine alkaloids (-)-
anabasine (82), derived from nicotinic acid, and to (+)-coniine (83) (Scheme 16, 
Scheme 17).57 The intermediate dihydropyridone 84 was obtained in 68 % yield and 90 
% ee, and then converted to (-)-anabasine 82 in 3 steps with 49 % total yield from 84 
(Scheme 16). 
 
Scheme 16 Synthesis of (-)-anabasine. 
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 On the other hand, the diastereomer 86 was obtained in its homochiral form in 
41 % yield. Its FGT gave (+)-coniine 83 in 54 % overall yield from 86 (Scheme 17). Of 
course a double asymmetric induction is behind the DA process in this case. Boron 
Lewis acid was used in stoichiometric quantities in all cases. 
 
Scheme 17 Asymmetric synthesis of (+)-coniine. 
 
 
 Yamamoto58 showed the interest of a Bronsted acid-assisted chiral boron Lewis 
acid (BLA) 87, obtained from a 2:3 mixture of BINOL and triphenylborate as a chiral 
inductor catalyst in DA cycloadditions (Scheme 18). 
 
 
Scheme 18 Formation of the chiral BLA-87 promoter. 
 
 
 Diels-Alder cycloaddition of benzylidenebenzylamine 80a to Danishefsky’s 
diene 71 in the presence of BLA afforded 89a in 78 % yield and 86 % ee. The reaction 
of diene 71 with chiral aldimine 90 gave cycloadduct 89b in a 64 % yield, and 99 % ee 
showing a matched double asymmetric induction (Scheme 19).  
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Scheme 19 Asymmetric aza-Diels-Alder cycloadditions catalysed by BLA-87. 
 
 
1.3 Aluminium-BINOL catalysts 
 Wulff worked on the influence of catalysts obtained from diethylaluminium 
chloride and BINOL.59 Exo-selectivities were good to excellent in all cases, but 
enantiomeric excesses were modest (13-41 %). Enantioselectivities could be largely 
improved with a biaryl inductor, (VAPOL, 91) (Table 13). 
 
Table 13 Selectivity of the Diels-Alder reaction catalysed by the Et2AlCl/diol system. 
 
Entry diol cat. (mol %) yield (%) exo/endo ee (%) 
1 (S)-BINOL 10 99 97/3 23 
2 (S)-VAPOL 10 100 98/2 98 
3 (S)-VAPOL 0.5 98 97/3 88 
 
 
 A BINOL-AlMe catalyst, obtained from (S)-BINOL and AlMe3, has been used by 
Jörgensen to promote the hetero Diels-Alder cycloaddition preferentially to ene addition 
in the reaction between 1,3-butadienes 92 and glyoxylate esters (Table 14).60 Simple 
dienes such as isoprene were also combined with glyoxylate esters under BINOL-Ti 
catalysts. In this case an ene reaction is concurrent giving the ene product as the major 
component.8 
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Table 14 Hetero Diels-Alder reaction catalysed by the aluminium-BINOL system. 
 
Entry R1 R2 R3 
93 94 
yield (%) ee (%) yield (%) ee (%) 
1 Me Me Et  73 97 9 88 
2 Me H Et 29 97 14 88 
3 Me H Me 13 70 3 27 
 
 
 Diels-Alder cycloaddition between methyl 2-(benzoylamino)methylene-3-
oxobutanoate 95 and methylketene diethyl acetal (96) in the presence of an equimolar 
amount of (S)-BINOL-AlEt led 98 with a high trans-selectivity (76 %) and ee, after 
crystallization (74 %) (Scheme 20). Cycloadduct 98 was transformed first into 97, an 
intermediate of 1-methylcarbapenem antibiotic and then in the proper antibiotic.61  
 
 
Scheme 20 HDA reaction leading to a key 1-methylcarbapenem intermediate 98. 
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 Recently, Olson reported an interesting result as part of a study directed 
towards the feasibility of DA reaction of “noncompatible” diene 99 with dienophile 100 
by means of a temporary tethering with Al or Zr.62 This combination resulted in the one-
step formation of substituted cyclohexene 1,2-bis-methanols 101 and 102, in 58 % 
yield with excellent regioselectivity and significant endo/exo-selectivity (3:1) (Scheme 
21). 
 
 
Scheme 21 Aluminium tethered Diels-Alder reaction between diene 99 and dienophile 100.  
 
 
 Later, Renaud63 reported the use of hydroxamic acids as dienophiles in 
enantioselective Diels-Alder reactions. The chiral Lewis acid was prepared by mixing 
optically pure BINOL with 3 eq. of trimethylaluminium in the reaction of N-hydroxy-N-
phenylacrylamide 104 with cyclopentadiene 2. The product was obtained in high yield 
(>96 %) and moderate to good enantioselectivity. It was used in particular as a key 
intermediate in the synthesis of peduncularine 103, a major alkaloid isolated from a 
Tasmanian shrub Aristotelia peduncularis (Figure 12).64  
 
 
Figure 12 Structure of alkaloid peduncularine 103.
 
 
 Facile conversion of adducts 105 to the corresponding alcohols or aldehydes 
makes the hydroxamic acid products useful intermediates building blocks in synthesis 
(Scheme 22). 
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Scheme 22 Enantioselective DA reactions with N-hydroxy-N-phenylacrylamide 104. 
 
 
1.4 Zinc-Magnesium-BINOL catalysts 
 Dialkylzinc represents an attractive alternative to trialkylaluminium for 
preparation of mild Lewis acids.65 The Lewis acid obtained from dimethylzinc and 
BINOL, known as Yamamoto’s Zn-BINOL catalyst. It was examined in the Diels-Alder 
reaction between N-alkoxyacrylamides 106 and cyclopentadiene 2.66 Reactions proved 
to be very efficient and enantioselectivities obtained were up to 96 % ee (Table 15). 
 
Table 15 Reaction of N-alkoxyacrylamides 106 with cyclopentadiene 2 catalysed by (R)-BINOL-
Zn system. 
 
 
Entry R1 R2 eq. of catalyst endo:exo ee (endo) (%) 
1 Me OMe 1.1 7:1 89 
2 Ph OMe 1.1 54:1 96 
3 Ph OMe 0.25 41:1 90 
4 Ph OEt 1.1 29:1 86 
5 Ph Oi-Pr 1.1 14:1 76 
 
 
 The simplicity of the Zn-BINOL experimental procedure makes it very attractive 
from a synthetic point of view. Conversion of N-alkoxyamide Diels-Alder cycloadducts 
108 into useful building blocks is facilitated by the well-known synthetic versatility of 
Weinreb amides. 
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 As part of a program aimed to developing new strategies for the preparation of 
readily elaborated chiral synthons for the synthesis of piperidine alkaloids, Whiting 
screened a number of different Lewis acids and chiral ligands to induce facial 
discrimination in aza-Diels-Alder reactions with N-imine functions.67 Zn-BINOL system 
was the only one to provide some asymmetric induction in reaction between imine 108 
and Danishefsky’s diene 71. Products were obtained in low yields and low to moderate 
ee (18-77 %), as outlined in Scheme 23. 
 
 
Scheme 23 Asymmetric synthesis of cycloadducts 109 using Zn(II)-(S)-BINOL complex. 
 
 
In further studies, Whiting68 showed that the use of Zn-BINOL complex catalysed the 
asymmetric aza-Diels-Alder reaction of an ethyl glyoxylate-derived N-aryl imine 110 
with Danishefsky’s diene 71 affording the corresponding cycloadduct 111 with 78 % 
yield and 93 % ee (Scheme 24). 
 
 
Scheme 24 BINOL-zinc complex catalysis of aza-Diels-Alder reaction between imine 110 and 
Danishefsky’s diene 71. 
 
 
 The ready availability of BINOL, the ease of preparation of the catalyst and 
reproducibility of the system makes this process highly attractive for piperidine alkaloid 
and related compound synthesis. 
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 Later, Ward69 reported a new strategy to control Diels-Alder cycloadditions 
based on a Lewis acid bimetallic complex of Mg and Zn, that “self-assemble” reagents 
and catalyse the process (LACASA-DA). In this approach, a simultaneous coordination 
of the diene, dienophile and BINOL in a Lewis acid template turns process a kind of 
“intramolecular” Diels-Alder reaction (see intermediate proposed in Scheme 25) with 
enhanced reactivity, regioselectivity and diastereo / enantioselectivivity. Combination of 
2,4-hexadienol 112 with methyl acrylate 1 under these conditions and using (R)-BINOL 
as chiral inductor afforded cycloadduct 113 in excellent yield (95 %) and high 
enantioselectivity (96 % ee) (Scheme 25). 
 
Scheme 25 LACASA-DA reaction of 112 with 1 using a multinuclear Lewis acid (R)-BINOL 
catalyst. 
 
 
 The synthetic potential of LACASA-DA strategy was demonstrated by Barriaud 
et al in the synthesis of the tricyclic core of Penostatin F 114 (Figure 13), a natural 
product isolated from Penicillium sp. Compound 114 is known to exhibit a significant 
cytoxicity against P388 Leukemia cells.70 
 
 
 
Figure 13 Structure of Penostatin F.
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 Recently, Ding71 developed a magnesium binaphthoxide system (BINOL-
Bu2Mg) capable of efficiently catalyse the hetero Diels-Alder reaction of Danishefsky’s 
diene 71 with aldehydes to afford a variety of 2-substituted 2,3-dihydro-4H-pyran-4-
ones 115 in high yields and with excellent ee values (Table 16). 
 
Table 16 Enantioselective HDA reactions of Danishefsky’s diene 71 and aldehydes by catalysis 
of BINOL-Mg complexes. 
 
Entry R yield (%) ee (%) 
1 C6H5 94 96 
2 C6H5CH2CH2 54 63 
3 (E)-C6H5CHCH 61 91 
4 furan-2-yl 62 82 
5 3-MeC6H4 99 94 
6 4-BrC6H4 87 88 
7 2-MeC6H4 77 92 
 
 
 Approaches to the asymmetric synthesis of this type of six-membered oxo 
heterocycle have extensive applications in natural and unnatural product synthesis,2-3, 
36b, 65, 72 e.g. mevilonin 17a and compactin 17b.2-3, 34b, 57, 64 
 
1.5 Indium-BINOL catalysts 
 Indium(III) complexes have gained a lot of attention in recent years due to their 
capability as Lewis acid catalysts for various organic synthetic transformations and for 
its aqueous media tolerance.73,74  
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 Loh described a new type of catalyst made by addition of (S)-BINOL-In(III) 
complex (pre-catalyst) to allyltributyl stannane (activator). The complex generated is a 
potent Lewis acid.73 A variety of cyclic and open-chain dienes were combined to 2-
methacrolein 5 and 2-bromocrolein 116 resulting in products 120-122 obtained in good 
yields and high ee (Table 17). 
 
Table 17 Diels-Alder reaction of open-chain 1,3-dienes with 2-methacroleine 5 and 2-
bromoacrolein 116 catalysed by chiral (S)-BINOL-In(III) complex. 
 
Entry Reactants T (ºC), t (h) Product  R1 yield (%) 
ee 
(%) 
1 117+5 rt, 20 
 
120a R1 = Me 
120b R1 = Br 
Me 63 98 
2 117+116 -20, 20 Br 74 98 
3 117+116 rt, 20 + H2O Br 70 80 
4 118+5 -20, 20 
 
121a R1 = Me 
121b R1 = Br 
Me 71 98 
5 118+116 -20, 20 Br 72 98 
6 118+116 rt, 20 + H2O Br 72 66 
7 119+5 -20, 20 
 
122a R1 = Me 
122b R1 = Br 
Me 75 97 
8 119+116 -20, 20 Br 77 94 
9 119+116 -20, 20 + H2O Br 61 94 
 
 
 In further publications, Loh reported the usefulness of ionic liquids as “green” 
alternative to conventional solvent media in these reactions.75 2-Methacroleine 5/ 2-
bromocrolein 116 was reacted with cyclopentadiene, isoprene and diene 117 in the 
presence of BINOL-In(III) complex and allyltributyl stannane in [hmim][PF6-] ionic liquid. 
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Reaction proceeded with yields and enantioselectivities comparable to those obtained 
in CH2Cl2. In an attempt to apply this method to the synthesis of steroids, diene 119 
was reacted with 116 (Scheme 26). Cycloadduct 122b was obtained with 89 % yield 
and 92 % of enantiomeric excess. 
 
 
Scheme 26 Catalytic enantioselective DA reaction in ionic liquid via a chiral In(III) complex. 
 
 
 The chiral In(III) complex can be reused for seven successive cycles with 
comparable enantioselectivities and yields.  
 
 
1.6 Lanthanide/Transition metals-BINOL catalysts (Sc, Yb) 
 Kobayashi, as part of his studies on lanthanide triflates as Lewis acids, reported 
a series of papers describing the enantioselectivity induced by BINOL-ytterbium76 and 
BINOL-scandium triflates77 in reactions of cyclopentadiene 2 with various acyl-1,3-
oxazolidin-2-ones (123). Catalysts were prepared by mixing the metal triflate with 
BINOL in the presence of MS 4Å, followed by addition of a tertiary amine (Scheme 27). 
 
 
Scheme 27 Preparation of chiral Yb or Sc catalysts. 
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 The asymmetric induction observed in these reactions can be rationalized by 
assuming an octahedral metal-dienophile complex (Figure 14). The axial chirality of 
(R)-BINOL is transferred to the amine. The re face of acyl-1,3-oxazolidin-2-one is 
effectively shielded by the amine part, and the diene has to approach to dienophile 
from the si face. Cycloadduct was afforded in high enantioselectivity.  
 
 
Figure 14 Assumed transition state.
 
 
 Kobayashi and other authors showed that both cycloadduct’s enantiomers can 
be obtained with the same chiral BINOL, by adding an achiral ligand 3-
phenylacetylacetone (PAA) as an additive to the ytterbium complex (Table 18, Scheme 
28).78  
 
Table 18 Results of DA reaction catalysed by chiral Yb catalyst with PAA additive. 
 
Entry additive R yield (%) endo:exo 124:125 ee (%) 
1 none Me 77 89:11 97.5:2.5 95 
2 PAA Me 83 93:7 9.5:90.5 81 
3 none n-Pr 81 80:20 91.5:8.5 83 
4 PAA n-Pr 81 91:9 10:90 80 
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 This result can be explained by the coordination’s nature. Two binding sites are 
postulated for the ligands to ytterbium catalysts. Under equilibrium conditions, and in 
the absence of PAA, acyl-1,3-oxazolidin-2-ones 123 coordinates to site A, stabilizing 
the original catalyst system. Thus, coordination forces cyclopentadiene to attack at the 
si face to afford cycloadduct 124. However, when PAA was added, its coordination 
occur at site A forcing the dienophile to approach site B of the catalyst. This leaves the 
re face opened leading to cycloadduct 125 (Scheme 28). 
 
 
Scheme 28 Synthesis of enantiomers 124 and 125 under the same chiral source and in the 
presence/absence of PAA. 
 
 
 Other lanthanides (Lu, Tm, Er, Ho, Y and Gd) were used to prepare catalysts 
with BINOL, but the ee of the products obtained strongly depends on the ionic radii of 
lanthanide. The yields and selectivity diminished rapidly with ionic radii enlargement.78a 
 Cycloadduct 124 (R = Me) is a valuable synthetic precursor of alkaloid 251F 
(Figure 15), a natural product detected in the skin’s extract of the dendrobatid frog 
species Minyobates bombetes.79 
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Figure 15 Structure of dendrobatid alkaloid 251F.
 
 
 Marko80, as part of a program aimed a rapid and efficient synthesis of complex 
natural products, used the Kobayashi catalyst in a Diels-Alder reaction between vinyl 
ethers or vinyl sulphides 126 and 3-carbomethoxy-2-pyrone (3-CMP), 127. Under 
optimized conditions, high yields (90-91 %) and excellent enantioselectivities (>90 % 
ee) were obtained in some cases (Scheme 29).  
 
 
 
 Byciclic lactones 128 are key intermediates of important subunits present in 
biologically active natural products, such as gibberellins (Figure 16). Gibberellins are a 
group of highly functionalised diterpenoids, which play an important role in plant growth 
and development.81 
 
 
 
Scheme 29 Catalytic enantioselective inverse electron-demand DA reaction of vinyl ethers and 
sulphides 126 with 3-CMP 127. 
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Figure 16 Structure of some relevant gibberellins. 
 
 
 Kobayashi82 reported the first example of catalytic asymmetric aza-Diels-Alder 
reaction using a chiral lanthanide Lewis acid. N-Benzylideneaniline was reacted with 
cyclopentadiene 2 in the presence of 20 mol % of chiral ytterbium Lewis acid prepared 
from Yb(OTf)3, (R)-BINOL, and 1,3,5-trimethylpiperidine (TMP). The reaction 
proceeded smoothly to afford the desired tetrahydroquinoline derivative in 53 % yield, 
however no chiral induction was observed. Believing that a bidentate coordination of 
the substrate might be necessary for chiral induction, the aromatic imine 129 was used 
as diene. The product was obtained with high yield, but low enantiomeric excess (6 %). 
The selectivity was greatly improved by using DBU instead of TMP as additive. Two 
DBU unities should interact with BINOL hydrogens, and the phenolic hydrogen of the 
diene would interact best to form N…H-O hydrogen bond with an additive, such as N-
methylimidazole (NMI), DTBP, 2,6-dimethylpyridine (DMP), or 2,6-di-t-butyl-4-
methylpyridine (DTBMP) (Table 19). If DBU interacts with the phenolic hydrogen a 
decrease of selectivity is observed.  
 
Table 19 Effect of additive in DA reaction of imine 129 and cyclopentadiene 2. 
 
Entry Additive T (ºC) yield (%) cis:trans ee (%) (cis) 
1 ____ -15 to 0 48 99:1 68 
2 DTBP 0 67 99:1 61 
3 DMP 0 14 98:2 56 
4 DTBMP -15 82 >99:1 70 
5 DTBP -15 92 >99:1 71 
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 Other dienes and dienophiles were tested under similar conditions (Table 20). 
The corresponding tetrahydroquinolines 131 were obtained in 58-90 % yield, with a 
cis:trans selectivity greater than 90:10, and ee ranging from 68-91 % for the major (cis) 
isomer.  
 
a Conditions: 10 mol % of ytterbium catalyst at -45 ºC. 
 
 
 The proposed transition state that accounts for the experimental results is 
depicted in Figure 17. DBU establishes hydrogen bonds with the coordinated (R)-
BINOL transferring axial chirality of the alcohol to the aza-diene region favouring the 
chiral induction. According to the transition state in Figure 17, the imine is fixed to 
Yb(III) in a bidentate coordination, and DTBP additive interacts with the phenolic 
hydrogen creating a rigid structure. The top face of the imine diene is shielded by DBU, 
Table 20 Asymmetric synthesis of tetrahydroquinolines derivatives 131. 
 
Entry R alkene additive yield (%) cis:trans ee (%) (cis) 
1a Ph  DTBP 52 94:6 77 
2 -Naph  DTBP 69 >99:1 86 
3 -Naph  DPP 65 99:1 91 
4 -Naph  DTBMP 74 >99:1 91 
5 -Naph  DTBMP 80 66:34 70 
6 -Naph 
 
DTBMP 90 91:9 78 
7 -Naph 
 
DPP 67 93:7 86 
8 -Naph 
 
DTBMP 69 >99:1 68 
9 c-C6H11 
 
DTBMP 58 >99:1 73 
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and so the dienophile must approach the diene from the bottom face. This leads to 
good levels of facial selectivity (see Table 19 and Table 20). 
 
 
Figure 17 Transition state proposed for reaction of imine 129 and different dienophiles.a 
a Triflate anions are omitted for clarification. 
 
 
2. Conclusions 
 Advances in enantioselective DA cycloaddition with titanium, boron, aluminium, 
zinc, magnesium, indium and lanthanides Lewis acids attached to BINOL is reviewed 
from 1990 to the present. The focus of this work is made on the synthesis of chiral 
synthons used to build up biologically active compounds. Generally cycloadducts were 
obtained in high levels of facial selectivities. Some titanium, boron and aluminium 
systems require stoichiometric amounts of the catalyst, but in most cases only catalytic 
amounts are involved.  
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1. Abstract 
 
 
 A new expeditious preparation of homochiral (-)-1-azafagomine and (+)-5-epi-1-
azafagomine has been devised. Stoodley's diastereoselective cycloaddition of dienes 
bearing a 2,3,4,6-tetraacetyl glucosyl chiral auxiliary to 4-phenyl-1,2,4-triazole-3,5-
dione was merged with Bols's protocol for functionalizing alkenes into molecules 
bearing a glucosyl framework. Homochiral (+)-5-epi-1-azafagomine was synthetized for 
the first time. Partial reductive cleavage of the phenyltriazolidinone moiety afforded new 
homochiral 1-N-phenyl carboxamide derivatives of 1-azafagomine. Both enantiomers of 
these derivatives were synthetized and tested, displaying a very good enzymatic 
inhibition toward baker's yeast -glucosidase. The molecular recognition mechanism of 
the 1-N-phenyl carboxamide derivative of 1-azafagomine by -glucosidase from 
baker's yeast was studied by molecular modelling. The efficient packing of the aromatic 
ring of the 1-N-phenyl carboxamide moiety into a hydrophobic subsite (pocket) in the 
enzyme's active site seems to be responsible for the improved binding affinity in 
relation to underivatized (-)-1-azafagomine and (+)-1-azafagomine. 
 
2. Introduction 
 The synthesis of iminosugars is receiving increasing interest because many of 
these structures are biological tools and potential therapeutics. The first iminosugar 
medicine registered was miglitol (Glyset, PHARMACIA, and UPJOHN).1 The biological 
properties of iminosugars arise from their interference with glycosidases, the natural 
carbohydrate degrading enzymes, and with carbohydrate-recognizing receptors spread 
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in all living organisms. 1-Deoxynojirimycine (1) is a natural iminosugar resembling the 
structure of glucose. The biological activity of this compound seems to be dependent 
on its conjugated ammonium form mimicking the transition state for glycoside 
cleavage.2 Bols and co-workers have demonstrated that (-)-1-azafagomine (2) is a 
potent competitive inhibitor of almond -glucosidase (Ki = 0.32 μM), yeast -
glucosidase (Ki = 6.9 μM), and isomaltase (Ki = 0.27 μM).3 On the other hand, racemic 
(±)-5-epi-1-azafagomine (3) was found to be a much weaker glycosidase inhibitor of 
almond -glucosidase (Ki = 137 μM) and Escherichia coli -galactosidase (Ki = 149 
μM) (Figure 1).4 5-epi-1-Azafagomine (3), as far as we could find, was previously 
unknown in any of the enantiomeric pure forms.  
 
 
Figure 1 Structure of some known iminosugars. 
 
 
 The synthesis of homochiral (-)-1-azafagomine (2) was accomplished by Bols 
and co-workers through a synthetic sequence based on the Diels-Alder cycloaddition to 
4-phenyl-1,2,4-triazole-3,5-dione (PTAD) 4 to achiral dienes: 2,4-pentadienoic acid, 
methyl 2,4-pentadienoate, and 2,4-pentadienol (5).4 The racemic cycloadduct 6 
obtained from 2,4-pentadienol and PTAD was resolved by lipase-mediated 
transesterification. The olefin portion of each enantiomer's precursor of 2 was oxidized 
to oxirane and further opened under highly acidic conditions to yield the glucosyl 
framework of 1-azafagomine, compound 7. After hydrazinolysis, both enantiomers of 1-
azafagomine were obtained in 9 % total yield5 (Scheme 1). Osmilation of the double 
bond on the racemic cycloadduct 6 led to racemic diol 8, which after hydrazinolysis 
gave 5-epi-1-azafagomine (3). Bols3 also achieved the synthesis of (-)-1-azafagomine 
(2) from relatively expensive L-xylose in six steps. L-2,3,5-Tribenzyl xylofuranose was 
isolated as an intermediate after three steps with no explicit yield. 1-Azafagomine was 
then isolated in 37 % overall yield from this intermediate.6,7  
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Scheme 1 
 
 
 Alternatives to the enzymatic resolution of racemic adducts of type 6 are 
desirable for the production of chiral synthons for further elaboration into homochiral 
compounds. Stoodley, in the 1990’s, combined 2,4-pentadienoates, bearing a 
tetraacetyl glucosyl chiral auxiliary in the position 1, compound 9a, with PTAD to obtain 
cycloadduct 10 in 70 % yield and in a high degree of diastereoselectivity (Scheme 2).8,9 
The chemistry of cycloadduct 10 had been pushed forward for the synthesis of 
dehydropiperazic acid, a non proteinogenic amino acid constituent of antrimycins-linear 
heptapeptides with antitubercular activity.10 Lately, dienes bearing oxazolidinone chiral 
auxiliary were combined with PTAD to generate (S)-piperazinic acid.11 To the best of 
our knowledge, nobody has merged the Stoodley cycloaddition entry into chiral alkenes 
of type 11 with Bols' olefin functionalization methodology for synthetizing enantiopure 
iminosugars. 
 
3. Results and discussion 
3.1. New Synthetic Sequence for Preparing Homochiral (-)-1-Azafagomine 
and (+)-5-epi-1-Azafagomine 
 In this paper we report a new synthetic route for obtaining homochiral (-)-1-
azafagomine (-)-2 and (+)-5-epi-1-azafagomine (+)-3 from chiral alkene (-)-11 (Scheme 
2).  
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Scheme 2 
Reagents: i) Et3SiH, TFA, DCM, 5h, rt, 61 %; ii) oxone®, CF3COCH3, NaHCO3, CH3CN/H2O (3.5:2), 24h, 
65 % iii) H2O (exc.), H2SO4 (cat.), reflux, 8h, 52 %; iv) NaBH4 (3 eq.), EtOH, 3d, rt, 59 %; v) NH2NH2.H2O, 
100 ºC, 18h, 68 % (-)-2; 64 % (+)-3; vi) OsO4, NMO, Acetone:H2O (2:1), 5d, rt, 79 %; vii) NaBH4 (3 eq.), 
EtOH, 3d, rt, 52 %. 
 
 
 Cycloadduct 10 was submitted to reductive cleavage with triethylsilane, 
according to Stoodley's protocol, to generate known compound (-)-11.9 Treatment of 11 
with oxone/trifluoroacetone in the presence of NaHCO3 at room temperature for 1 day 
generated a 3:1 mixture of oxiranes as reported previously by Bols for his racemic 
compounds.4 Selective crystallization afforded the major isomer 12 in 65 % yield. 
Opening of oxirane 12 was achieved with total regio- and stereoselectivity by refluxing 
in aqueous H2SO4 giving 13. Osmilation of compound 11 produced cis-diol 14 with total 
stereoselectivity. Selective reduction of trans-diol 13 and cis-diol 14 with NaBH4 gave, 
respectively, triols 15 and 16. These compounds were further treated with hydrazine 
under reflux to produce the target compounds: (-)-1-azafagomine (2) in 14 % overall 
yield and (+)-5-epi-1-azafagomine (3) in 26 % overall yield from alkene (-)-11 (Scheme 
2). Whereas (-)-1-azafagomine 2 is a known compound, (+)-5-epi-1-azafagomine 3 
was obtained displays NMR spectra compatible with the data published for the racemic 
compound 3. The specific optical rotation obtained for (+)-5-epi-1-azafagomine is [α]D = 
+65º (c 0.70, H2O). The specific optical rotation value measured for (-)-1-azafagomine, 
[α]D = -20º (c 0.85, H2O), differs from the one reported in the literature, [α]D = -9.8º (c 
0.85, H2O).3 
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3.2. New Synthetic Sequence for Preparing Homochiral 1-N-Phenyl 
Carboxamide Derivatives of 1-Azafagomine (+)-22 and (−)-22 
 Stoodley was able to prepare the precursors of (-)-22 and (+)-22 from (E,E)-
diene 9b and (E,Z)-diene 17, respectively, by the method described in Scheme 3.9  
 
 
Scheme 3 Stoodley´s synthetic sequence for precursors related to compounds (-)-2, (-)-22 and 
(+)-22. 
 
 
 (E,E)-Diene 9b was isolated in 70 % yield and (E,Z)-diene 17 in 14 % yield. 
Applying Still's olefination, the yield of the (E,Z)-diene could be improved to 36 %9 
(Scheme 3). Having in mind the shortcomings in the synthesis of compound 17, 
epimerization of compound 10 obtained by Stoodley's method was tried in various 
conditions: (i) triethylamine in MeOH, (ii) NaN3 in MeOH, and (iii) triethylamine/p-
chlorothiophenol in MeOH (Scheme 4). When triethylamine was the sole reagent, 
isolation of compound 18 was difficult because of the competing elimination of glucosyl 
moiety giving the 1,3-diene compound. The same applied for the attempt with NaN3. 
The mixture of triethylamine/p-chlorothiophenol afforded after 40 min of reaction 88 % 
yield of compound 18. This represents an important achievement concerning the 
synthesis of compound 18. Extending the reaction time, a Michael addition of p-
chlorothiophenol occurs, leading to compound (±)-19 (Scheme 4).  
 
Scheme 4 Epimerization of compound 10 into compound 18. 
Reagents: NEt3, p-chlorothiophenol, MeOH, 0ºC -> rt. 
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 Knowledge of the bridged structure of compound 20 allowed us to propose a 
plausible mechanism for its formation and the formation of compound 21 (Scheme 5). 
 
 
Scheme 5 
Reagents: i) LiAlH4 (7 eq.)a), THF, 4h, 0 ºC -> rt, 86 %; ii) LiAlH4 (15 eq.)b), THF, 4h, 0 ºC -> rt, 48 %. 
a) from a long-time opened bottle 
b) from a recently opened bottle 
 
 
 The Schiff salt initially formed by reduction of one of the carbonyl groups is 
trapped by internal nucleophilic attack of the alcohol function. A large excess of hydride 
was necessary to cleave intermediate 20 to final product 21. Compounds 20 and 21 
display a major difference in their 13C NMR spectra: a peak at δC = 86.3 ppm, assigned 
to the methylene attached to the oxygen and nitrogen atoms in compound 20, is not 
apparent in the 13C NMR spectrum of compound 21. 
 
ii) In the Synthesis of Compounds (-)-22 and (+)-22 
 Attempted epoxidation of compound 21 was unsuccessful, leading to a complex 
mixture. As an alternative, compound (-)-13 was subjected to treatment with LiAlH4 in 
THF to give compound (-)-22. The synthesis of compound (+)-22 was obtained from 18 
(Scheme 4) by reductive cleavage of the glucosyl moiety to give (+)-11 followed by the 
functional group transformation described in Scheme 6. 
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Scheme 6
 
 
 The enantiopure compounds (-)-1-N-phenyl carboxamide 1-azafagomine (-)-22 
and (+)-1-N-phenyl carboxamide 1-azafagomine (+)-22 were obtained following the 
same sequence of reactions in 29 and 10 % overall yield starting from compounds 10 
and 18, respectively.  
 
3.4. 1-N-Phenyl Carboxamide Derivatives of 1-Azafagomine: New Leads 
for the Synthesis of Potent α-Glycosidase Inhibitors 
 A structure-activity relationship study of a series 2-N-alkylated 1-azafagomines 
as glycosidase inhibitors revealed that these compounds are better -glycosidase 
inhibitors than -glycosidase inhibitors. Moreover, the inhibition constant (Ki) was found 
to be dependent on the chain length. The best results have been obtained with the N-
propylphenyl derivative 23 (Ki = 0.032 μM) and the N-hexyl derivative 24 (Ki = 0.055 
μM)12 (Table 1). 
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Table 1 Ki Values (μM) for the inhibition of - and -glucosidases by compounds 22 and other 
azasugars at different pH values. 
Compound 
-glucosidase 
(bakers’ yeast) 
-glucosidase 
(almonds) 
/-
selectivity 
 
 
(-)-23 
 
6.90[a] 
 
0.32[a] 
 
22 
 
 
2312 
 
158[a] 
 
0.032[a] 
 
4938 
 
 
2412 
 
278[a] 
 
0.55[a] 
 
5054 
 
(-)-22 
3.36[b] 
____[c,d] 
14.7[b] 
67.4[c] 
0.23 
 
(+)-22 
10.6[b] 
____[c,d] 
25.2[b] 
90.0[c] 
0.42 
a pH 6.8. b pH 7.0. c pH 5.0. d Enzyme inactive. 
 
 
 The N-propylphenyl derivative 23 is around an order of magnitude more 
effective as a -glucosidase inhibitor than (-)-1-azafagomine 2. On the other hand, 
derivative 23 is a much weaker inhibitor of -glucosidase than its parent compound (2), 
making compound 23 a potent inhibitor selective for -glucosidase.12  
 The most striking results of the inhibition studies with the 1-N-phenyl 
carboxamide derivatives of 1-azafagomines 22 are Ki values toward -glucosidase 
substantially lower than the N-propylphenyl derivative 23. Compound (-)-22, displaying 
the same stereochemistry as (-)-1-azafagomine 2, is around two times more active, 
whereas its isomer (+)-22 is slightly less active. Both enantiomers of compound 22 
display lower activity toward -glucosidase than their parent compound 2 and the N-
propylphenyl derivative. A moderate / selectivity was observed for compounds 22. 
The low Ki values obtained for compounds 22 toward -glucosidase suggests an 
efficient recognition mechanism between both enantiomers and the enzyme. The 
levorotatory isomer was slightly more active than the dextrorotatory isomer (Table 1). 
This observation is in contrast with the results reported by Bols, who demonstrated that 
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(-)-1-azafagomine is the active enantiomer, whereas (+)-1-azafagomine is virtually 
inactive toward the same -glucosidase that was used in this study.3  
 The yeast -glucosidase enantioselective discrimination toward (+)-22 and (-)-
22 was studied using molecular docking methodologies. This enzyme, as well as the 
Saccharomyces cerevisiae enzyme used for the homology modelling,13 belongs to the 
glycoside hydrolase family 13 (GH 13). This family of retaining glucosidases is 
characterized by strong recognition of the glucoside moiety of synthetic p-nitrophenyl 
glucosides and heterogeneous substrates such as sucrose, while being inactive toward 
hydration of D-glucal and the hydrolysis of p-nitrophenyl -2-deoxyglucosides.14,15 The 
active site structure in Figure 4 illustrates that this enzyme retains the nucleophile 
aspartate 214 and the catalytic residues glutamate 276 and aspartate 349. Our 
theoretical binding affinity estimate for (+)-22 and (-)-22 against yeast -glucosidase 
are of -7.8 and -7.5 kcal/mol, respectively. The binding affinity free energy difference 
between the two enantiomers is within the docking standard error (∼2 kcal/mol), and 
consequently, it suggests low enantiomeric discrimination of (+)-22 and (-)-22. 
However, our experimental Ki data (Table 1) indicates a preferential binding of (-)-22 
when compared to (+)-22. This discrepancy can be explained by the lack of mobility of 
enzyme to reorganize during the docking experiments and, consequently, to properly 
recognize the most potent enantiomeric compound, (-)-22. Despite this, the observation 
of the binding pose of both enantiomers of 22 provides a structural explanation of their 
binding mechanism (Figure 4) and a rational approach for their future improvement. 
These complexes correspond to lowest binding energy pose. They belong to the most 
populated cluster of docking solutions, 7 and 8 docking poses out of 20, respectively, 
for each enantiomer.  
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4. Conclusions 
 In this paper we report the preparation of homochiral 1-azafagomine (-)-2 and 
(+)-5-epi-1-azafagomine (+)-3. The synthetic route devised merges Stoodley 
diastereoselective Diels-Alder cycloaddition methodology with Bols protocol for 
functionalizing alkenes into molecules bearing sugar-like frameworks. Novel 1-N-
phenyl carboxamide derivatives of 1-azafagomine 22 were obtained in enantiomeric 
pure forms. The epimerization of cycloadduct 10 was revealed to be the key step in the 
synthesis of the dextrorotatory compound 22. This methodology represents an 
advantageous alternative to other more conventional approaches for obtaining 
enantiopure (+)-2 (not isolated in this work) and its derivatives (e.g., N-phenyl 
carboxamides). Compounds 22 were tested as inhibitors against - and -
glucosidases. Both enantiomeric forms of 22 are potent inhibitors of -glucosidase, in 
contrast to the current wisdom that only (-)-2 enantiomer of 1-azafagomine is active 
toward - and -glucosidase. The low Ki value determined toward -glucosidase 
inhibition is particularly relevant in comparison with its analogue N-propylphenyl 
azafagomine, the compound in Table 1 with a closer side chain length. The molecular 
recognition mechanism between the enantiomeric compounds 22 and the -
glucosidase studied by molecular modeling has shown that the aromatic group is 
accommodated in a hydrophobic pocket of the enzyme binding site with polar 
characteristics at its end. This evidence has provided further clues for improving the 
binding affinity and, possibly, the / selectivity by increasing the length of the N-
carboxamide moiety and the introduction of donor/acceptor hydrogen bond groups on 
the aromatic ring.  
 The results of this study suggest that 1-N-phenyl carboxamide derivatives of 1-
azafagomine are potential new leads for the synthesis of potent -glycosidase 
inhibitors. 
 
5. Experimental section 
5.1. General Methods 
 Solvents were distilled under anhydrous conditions. The (S)-ethyl 2-phenyl-
2,4,9-triazabicyclo[4.3.0]non-6-ene-1,3-dione-5-carboxylate (-)-11 was obtained 
according to Stoodley's protocol for the (S)-methyl carboxylate derivative; 2,3,4,6-tetra-
O-acetyl-α-D-glucopyranosyl bromide (ABG) was prepared according to the literature,16 
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and potassium 3-hydroxypropenal17 was combined to ABG18 followed by addition of 
tributylphosphorane.9 The diene obtained was subjected to 4-phenyl-1,2,4-triazole-3,5-
dione (PTAD) to obtain the adduct 10. The glucose moiety was removed by reduction 
with triethylsilane.10 Compound 7 (R = CH2OH) was obtained according to the 
literature.4 Functionalization of the double bond was obtained by osmilation with OsO4 
in acetone/water or with oxone, trifluoromethylacetone, in the presence of NaHCO3 and 
aqueous acetonitrile. Reduction of the oxazolidinone was done either with freshly 
opened LiAlH4 1 M in THF or with long-term opened bottles (over a month) of LiAlH4 1 
M in THF. All reagents were purchased and used without further purification. 
Glassware was dried prior to use. Compounds were purified by dry flash 
chromatography using silica 60, <0,063 mm and water pump vacuum or by flash 
chromatography using silica 60Å 230−400 mesh as stationary phases. TLC plates 
(silica gel 60 F254) were visualized either at a UV lamp or in I2. 
 
5.2. Synthesis of ethyl 5-(2′,3′,4′,6′-tetra-O-acetyl-β-D-glucopyranosyloxy)-
2,4-pentadienoate 9 
 To a solution of ethyl tributyl phosphorane9 (3.37 g; 11.70 mmol) in DCM (15 
mL) was added 3-(2′,3′,4′,6′-tetra-O-acetyl--D-glucopyranosyloxy)-1-propenal17 (1.32 
g; 3.42 mmol); the orange solution formed was stirred at rt for 24 h. The solvent was 
evaporated, giving an oil subjected to dry-flash chromatography (petroleum 
ether/diethyl ether; gradient of polarity) (9; 1.17 g; 63 %). 
[α]D20 +27.0° (c 1, CH2Cl2). max (nujol) 2955, 2934, 1736, 1698, 1635 cm−1. 1H NMR 
(δH, 300 MHz, CDCl3) 1.27 (3H, t, J 7.2 Hz, CH3), 2.01, 2.03, 2.04, 2.08 (12H, 4 × s, 4 × 
CH3CO2), 3.81 (1H, ddd, J 9.0, 6.0, 3.0 Hz, H-5′), 4.13 (1H, dd, J 9.0, 3.0 Hz, H-6′), 
4.18 (2H, q, J 6.0 Hz, CH2), 4.26 (1H, dd, J 12.0, 3.0 Hz, H-6′), 4.87 (1H, d, J 9.0 Hz, 
H-1′), 5.08−5.29 (3H, m, H-2′ + H-3′ + H-4′), 5.78 (1H, d, J 15.0 Hz, H-2), 5.90 (1H, t, J 
12.0 Hz, H-4), 6.81 (1H, d, J 12.0 Hz, H-5), 7.20 (1H, dd, J 15.0, 12.0 Hz, H-3) ppm. 
13C NMR (δC, 75.5 MHz, CDCl3) 14.2 (CH3), 20.5, 20.5, 20.7 (CH3CO2), 60.1 (CH2), 
61.6 (C-6′), 67.8, 70.6, 72.3 (C-2′, C-3′, C-4′), 72.4 (C-5′), 99.7 (C-1′), 110.1 (C-4), 
118.7 (C-2), 140.9 (C-3), 152.6 (C-5), 167.0 (C=O ester), 169.1, 169.2, 170.1, 170.5 
(CH3CO2) ppm. 
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5.3. Synthesis of (5S,8S)-ethyl 8-(2′,3′,4′,6′-tetra-O-acetyl-β-D-
glucopyranosyloxy)-2-phenyl-2,4,9-triazabicyclo[4.3.0]non-6-eno-1,3-
dione-5-carboxylate 10 
 To a solution of diene 9 (1.31 g; 2.86 mmol) in DCM (15 mL) was added 4-
phenyl-1,2,4-triazole-3,5-dione (0.50 g; 2.86 mmol), giving a red colored solution that 
quickly lost its color. The reaction mixture was stirred for a further 30 min and then 
evaporated. The residue was tritured with ethyl ether. A white solid was formed and 
filtered, giving the title compound (10; 1.302 g; 70 %). 
[α]D20 +23,8° (c 1, CH2Cl2). max (nujol) 2954, 2853, 1743, 1620, 1635, 1218 cm−1. 1H 
NMR (δH, 300 MHz, CDCl3) 1.35 (3H, t, J 6.0 Hz, CH3), 2.00, 2.01, 2.02, 2.04 (12H, 4 × 
s, 4 × CH3CO2), 3.87 (1H, ddd, J 12.0, 6.0, 3.0 Hz, H-5′), 4.05 (1H, dd, J 12.0, 3.0 Hz, 
H-6′), 4.27 (1H, dd, J 15.0, 9.0 Hz, H-6′), 4.34 (2H, dq, J 7.2, 1.2 Hz, CH2), 5.01 (2H, m, 
H-5 + H-2′), 5.09 (1H, t, J 9.9 Hz, H-4′), 5.19−5.26 (2H, m, H-3′ + H-1′), 6.06-6.12 (2H, 
m, H-8 + H-7), 6.19-6.26 (1H, m, H-6), 7.39-7.56 (5H, m, Ph) ppm. 13C NMR (δC, 75.5 
MHz, CDCl3) 14.0 (CH3), 20.5, 20.6, 20.6 (CH3CO2), 56.7 (C-5), 61.5 (C-6′), 62.9 (CH2), 
67.8 (C-4′), 71.0 (C-2′), 72.1 (C-5′), 72.8 (C-3′), 74.6 (C-8), 97.2 (C-1′), 123.3 (C-7), 
124.9 (C-6), 125.4 (CH, Ph), 128.5 (CH, Ph), 129.2 (CH, Ph), 130.7 (Cq, Ph), 150.2 
(C=O), 151.4 (C=O), 165.6 (C=O ester), 169.4, 169.4, 170.2, 170.7 (CH3CO2) ppm. 
HRMS (FAB): calcd for C29H33N3O14: 648.2041; found, 648.2041. 
 
5.4. Synthesis of (S)-ethyl 2-phenyl-2,4,9-triazabicyclo[4.3.0]-non-6-ene-
1,3-dione-5-carboxylate (-)-11 
 To a solution of the cycloadduct 10 (1.31 g; 2.03 mmol) in DCM (20 mL) were 
added triethylsilane (12.7 mL; 0.78 mol) and trifluoroacetic acid (12.7 mL; 0.17 mol). 
The resulting yellow suspension was kept under stirring at rt for 5 h. The solvent was 
removed under vacuum and the residue redissolved in DCM (30 mL). The solution was 
washed with an aq saturated solution of NaHCO3 (3 × 50 mL) and water (50 mL). The 
combined organic layers were dried over magnesium sulphate and filtered, and the 
solvent was evaporated. From the residual oil crystallized a white solid that was 
washed with diethyl ether and proved to be the title compound ((-)-11; 0.313 g; 51 %). 
[α]D20 −311.0° (c 2.15, CH2Cl2). mp 140−142 °C. max (nujol) 2954, 2923, 1742, 1714 
cm−1. 1H NMR (δH, 300 MHz, CDCl3) 1.29 (3H, t, J 7.2 Hz, CH3), 3.99-4.06 (1H, dm, H-
8), 4.25 (2H, q, J 7.2 Hz, CH2), 4.38-4.45 (1H, dm, H-8), 5.09-5.12 (1H, m, H-5), 
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6.05−6.16 (2H, m, H-6 + H-7), 7.38−7.57 (5H, m, Ph) ppm. 13C NMR (δC, 75.5 MHz, 
CDCl3) 14.1 (CH3), 43.1 (C-8), 55.9 (C-5), 62.4 (CH2), 119.7 (C-6 or C-7), 123.3 (C-6 or 
C-7), 125.6 (CH, Ph), 128.2 (CH, Ph), 129.1 (CH, Ph), 131.1 (Cq, Ph), 152.3 (C=O), 
153.3 (C=O), 166.7 (C=O ester) ppm. EA calcd for C15H15N3O4: C, 59.79%; H, 5.02%; 
N, 13.95%; found: C, 59.90%; H, 4.93%; N, 13.86%. 
 
5.5. Synthesis of (R)-ethyl 2-phenyl-2,4,9-triazabicyclo[4.3.0]-non-6-ene-
1,3-dione-5-carboxylate (+)-11 
 To a solution of the cycloadduct 18 (1.03 g; 1.59 mmol) in DCM (25 mL) were 
added triethylsilane (9.85 mL; 0.78 mol) and trifluoroacetic acid (9.85 mL; 0.17 mol). 
The resulting yellow solution was kept under stirring at rt for 5 h. The solvent was 
removed under vacuum, and the residue was redissolved in DCM (25 mL). The 
solution was washed with an aq saturated solution of NaHCO3 (3 × 25 mL) and water 
(25 mL). The combined organic layers were dried over magnesium sulphate and 
filtered, and the solvent was evaporated. From the residual oil crystallized a white solid 
that was washed with diethyl ether and proved to be the title compound ((+)-11; 0.292 
g; 61 %). 
[α]D20 +370.0° (c 1, CH2Cl2). 
 
5.6. Synthesis of (5S,6R,7S)-ethyl 6,7-epoxy-2-phenyl-2,4,9-triazabicyclo 
[4.3.0]nonane-1,3-dione-5-carboxylate (−)-12 
 To a solution of compound (-)-11 (0.48 g; 1.59 mmol) in acetonitrile (28.0 mL), 
water (16.0 mL) and 1,1,1-trifluoracetone (3.21 mL), were added solid NaHCO3 (2.44 g; 
29.02 mmol) and oxone® (12.00 g; 39.04 mmol) for 20 min at 0 °C. The mixture was 
stirred for 18 h. A new portion of solid NaHCO3 (2.44 g; 29.02 mmol) and oxone® 
(12.00 g; 39.04 mmol) was added and stirred for another 4 h. Then water (100 mL) was 
added to the reaction mixture, which was extracted with CHCl3 (8 × 40 mL). The 
organic layers were combined and dried with magnesium sulphate. After removal of the 
solvent, recrystallization with diethyl ether gave a white solid identified as the title 
compound ((-)-12; 0.329 g; 65 %). 
[α]D20 -238.0° (c 0.8, CH2Cl2). mp 218−220 °C. max (nujol) 2950, 2923, 1775, 1750, 
1715, 1458, 1094,1034 cm−1. 1H NMR (δH, 300 MHz, CDCl3) 1.32 (3H, t, J 7.1 Hz, 
CH3),3.53-3.65 (2H, m, H-7 + H-8), 3.89 (1H, dd, J 5.6, 3.8 Hz, H-6), 4.19-4.40 (2H, m, 
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CH2), 4.47 (1H, dd, J 13.6, 1.4 Hz, H-8), 5.01 (1H,d, J 5.7 Hz, H-5), 7.33-7.51 (5H, m, 
Ph) ppm. 13C NMR (δC, 75.5 MHz, CDCl3) 14.1 (CH3), 43.0 (C-8), 49.0 (C-6), 50.1 (C-
7), 54.8 (C-5), 62.7 (CH2), 125.6 (CH, Ph), 128.4 (CH, Ph), 129.1 (CH, Ph), 130.9 (Cq, 
Ph), 153.3 (C=O), 153.56 (C=O), 165.6 (C=O ester) ppm. HRMS (FAB): calcd for 
C15H16N3O5: 318.1089; found, 318.1087. 
 
5.7. Synthesis of (5R,6S,7R)-ethyl 6,7-epoxy-2-phenyl-2,4,9-triazabicyclo 
[4.3.0]nonane-1,3-dione-5-carboxylate (+)-12 
 To a solution of compound (+)-11 (0.37 g; 1.21 mmol) in acetonitrile (21.1 mL), 
water (12.3 mL), and 1,1,1-trifluoracetone (2.40 mL) were added solid NaHCO3 (1.86 g; 
29.02 mmol) and oxone® (9.15 g; 39.04 mmol) for 20 min at 0 °C. The mixture was 
stirred for 18 h. A new portion of solid NaHCO3 (1.86 g; 29.02 mmol) and oxone® (9.15 
g; 39.04 mmol) was added and stirred for another 4 h. Then water (60 mL) was added 
to the reaction mixture, which was extracted with DCM (10 × 40 mL). The organic 
layers were combined and dried with magnesium sulphate. After removal of the 
solvent, recrystallization with diethyl ether gave a white solid identified as the title 
compound ((+)-12; 0.233 g; 60 %). 
[α]D20 +232.8° (c 0.8, CH2Cl2). 
 
5.8. Synthesis of (5S,6R,7R)-ethyl 6,7-dihydroxy-2-phenyl-2,4,9-
triazabicyclo[4.3.0]nonane-1,3-dione-5-carboxylate (−)-13 
 To a solution of epoxide (-)-12 (0.20 g; 0.63 mmol) in water (30 mL) was added 
concentrated H2SO4 (0,5 mL), and the mixture was refluxed for 8 h. After this time, 
solid NaHCO3 (0.86 g; 10.24 mmol) was added, and the water was evaporated until 
dryness. The residue was dissolved in ethyl acetate (100 mL) and washed with NaCl 
(50 mL). The organic phase was separated, and the aqueous phase was extracted with 
ethyl acetate (100 mL). The organic phases were combined and dried with magnesium 
sulphate, filtered, and concentrated in the rotary evaporator. The yellowish solid 
obtained was washed with diethyl ether and found to be the title compound ((-)-13; 
0.110 g; 52 %). 
[α]D20 −22.8° (c 2, acetone). max (nujol) 3596−3540, 2954, 2923, 1729, 1698, 1122, 
1088 cm−1. 1H NMR (δH, 400 MHz, CDCl3) 1.24 (3H, m, CH3), 3.64 (1H, d, J 12.0 Hz, H-
8), 3.95 (1H, bs, H-7), 3.99 (1H, d, J 12.8 Hz, H-8), 4.13-4.28 (2H, m, CH2), 4.46 (1H, t, 
Chapter 2.1 
 
 
73 
J 2.8 Hz, H-6), 4.74 (1H, d, J 2.8 Hz, H-5), 7.38−7.50 (5H, m, Ph) ppm. 13C NMR (δC, 
100 MHz, CDCl3) 13.9 (CH3), 44.3 (C-8), 59.4 (C-5), 62.6 (CH2), 65.9 (C-7), 67.4 (C-6), 
125.9 (CH, Ph), 128.6 (CH, Ph), 129.3 (CH, Ph), 131.0 (Cq, Ph), 152.1 (C=O), 154.1 
(C=O), 167.3 (C=O ester) ppm. HRMS (FAB): calcd for C15H18N3O6: 336.1196; found: 
336.1207. 
 
5.9. Synthesis of (5R,6S,7S)-ethyl 6,7-dihydroxy-2-phenyl-2,4,9-
triazabicyclo[4.3.0]nonane-1,3-dione-5-carboxylate (+)-13 
 To a solution of epoxide (+)-12 (0.23 g; 0.73 mmol) in water (35 mL) was added 
concentrated H2SO4 (0.7 mL), and the mixture was refluxed for 10 h. After this time, 
solid NaHCO3 (1.42 g; 16.90 mmol) was added, and the water was evaporated until 
dryness. The residue was dissolved in ethyl acetate (100 mL) and washed with NaCl 
(50 mL). The organic phase was separated, and the aqueous phase was extracted with 
ethyl acetate (3 × 100 mL). The organic phases were combined and dried with 
magnesium sulphate, filtered, and concentrated in the rotary evaporator. The yellowish 
solid obtained was washed with diethyl ether and found to be the title compound ((+)-
13, 0.121 g; 49 %). 
[α]D20 +26.9° (c 0.5, acetone). 
 
5.10. Synthesis of (5S,6R,7S)-ethyl 6,7-dihydroxy-2-phenyl-2,4,9-
triazabicyclo[4.3.0]nonane-1,3-dione-5-carboxylate 14 
 To a solution of (-)-11 (0.30 g; 1.00 mmol) in acetone (1 mL) and water (0.5 mL) 
were added 4-methylmorpholine N-oxide (0.18 g; 1.49 mmol) and a solution of OsO4 in 
water 4 % (108 mL). The mixture of stirred for 5 days. Then an aq. solution of Na2S2O3 
5 % (25 mL) was added to mixture, which was stirred for 15 min. The solution was 
extracted with ethyl acetate (4 × 30 mL) and the organic phases were washed with 
water (10 mL). The organic phase was dried over MgSO4, filtered, and concentrated to 
give a white solid (14; 0.26 g; 79 %). 
[α]D20 -110.6° (c 2.05, acetone); max (nujol) 3425, 1768, 1749, 1736, 1287, 1204 cm−1. 
1H NMR (δH, 400 MHz, CDCl3) 1.27 (3H, t, J 7.2 Hz, CH3), 3.35 (1H, d, J 10.8 Hz, H-8), 
3.83 (1H, ddd, J 10.0, 5.2, 2.8 Hz, H-7), 4.03 (1H, dd, J 11.6, 5.2 Hz, H-8), 4.24 (2H, q, 
J 7.2 Hz, CH2), 4.52 (1H, t, J 2.8 Hz, H-6), 4.90 (1H, d, J 3.6 Hz, H-5), 7.40−7.49 (5H, 
m, Ph) ppm. 13C NMR (δC, 100 MHz, CDCl3) 14.0 (CH3), 43.2 (C-8), 60.6 (C-5), 62.8 
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(CH2), 65.1 (C-7), 67.2 (C-6), 125.8 (CH, Ph), 128.6 (CH, Ph), 129.3 (CH, Ph), 130.9 
(Cq, Ph), 151.4 (C=O), 153.8 (C=O), 166.4 (C=O ester) ppm. HRMS (FAB): calcd for 
C15H18N3O6: 336.1196; found: 336.1195. 
 
5.11. Synthesis of (5S,6R,7R)-6,7-dihydroxy-5-hydroxymethyl-2-phenyl-
2,4,9-triazabicyclo[4.3.0]nonane-1,3-dione 15 
 To a solution of the diol (-)-13 (0.07 g; 0.22 mmol) in ethanol (3 mL) was added 
NaBH4 (8 mg; 0.22 mmol) under magnetic stirring at room temperature. After 1 h, an 
aliquot was quenched with HCl 0.4 M, extracted with ethyl acetate, dried over 
magnesium sulphate, and concentrated. 1H NMR spectrum showed that the reaction 
was not completed, so a new amount of NaBH4 (8 mg; 0.22 mmol) was added, and the 
mixture was stirred for another 4 h. The procedure was repeated with addition of 
NaBH4 (8 mg; 0.22 mmol). The reaction was quenched with aq. HCl 0.4 M (4.4 mL); the 
mixture was stirred for 10 min and evaporated. The residue was dissolved in water (10 
mL) and extracted with ethyl acetate (8 × 15 mL). The organic phases were combined 
and dried over magnesium sulphate. Evaporation of the solvent gave a white solid 
identified as the title compound (15, 0.037 g; 59 %). 
[α]D20 -70.4° (c 1.2, acetone).  
The spectroscopic data of the racemic mixture was reported before.4 
 
5.12. Synthesis of (5S,6R,7S)-6,7-dihydroxy-5-hydroxymethyl-2-phenyl-
2,4,9-triazabicyclo[4.3.0]-nonane-1,3-dione 16 
 To a solution of the diol 14 (0.224 g; 0.73 mmol) in ethanol (7 mL) was added 
NaBH4 (0.083 g). The mixture was stirred at room temperature overnight. After addition 
of aq. HCl 0.4 M (15.3 mL), the mixture was stirred for 15 min. Then the solvent was 
removed under vacuum, and the residue was dissolved in water (20 mL) and saturated 
aq. solution of NaHCO3 (10 mL) and extracted with ethyl acetate (14 × 25 mL). The 
organic layers were combined, dried over magnesium sulphate, and concentrated. It 
obtained a white solid identified as the title compound (16, 0.112 g; 52 %). 
[α]D20 -8.0° (c 0.75, acetone).  
The spectroscopic data of the racemic mixture was reported before.4 
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5.13. Synthesis of ethyl (5R,8S)-8-(2′,3′,4′,6′-tetra-O-acetyl-β-D-
glucopyranosyloxy)-2-phenyl-2,4,9-triazabiciclo[4.3.0]non-6-ene-1,3-
dione-5-carboxylate 18 
 To a suspension of compound 10 (0.22 g; 0.33 mmol) in methanol (5 mL) were 
added 4-chorothiophenol (0.10 g; 0.68 mmol) and triethylamine at 0 °C and under 
magnetic stirring. After 40 min, the solvent was evaporated, and the crude was 
subjected to dry-flash chromatography (petroleum ether/ether 1:3). The product was 
obtained as a white solid (18; 0.187 g; 88 %). 
[α]D20 +219.7° (c 1, acetone); mp 154−157 °C. max (nujol) 2955, 2924, 1744, 1723, 
1226 cm−1. 1H NMR (δH, 400 MHz, CDCl3) 1.28 (3H, t, J 7.2 Hz, CH3), 1.88, 1.98, 2.02, 
2.07 (12H, 4 × s, 4 × CH3CO2), 3.74-3.79 (1H, m, H-5′), 4.15 (1H, dd, J 12.4, 2.4 Hz, H-
6′), 4.23 (2H, q, J 7.2 Hz, CH2), 4.25 (1H, dd, J 12.0, 4.4 Hz, H-6′), 4.95 (1H, dd, J 9.6, 
8.0 Hz, H-2′), 5.07 (1H, t, J 10.0 Hz, H-4′), 5.15 (1H, dd, J 5.2, 2.0 Hz, H-5), 5.18-5.23 
(2H, m, H-1′ + H-3′), 5.96 (1H, d, J 4.8 Hz, H-8), 6.07 (1H, ddd, J 10.0, 4.4, 2.0 Hz, H-
6), 6.31 (1H, ddd, J 10.0, 5.2, 0.8 Hz, H-7), 7.27-7.56 (5H, m, Ph) ppm. 13C NMR (δC, 
100 MHz, CDCl3) 14.0 (CH3), 20.5, 20.5, 20.7 (CH3CO2), 56.0 (C-5), 61.6 (C-6′), 62.7 
(CH2), 68.0 (C-4′), 71.1 (C-2′), 72.2 (C-5′), 72.6 (C-3′), 76.0 (C-8), 99.6 (C-1′), 123.9 (C-
7), 124.1 (C-6), 125.6 (CH, Ph), 128.6 (CH, Ph), 129.2 (CH, Ph), 130.8 (Cq, Ph), 151.5 
(C=O), 153.4 (C=O), 166.0 (C=O ester), 169.2, 169.4, 170.1, 170.6 (CH3CO2) ppm. EA 
calcd for C29H33N3O14: C, 53.79%; H, 5.14%; N, 6.49%; found: C, 53.58%; H, 5.23%; N, 
6.38%. 
 
5.14. Synthesis of (S)-N-phenyl-3-oxa-1,9-diazabicyclo[3.3.1]non-6-ene-9-
carboxylate 20 
 To a solution of ester (-)-11 (0.205 g; 0.68 mmol) solubilized in dry THF (13 mL) 
was added LiAlH4 1 M in THF (7 eq., 5.2 mL), from a flask containing a white deposit, 
at 0 °C. The mixture was kept under stirring for 4 h at rt. The reaction was quenched 
with a sequence addition of water (1 drop), aq. NaOH 15 % (2 drops), and water (1 
drop), during which time a large amount of H2 was released. Then a portion of water 
(15 mL) was added, and the mixture was extracted with ethyl acetate (4 × 25 mL). The 
combined organic layers were washed with saturated aq. NaHCO3 (25 mL) and brine 
(25 mL) and then dried over MgSO4. After evaporation of the ethyl acetate, a yellowish 
crude crystallized giving 20 (0.088 g; 48 %). 
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[α]D20 −57.5° (c 0.4, CHCl3). max (nujol) 3320, 1670, 1604, 1591, 1530 cm−1. 1H NMR 
(δH, 300 MHz, CDCl3) 3.45 (1H, dd, J 18.3, 1.2 Hz, H-8), 3.71 (1H, d, J 10.5 Hz, H-4), 
3.90 (1H, dd, J 2.7, 11.1 Hz, H-4), 4.00 (1H, dd, J 18.3, 1.2 Hz, H-8), 4.56 (1H, d, J 
10.5 Hz, H-2), 4.66 (1H, bs, H-5), 4.69 (1H, d, J 10.5 Hz, H-2), 6.07 (2H, bs, H-6 + H-
7), 7.04 (1H, t, J 7.2 Hz, CH, Ph), 7.31 (2H, t, J 7.2 Hz, CH, Ph), 7.49 (2H, d, J 7.2 Hz, 
CH, Ph), 8.00 (1H, bs, NH) ppm. 13C NMR (δC, 100 MHz, CDCl3) 44.4 (C-5), 50.7 (C-8), 
66.7 (C-4), 86.3 (C-2), 118.7 (CH, Ph), 122.9 (CH, Ph), 127.8 (C-7 or C-6), 128.9 (C-6 
or C-7), 128.9 (CH, Ph), 138.5 (Cq, Ph), 153.1 (C=O) ppm. HRMS (FAB): calcd for 
C13H16N3O2: 246.124252; found: 246.124172. 
 
5.15. Synthesis of (S)-6-(hydroxymethyl)-N-phenyl-2,3-dihydropyridazine-
1(6H)-carboxamide 21 
 To the ester (-)-11 (0.15 g; 0.5 mmol) solubilized in dry THF (10 mL) was added 
LiAlH4 1 M in THF (15 eq.; 13.5 mL), freshly open, at 0 °C. The mixture was kept under 
stirring for 4 h at rt. The reaction was quenched by a drop of water followed by 2 drops 
of aq. NaOH 15 % and another drop of water, during which time a large amount of H2 
was released. Then a portion of water (40 mL) was added, and the mixture was 
extracted with ethyl acetate (5 × 40 mL). The combined organic layers were washed 
with saturated aq. NaHCO3 (50 mL) and brine (50 mL) and then dried over MgSO4. 
After evaporation of the ethyl acetate, a yellowish crude was obtained, from which 
crystallized a solid (21; 0.10 g; 86 %). 
[α]D20 -150.8° (c 0.4, CHCl3). max (nujol) 3359, 3268, 3058, 1636, 1601, 1592, 1536 
cm−1. 1H NMR (δH, 300 MHz, CDCl3) 3.30 (1H, bd, J 17.2 Hz, H-3), 3.48-3.55 (1H, m, 
H-3), 3.75 (1H, dd, J 10.8, 5.2 Hz, CH2OH), 3.95 (1H, dd, J 11.2, 3.2 Hz, CH2OH), 4.20 
(1H, dd, J 11.2, 2.4 Hz, OH), 4.78 (1H, bs, H-6), 5.83 (1H, dm, J 8.4 Hz, H-4 or H-5), 
6.13 (1H, dm, J 8.4 Hz, H-4 or H-5), 7.02 (1H, t, J 7.6 Hz, CH, Ph), 7.30 (2H, t, J 7.6 
Hz, CH, Ph), 7.47 (2H, d, J 7.6 Hz, CH, Ph), 8.60 (1H, bs, NH) ppm. 13C NMR (δC, 100 
MHz, CDCl3) 45.3 (C-6), 50.7 (C-3), 65.1 (CH2OH), 122.7 (CH, Ph), 124.5 (C-4 or C-5), 
128.3 (C-5 or C-4), 128.9 (CH, Ph), 138.7 (Cq, Ph), 155.0 (C=O) ppm. HRMS (FAB): 
calcd for C12H16N3O2: 234.124432; found: 244.124252. 
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5.16. Synthesis of (4R,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-N-
phenylhexahydropyridazine-1-carboxamide (−)-22 
 To a solution of (-)-13 (0.06 g; 0.18 mmol) in dry THF (8 mL) was added at 0 °C 
a solution of LiAlH4 1 M in THF (7 eq.; 2.51 mL). The reaction mixture stirred for 3 h at 
rt, and then the quenching was followed by sequential addition of 1 drop of water, one 
drop of aq. NaOH 15 %, and water (20 mL). The aqueous solution was extracted with 
ethyl acetate (6 × 60 mL). The organic layers were combined, dried, and evaporated, 
giving an oil that was submitted to PLC (DCM/methanol 10 %), giving the title 
compound (-)-22 (0.014 g; 29 %). 
[α]D20 -54.4° (c 0.6, methanol). max (neat) 3346, 2925, 1656, 1592, 1534 cm−1. 1H NMR 
(δH, 400 MHz, CDCl3) 2.92 (1H, dt, J 1.2, 14.8 Hz, H-3), 3.32 (1H, dd, J 14.8, 2.0 Hz, 
H-3), 3.69−3.73 (1H, m, H-6), 3.82 (1H, dd, J 12.0, 4.8 Hz, CH2OH), 3.90−3.92 (1H, m, 
H-4), 4.11(1H, dd, J 12.2, 9.0 Hz, CH2OH), 4.44-450 (1H, m, H-5), 7.19−7.43 (5H, m, 
Ph). 13C NMR (δC, 100 MHz, CDCl3) 46.4 (C-3), 56.1 (C-5), 59.0 (CH2OH), 64.8 (C-6), 
66.2 (C-4), 121.5 (CH, Ph), 125.0 (CH, Ph), 129.1 (CH, Ph), 138.0 (Cq, Ph), 153.6 
(C=O) ppm. HRMS (FAB): calcd for C12H18N3O4: 268.1219; found: 268.1222. 
 
5.17. Synthesis of (4S,5S,6S)-4,5-dihydroxy-6-(hydroxymethyl)-N-
phenylhexahydropyridazine-1-carboxamide (+)-22 
 To a solution of (+)-13 (0.12 g; 0.36 mmol) in dry THF (10 mL) was added at 0 
°C a solution of LiAlH4 1 M in THF (7 eq.; 5.03 mL). The reaction mixture was stirred for 
1.5 h at rt, and then the quenching was followed by sequential addition of 1 drop of 
water, one drop of aq. NaOH 15 %, and water (50 mL). The aqueous solution was 
extracted with ethyl acetate (10 × 40 mL). The organic layers were combined, dried, 
and evaporated, giving an oil that was submitted to PLC (DCM/methanol 10 %), giving 
the title compound (+)-22 (0.010 g; 10 %). 
[α]D20 +51.3° (c 1, methanol). 
 
5.18. Measurement of Glycosidase Inhibition 
 -Glucosidase from baker's yeast (EC 3.2.1.20, Sigma G-5003) and -
glucosidase from almonds (EC 3.2.1.21, Sigma G-0395) were used as model 
glycosidases. Enzyme assays were conducted in 96 well Nunc plates, using 4-
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nitrophenyl -D-glucopyranoside or 4-nitrophenyl -D-glucopyranoside as substrates, in 
phosphate buffer 100 mM, pH 7.0 or citrate buffer 100 mM, pH 5.0 at 25 °C. A range of 
substrate concentrations from 3.3 × 10−5 M to 2.0 × 10−3 M (11 different 
concentrations), in a final volume of 300 μL, was tested using 0.2 units/mL of -
glucosidase or 0.15 units/mL of -glucosidase, in the absence and in the presence of 
inhibitor ((+)- and (-)-22, 5 × 10−6 M and 10 × 10−6 M). Blanks were set containing all 
reaction components but enzyme. All assays were performed in triplicate.  
 The formation of 4-nitrophenol was monitored for 20 min at 25 °C, measuring 
the absorbance (1 reading each minute) at 400 nm. A value of ε l = 787.73 M−1 (pH 7.0) 
or 28.29 M−1 (pH 5.0), determined in the same conditions as used for the enzyme 
assays, was used to convert absorbance into product concentration. Initial velocities 
were calculated from the slopes of the absorbance vs time graphs for each 
concentration of substrate and used to construct Michaelis-Menten plots. The kinetic 
parameters KM and Vmax were determined by fitting the experimental results to a 
rectangular hyperbole using the Origin 8 Graph Pad and by Lineweaver-Burk analysis. 
The inhibition type was established as competitive for all enzymes and inhibitors 
tested, using two different concentrations of inhibitors (in duplicate) and by examining 
the Lineweaver-Burk plot. For each inhibitor concentration, individual Ki values were 
obtained using the expression for competitive inhibition (Ki = [I]/((KMapp/KM)-1), where 
KM and KMapp represent the Michaelis−Menten constant in the absence and in the 
presence of inhibitor, respectively. Reported Ki values are expressed as average of two 
independent Ki determinations. 
 
5.19. Structural Molecular Modelling Studies 
 Structural enzyme-compound complexes and theoretical binding free energy of 
(-)-2, (+)-2, and 22 toward yeast -glucosidase structure were done with computational 
docking methodologies using AUTODOCK 4.19 The modelling of the enzyme-
compound complexes with almond -glucosidase was not calculated because, to the 
best of our knowledge, no structure or protein sequence is available. In the docking 
calculations, all possible torsions of the compounds were set flexible except the amide 
bonds in both enantiomers of compound 22. The protonation state of the amine N-1 
and N-2 of the compounds was set neutral, in agreement with previous NMR 
evidence.20 The grid for probe-target energy calculations was placed with its centre at 
the enzyme-binding site. The docking grid size was 42 × 40 × 42 grid points with 0.375 
Å spacing. For each ligand, 20 runs using the Lamarckian genetic algorithm with 150 
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individuals in each population were carried out. The maximum number of generations 
was set to 27 × 103 and the maximum number of energy evaluations to 5 × 106. The 
resulting docking solutions were clustered using AUTODOCK with a structural root-
mean-square deviation cutoff of 1Å. Since no experimental structure exists for the 
yeast α-glucosidase enzyme, a theoretical structural model of this enzyme was derived 
using MODELER,21 employing the crystal structure of isomaltase from S. cerevisiae 
structure (PDB ID: 3A4A)13 as template. Isomaltase and -glucosidase from S. 
cerevisiae share 72 % sequence similarity. Twenty models were generated using an 
initial alignment between the isomaltase and -glucosidase enzyme sequences. The 
model with the lowest objective function21 was chosen, and its quality was evaluated on 
the basis of its stereochemistry given by Procheck.22 A high quality model of the yeast 
-glucosidase enzyme was obtained with no residues in disallowed regions in the 
Ramachandran plot. The protonation states of the acidic and basic residues were set to 
their standard state found in aqueous solution at pH 7. 
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1. Abstract 
 Maleimides were combined with D-erythrose benzylidene-acetal 1,3-butadienes 
to study the facial selectivity of the Diels-Alder cycloadditions. The selectivity was found 
to range from moderate to good. The reaction diastereotopicity can be reversed with 
the temperature. Simultaneous coordination of the diene, having a free hydroxyl group, 
and maleimide to a chiral bimetallic Lewis acid catalyst (LACASA-DA reaction) occurs 
with complete diastereocontrol to give a single adduct, using an extra chiral inductor 
either (R)- or (S)-BINOL. 
 
2. Results and discussion 
 Small chiral synthons are becoming more and more appealing to synthetic 
chemists to build up target molecules possessing multistereogenic centers. We have 
been investigating the utility of D-erythrose 1,3-butadienes, such as 1 and 2,1 as chiral 
counterparts in diastereoselective Diels-Alder cycloadditions. In the past a high 
diastereotopicity was demonstrated in Diels-Alder reactions of these dienes with 2-
methoxycarbonyl-p-benzoquinones.1 In a previous study in our laboratory a complete 
chiral induction was also found in [4+2] cycloadditions of certain D-erythrose 
benzylidene-acetal 1,3-butadienes, having ether protection at C-5, with 4-phenyl-1,2,4-
triazoline-3,5-dione (PTAD).2 Maleimide (3) and N-phenylmaleimide (4) were now 
combined with D-erythrose dienes 1 and 2. The facial selectivities were moderate to 
good under elevated temperatures, and interestingly the topicity was reversed when 
the cycloadditions were carried out at 5 ºC. Self-assembly of the reaction components 
on a Lewis acid template made the selectivity complete in two cases. 
 D-Erythrose benzylidene-acetal 1,3-butadienes possessing the alcohol function 
protected (e.g., 2) reacted with PTAD to give solely the endo, (S)-configuration adduct 
at the new stereogenic centre.2 The reaction turned out to be less selective when the 
diene bore an unprotected hydroxyl group at C-5 (1). However, when reacting diene 2 
with N-phenylmaleimide in dichloromethane (the solvent used in reactions with PTAD) 
the selectivity was reduced to a 2:1 ratio of endo-diastereomers; the major being the R 
isomer (5) and the minor, its (S)-diastereomer (6). The selectivity dropped to zero when 
diene 1 reacted with N-phenylmaleimide (4). The best selectivity with maleimides 
occurs when at least one of the reagents has the possibility of acting as a proton donor 
in a hydrogen bond. Thus combination of diene 2 and maleimide (3) affords a 3:1 (R/S) 
ratio of isomers; while reaction of diene 1 with maleimide (3) also yields the same ratio 
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of isomers. Scheme 1 depicts the four possible combinations of the reagents and 
reaction conditions, and the yields of products are collected in Table 1. 
 
 
Scheme 1 Four possible combinations of dienes 1 and 2 to maleimides 3 and 4 giving 
compounds 5 and 6. 
 
 
 Considering the unexpected behavior of maleimides in relation to PTAD, Figure 
1 shows a possible explanation for the observation. Reagent superimposition in 
situations A, B and C show the dienophiles approach to the re face of the diene, 
leading to the (S)-configuration of products. In case A the proximity in space between 
the two electronegative atoms of the diene and dienophile may result in repulsion 
between reagents and render such an approach unlikely. Approach B does not indicate 
repulsion due to the nature of maleimides, which may favor such an approach. Finally, 
as shown in approach C, attack on the si face would result in the least hindered 
interaction between reagents, which may explain the (R)-configured compounds as the 
major isomers in most reactions. 
 
 
Figure 1 Different interaction at the rear double bond in maleimides and PTAD with the 
erythrose dienes (A, B, and C). 
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 Table 1 displays some relevant reaction conditions employed in Diels-Alder 
reactions between erythrose dienes 1 and 2 and maleimides 3 and 4. In the majority of 
the cases a higher yield of the (R)-configured product is observed. The reactions 
usually require several days, but in one case reaction was shortened from 5 days to 15 
hours by increasing the temperature to 40 ºC with some loss of selectivity (Table 1, 
compare entries 3 and 4). Diene 1 and maleimide (3) were also combined at 5 ºC 
(Table 1, entry 2) when (S)-diastereomer became the major product, showing that the 
manner of approach of reagents is highly dependent on temperature. A possible 
interpretation for this fact may be the development of a hydrogen bond in the approach 
of maleimide by the re face of the diene as shown in Figure 2 which is influential at 
lower temperatures. There is a good deal of information in the literature that relates the 
outcome of Diels-Alder cycloadditions with possible hydrogen-bonding effects between 
reactants.3a-g This is reinforced by the result of the experiment carried out at 5 ºC 
between diene 2 and N-phenylmaleimide (4), which has no possibility of forming a 
hydrogen bond. The major isomer has the (R)-configuration at both temperatures 
(Table 1, entries 5 and 6), with some selectivity improvement at the lower temperature, 
showing a different trend from the one in entries 2 and 3 (Table 1). 
 
Table 1 DA cycloadditions of dienes 1 and 2 with maleimide (3) and N-phenylmaleimide (4). 
Entry Diene Dienophile (2 eq.) Product Solvent T (ºC) Time dr (R/S) 
η (%) 
5R/6S 
1 1 4 5a/6a toluene rt 3 d 1a:1 22 – 23 
2 1 3 5b/6b CH2Cl2 5 18 d 1:2 30 – 19 
3 1 3 5b/6b CH2Cl2 rt 5 d 3:1 b 
4 1 3 5b/6b CH2Cl2 40 15 h 2:1 33 – 21 
5 2 4 5c/6c CH2Cl2 rt 9 d 2:1 43 – 20 
6 2 4 5c/6c CH2Cl2 5 18 d 3:1 22 – 4c 
7 2 3 5d/6d CH2Cl2 rt 5 d 3:1 41–39d 
a Submitted to X-Ray crystal structure analysis. 
b Not isolated; dr obtained by 1H NMR spectroscopy. 
c An additional 11 % of a 1:1 mixture of (S)- and (R)-isomers was isolated. The ratio was based up on 1H 
NMR spectroscopic analysis of the sample. 
d 39 % is not pure S isomer; it is formed by a 1:2.9 (R/S) mixture of isomers based on 1H NMR 
spectroscopic analysis of the sample. 
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Scheme 2. This method has been first developed by Inomata6a,b using a tartaric acid-
zinc complex in reaction of nitroso dienophiles with a dienol, and later by Ward.7a,b 
 
 
Scheme 2 Bimetallic complex of Mg(II) and Zn(II) assembling together diene 1, N-
phenylmaleimide (4) and (R)-BINOL. 
 
 
 The reaction combining (S)-BINOL (A), maleimide, and diene 1 was completely 
selective, forming exclusively the (R)-product in 33 % yield.8 Scheme 3 represents the 
assembly of the reagents, and the direction of attack of maleimide to the front face of 
the diene leading to the (R)-configured product. The high selectivity observed is 
probably due to the covalent bond between the Mg and the nitrogen atom that forces 
the antarofacial interaction. The assembly of (R)-BINOL (B), NH-maleimide, and diene 
1 give also a single (R)-configured product (29 %). This means that although the 
flexibility of the complex is higher in the case of B, a similar approach takes place. 
 
 
Scheme 3 Coordination of the erythrose diene 1 with maleimide (1) using bimetallic complex of 
Mg(II) and Zn(II) with (S)-BINOL (A) and (R)-BINOL (B). 
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 When N-phenylmaleimide (4) was used in place of maleimide (3) with (R)-
BINOL and diene 1 a 2.5:1 ratio of isomers was obtained, in 50 % yield, favoring the 
(S)-compound. These products were isolated in 35 % (S) and 15 % (R) yields. In this 
case no covalent bond could have been established, and the reaction attack of the 
dienophile could now occur by the less bulky rear face of the diene. 
 In conclusion maleimides 3 and 4 reacted with erythrose dienes 1 and 2 
showing at its best a 1:3 ratio of isomer products. It was found possible to reverse the 
selectivity on lowering the reaction temperature. Pure (R)-isomers were isolated in 
moderate yields in the case of maleimide (3) and diene 1 by using bimetallic complex 
templates of Zn(II) and Mg(II) and (R)- or (S)-BINOL. Combination of diene 1, N-
phenylmaleimide (4) and (R)-BINOL under the same conditions led to the (S)-isomer 
(35 % yield) together the (R)-isomer (15 % yield). 
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P. J.; Thornton, E. R. J. Am. Chem. Soc. 1991, 113, 7630-7640. 
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4. Analytical data for some typical compounds 
Compound 5a: [α]D20 -92.4° (c 0.45, EtOAc). max (nujol) 3441, 1690, 1457 cm-1. 1H 
NMR (δH, 400 MHz, CDCl3) 2.22-2.32 (1H, m, H-7), 2.75-2.90 (2H, m, H-7+ H-3a), 3.35 
(1H, tdd, J 11.6, 5.8, 3.5 Hz, H-4), 3.60 (1H, td, J 11.2, 0.8 Hz, H-6’), 3.83 (1H, bs, H-
5’), 3.96 (1H, dt, J 15.0, 7.5 Hz, H-7a), 4.28 (1H, t, J 9.0 Hz, H-4’), 4.36 (1H, ddd, J 
11.0, 5.1, 2.3 Hz, H 6’), 5.52 (1H, s, H-2’), 6.02-6.13 (1H, m, H-6), 6.17 (1H, dt, J 9.4, 
3.2 Hz, H-5), 7.11-7.18 (2H, m, Ph), 7.32-7.54 (8H, m, Ph) ppm. 13C NMR (δC, 100 
MHz, CDCl3) 24.27 (C-7), 39.23 (C-3a), 40.41 (C-4), 41.43 (C-7a), 66.44 (C-5’), 71.89 
(C-6’), 80.46 (C-4’), 101.10 (C-2’), 126.06 (C-H, Ph), 126.42 (C-H, Ph), 128.13 (C-6), 
128.23 (C-H, Ph), 128.83 (C-H, Ph), 128.94 (C-H, Ph), 129.12 (C-H, Ph), 130.14 (C-5), 
131.56 (Cq, Ph), 137.49 (Cq, Ph), 178.53 (C=O), 179.81 (C=O) ppm. HRMS (ESI): 
calcd for C24H23NNaO5: 428.1467; found: 428.1468. 
Compound 6a: [α]D20 -118.2° (c 0.45, EtOAc). max (nujol) 3442, 1690, 1411, 1072 cm-1. 
1H NMR (δH, 400 MHz, CDCl3) 2.17-2.31 (1H, m, H-7), 2.64-2.76 (1H, m, H-4), 2.83 
(1H, ddd, J 15.4, 7.0, 1.6 Hz, H-7), 3.27 (1H, td, J 8.0, 1.6 Hz, H-3a), 3.65 (1H, t, J 10.4 
Hz, H-6’), 3.81 (2H, dd, J 9.0, 5.5 Hz, H-7a + H-5’), 4.27 (1H, dd, J 10.8, 5.1 Hz, H-6’), 
4.44 (1H, t, J 9.6 Hz, H-4’), 5.64 (1H, s, H-2’), 6.02 (1H, ddt, J 12.9, 6.5, 3.3 Hz, H-6), 
6.41 (1H, dt, J 9.4, 3.5 Hz, H-5), 7.19-7.22 (2H, m, Ph), 7.35-7.40 (4H, m, Ph), 7.43-
7.47 (2H, m, Ph), 7.50-7.52 (2H, m, Ph) ppm. 13C NMR (δC, 100 MHz, CDCl3) 25.00 (C-
7), 39.50 (C-3a), 40.09 (C-7a), 41.32 (C-4), 68.05 (C-5’), 71.24 (C-6’), 79.47 (C-4’), 
100.79 (C-2’), 126.08 (C-H, Ph), 126.54 (C-H, Ph), 127.54 (C-6), 128.19 (C-H, Ph), 
128.60 (C-H, Ph), 128.85 (C-H, Ph), 129.08 (Cq, Ph), 130.62 (C-5), 131.89 (Cq, Ph), 
137.70 (Cq, Ph), 177.21 (C=O), 179.05 (C=O) ppm. HRMS (ESI): calcd for 
C24H23NNaO5: 428.1473; found: 428.1468. 
5. Compound 5a: H-5: 6.40 (dt, J 3.2, 9.2 Hz), H-2’: 5.64 (s); Compound 5b: H-5: 6.38 
(dt, J 3.6, 9.2 Hz), H-2’: 5.66 (s); Compound 5c: H-5: 6.34 (dt, J 3.6, 9.2 Hz); H-2’: 
5.67 (s); Compound 5d: H-5: 6.28 (dt, J 3.6, 9.2 Hz), H-2’: 5.67 (s); Compound 6a: 
H-5: 6.17 (dt, J 3.2, 9.2 Hz), H-2’: 5.51 (s); Compound 6b: H-5: 6.12 (dt, J 3.6, 9.6 
Hz), H-2’: 5.54 (s); Compound 6c: H-5: 6.16 (bs), * H-2’: 5.42 (s); Compound 6d: H-
5: 6.08 (br t, J 2.0 Hz), *H-2’: 5.42 (s).* These signals coincide with H-6. 
6. a) Ding, X.; Ukaji, Y.; Fujinami, S.; Inomata, K. Chem. Lett. 2003, 32, 582-583; b) 
Ukaji, Y.; Inomata, K. Synlett 2003, 1075-1087. 
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7. a) Ward, D. E.; Souweha; M. S. Org. Lett. 2005, 3533-3536; b) Ward, D. E.; 
Mohammad, S. A. Org. Lett. 2000, 3937-3940. 
8. Preparation of solution A 
 A solution of diene 1 (0.05 g; 0.22 mmol) in dry toluene (1.0 mL) was added to a 
solution of Me2Zn (1.2 M) in toluene (178 µL; 0.22 mmol) at 0 ºC and stirred for 5 min.  
Preparation of solution B 
 A solution of (S)-BINOL (0.061 g; 0.22 mmol) in dry toluene (1.0 mL) was added 
to a solution of MeMgBr (1.4 M in toluene-THF; 152 μL; 0.22 mmol) at 0 ºC and stirred 
for 5 min. Solution A was added to solution B, the mixture diluted with dry toluene (1.8 
mL) and stirred for 5 min. This mixture was refrigerated at -78 ºC and a solution of 
maleimide (3, 0.02 g; 0.22 mmol) in dry toluene (1.5 mL) was then added. The 
temperature was allowed to rise gradually to rt. The reaction was complete after 17 d 
and was quenched with an aq. sat. solution of NaHCO3 (1 mL), filtered through a pad of 
Celite®, and the Celite® was washed with EtOAc (4 × 10 mL). The filtrates were 
combined and concentrated under reduced pressure to give a yellow oil that was 
submitted to “dry-flash” chromatography using a mixture of PE (40-60)-Et2O. (S)-BINOL 
was recovered (0.035 g; 57 %) from PE-Et2O (1:1), and the product was eluted with 
PE-Et2O (1:2.3) (0.024 g; 33 %). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
2.3
Asymmetric Diels-Alder Cycloadditions of D-Erythrose 1,3-
Butadienes to Achiral t-Butyl 2H-Azirine 3-Carboxylate 
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1. Abstract 
 Two D-erythrose 1,3-butadienes were reacted with electrophilic achiral t-butyl 
2H-azirine 3-carboxylate giving cycloadducts with good yields and moderate selectivity. 
The isomers could be separated to give the major (R)-isomers at C-2 in approximately 
50 % yield in both cases. Alternatively LACASA-DA methodology was applied to one of 
the reactions leading to homochiral (R)- and (S)-products by changing the chiral nature 
of an extra chiral BINOL inductor used.  
 
2. Introduction 
 D-Erythrose is an important chiral synthon used in many syntheses.1-5 However, 
the use of its 1,3-butadiene derivatives 1 is not common. The lack of interest in these 
dienes, namely as counterparts in Diels-Alder cycloadditions (DA), is probably due to 
the poor facial selectivity associated with DA thermal processes, although exceptions 
are known.6,7  Nevertheless, a series of interesting compounds could be envisaged by 
functional group transformations (FGT) of these DA cycloadducts mainly in the field of 
sugars/aza-sugars. Therefore we attempted to better understand the facial selectivity of 
dienes 1 with dienophiles in order to improve the selectivity. At first, 5-membered ring 
dienophiles (maleimides and 4-phenyl/methyl-1,2,4-triazoline-3,5-dione) were 
examined. The major or exclusive isomer obtained [(S) at C-2] was formed by the 
attack of the dienophile at the si face of the diene.7 Having in mind that the DA 
cycloadduct of D-erythrose-1,3-butadienes to 2H-azirines enables the synthesis of 
analogue precursors of neuraminic acid 3, especially if the C-2 (R)-configuration 
isomers could be formed in reasonable yields, we tested this C=N dienophile to see if 
an approach by the re face would be preferred. Figure 1 represents the close 
relationship of neuraminic acid with the (R)-cycloadduct 4a. Functionalization of the 
C=C bond would give an epimeric analogue of compound 3 at C-6.  
 
 
 
 
Figure 1 Structural comparison of neuraminic acid 3 and (2R)-cycloadduct 4a. 
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3. Results and discussion 
 Two D-erythrose butadienes 1a,b were prepared according to the literature6,7 
and combined with t-butyl 2H-azirine 3-carboxylate, obtained in situ from t-butyl -azido 
acrylate;9 the reaction occurs at 60 ºC. Two products were formed in each reaction in 
the same ratio. Primary cycloadducts obtained by the reaction of diene 1b lost the t-
butyldimethylsilyl group attached to the erythrose moiety according to 1H and 13C NMR 
spectra, thus giving the free alcohols 4b and 5b (Scheme 1). 
 
Scheme 1 Thermal cycloaddition of 2H-azirine 2 to diene 1. 
 
 
 The regiochemistry of the cycloaddition results from the attack of the 
nucleophilic terminal of the diene to the electrophilic center in the azirine.8 Such an 
approach can develop a hydrogen bond interaction between the nitrogen azirine ring 
atom of the dienophile and the hydroxyl group at the diene, favouring an attack at the si 
face (bottom representation in Figure 2) over re face (top representation depicted in 
Figure 2). However the stereochemistry of the products is incompatible with such 
reagent interactions: an approximate (R):(S) ratio of 2.5:1 was obtained in the thermal 
reaction of diene 1a to azirine 2 (Scheme 1). 
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 Figure 4 shows an alternative interaction of the approaching azirine to the re/si 
faces of the diene. The re approach shows a proximity between the nitrogen lone pair 
of the azirine and the  current of the aromatic ring. Attractive interactions at the van 
der Waals’ distance were explored by using aromatic rings with a wide range of 
substituents in triptycene scaffold.10 Many examples of such a positive interaction have 
also been reported between the oxygen atom of carbonyls and the aromatic groups in 
proteins, within an average of 3.5 Å distance.11 In the si approach, the lone pair of the 
nitrogen is too far from the phenyl group due to the different directions of attack. The 
(R)-configuration product would also be favoured from a kinetic profile point of view.  
 
 
Figure 4 The two possible endo approaches of 2H-azirine 2 to diene 1a. 
 
 
 On the other hand, the conformational free energy difference between the (R)-
and (S)-diastereomers using computational free energy perturbation methods was 
determined to be -8.9 kcal/mol, meaning that the (S)-product is thermodynamically 
preferred relative to the (R)-product. The isomeric ratio of products 4a/5a probably 
reflects the major importance of kinetics over thermodynamics in this cycloaddition. 
 The identification of isomers 4a/5a was made by measuring the dihedral angle 
between the two six-membered ring moieties in the more stable conformers A, B [(R)-
isomer], and C, D [(S)-isomer] (Figure 3). Both A and B display small dihedral angles: 
A 68º, B 47º; these values are in accordance with the small coupling constant shown in 
the 1H NMR spectrum (J ~2 Hz) for (R)-diastereomer. Considering that conformers A 
and B make up 98 % of the total population in chloroform an obvious relationship of the 
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 With the aim of enhancing the formation of compound 4a versus 5a, we thought 
that a coordination reaction might induce kinetics to completely control the process. 
Previous experience with a bimetallic complex of Mg(II) and Zn(II) having (R)-/(S)-
BINOL as a chiral ligand was applied before in a Diels-Alder cycloaddition based on a 
Lewis acid-catalysed reaction of a “self-assembled” complex (LACASA-DA). This 
method involves the existence of a free hydroxyl group in the diene and a carbonyl in 
the dienophile to coordinate all reagents and led to very good facial selectivities. 2,4-
Pentadienol was combined to nitroso dienophiles,12,13 and to methyl acrylate14,15 in the 
presence of tartaric acid or BINOL with excellent selectivities. We have previously 
reported on some control in reactions of diene 1a with maleimides.16 
 Combining diene 1a with azirine 2 at low temperatures gave homochiral 
compounds 4a or 5a depending on the stereochemistry of the BINOL (Scheme 2). 
Compound 5a was obtained in 47 % yield in the presence of (R)-BINOL, and 4a in 28 
% yield in the presence of (S)-BINOL. The excess reacting diene remained untouched 
according to 1H NMR spectra, even after the addition of fresh portions of azirine or 
prolonged reaction times. 
 
 
Scheme 2 The LACASA-Diels-Alder cycloaddition between diene 1a and 2H-azirine 2 tethered 
in a bimetallic complex of Mg(II) and Zn(II) having (R)-/(S)-BINOL as a chiral ligand. 
 
 
4. Conclusion 
 D-Erythrose 1,3-butadienes were combined with t-butyl 2H-azirine 3-
carboxylate. Thermal reactions occur at 60 ºC with moderate facial selectivity, 
favouring the (R)-enantiomer at C-2. The approach of the reagents has been inversed 
relative to other cases in the literature. The two (R)-products were separated to give 
the major isomer in 46 % and 47 % yield in cases a and b respectively. The moderate 
selectivity was explained by the antagonism of thermodynamics and kinetics of the 
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cycloadditions. An LACASA-DA methodology using Zn/Mg bimetallic complexes and 
BINOL as an extra chiral inductor gave pure (R)- and (S)-products. A significant 
improvement in the yield was achieved in the case of the (S)-product but not in the (R)-
product. The relative configuration of the new stereocentre in the products was 
obtained by combining the results of the conformational analysis with the 1H NMR 
coupling constants. 
 
 
5. Experimental section 
5.1. General 
 Starting with D-erythrose 1,3-butadienes 1a,b were obtained from (2R,4R,5R)-
5-hydroxy-2-phenyl-1,3-dioxane-4-carbaldehyde according to the literature.6,7 2H-
Azirine was prepared in situ from α-azido t-butyl acrylate.9 All other reagents were 
purchased and used without further purification. Solvents employed in reactions were 
dried: CH2Cl2 was freshly distilled under CaH2, and toluene was submitted to simple 
distillation to remove the head fraction. The petroleum ether 40-60 ºC used in flash 
chromatography was previously distilled, while all other solvents were used as 
purchased. Glassware was dried prior to use. Compounds were purified by dry flash 
chromatography, using silica 60 <0,063 mm as the stationary phase and water pump 
vacuum. TLC plates (Silica Gel 60 F254, Macherey-Nagel) were visualized either at a 
UV lamp or in I2. 1H NMR and 13C NMR were run on a Varian Unity Plus 300, or 
Brucker Avance III 400 or Bruker BioSpin GmbH spectrometers. Infrared spectra were 
recorded on a Bomem MB 104 or on a Perkin-Elmer spectrophotometer. Samples were 
run as nujol mulls and oils as thin films. MS spectra were recorded on a VG Autospec 
M. spectrometer.  
 
5.2. Reaction of D-erythrose diene 1a to t-butyl 2H-azirine 3-carboxylate 2 
5.2.1. Synthesis of cycloaducts 4a and 5a 
5.2.1.1. Thermal Method  
 The -azido acrylate9 (0.151 g; 0.893 mmol) was dissolved in toluene (16 mL) 
and refluxed under a nitrogen atmosphere for 90 min. The heating source was then 
removed and when the temperature reached 60 ºC, a solution of diene 1a (0.041 g; 
0.177 mmol) in a 1:1 mixture of toluene/DCM (2 mL) was added. The mixture was 
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maintained at 60 ºC for 3h. The solvent was evaporated until dryness and the crude 
subjected to flash chromatography in a 1:4 mixture of petroleum ether/ethyl ether. Two 
isomeric oily products were obtained. The (S)-Isomer, 5a, (0.018 g; 27 %) was 
contaminated with the (R)-isomer 4a, and isomer (R)-4a was obtained pure (0.031 g; 
47 %).  
Isomer (R)-4a: [α]D20 -14.9° (c 1.5, CH2Cl2). max (neat) 3368, 2977, 1723, 1158 cm−1. 
1H NMR (δH, 400 MHz, CDCl3) 1.48 (9H, s, 3 × CH3), 2.06 (1H, s, H-7), 2.36 (1H, s, H-
7), 2.65 (2H, t, J 4.0 Hz, H-5), 3.67 (1H, t, J 10.4 Hz, H-6’), 3.77 (1H, dd, J 9.3, 3.1 Hz, 
H-4’), 4.20 (1H, d, J 2.0 Hz, H-2), 4.33 (1H, dd, J 10.6, 5.3 Hz, H-6’), 4.38-4.50 (1H, m, 
H-5’), 5.44 (1H, s, H-2’), 5.46-5.54 (1H, m, H-3), 5.78 (1H, ddt, J 10.4, 5.4, 3.4 Hz, H-
4), 7.33-7.35 (3H, m, Hm and Hp, Ph), 7.42-7.45 (2H, m, Ho, Ph) ppm. 13C NMR (δC, 
100 MHz, CDCl3) 22.4 (C-5), 27.8 (CH3), 27.9 (CH3), 28.0 (CH3), 30.9 (C-7), 36.8 (C-6), 
53.0 (C-2), 61.0 (C-5’), 71.1 (C-6’), 81.5 (C-6), 81.6 (Cq, t-Bu), 85.0 (C-4’), 101.4 (C-2’), 
123.5 (C-3), 123.6 (C-4), 126.1 (Co, Ph), 128.1 (Cm, Ph), 128.8 (Cp, Ph), 138.1 (Cq, 
Ph), 172.0 (C=O) ppm. HRMS (ESI): calcd for C21H28NO5: 374.1960; found: 374.1962. 
Isomer (S)-5a: [α]D20 -11.2° (c 1.05, CHCl3). max (neat) 3366, 2977, 1724, 1155 cm−1. 
1H NMR (δH, 400 MHz, CDCl3) 1.47 (9H, s, 3 × CH3), 2.00 (1H, s, H-7), 2.22 (1H, s, H-
7), 2.67 (2H, dd, J 4.4, 1.6 Hz, H-5), 3.46 (1H, dd, J 9.6, 8.4 Hz, H-4’), 3.69 (1H, t, J 
10.8 Hz, H-6’), 5.51 (1H, s, H-2’), 3.96 (1H, d, J 10.0 Hz, H-2), 4.03 (1H, ddd, J 10.1, 
8.7, 5.2 Hz, H-5’), 4.38 (1H, dd, J 10.8, 5.2 Hz, H-6’), 5.75-5.84 (2H, m, H-3 + H-4), 
7.35-7.38 (3H, m, Hm + Hp, Ph), 7.47-7.50 (2H, m, Ho, Ph) ppm. 13C NMR (δC, 100 
MHz, CDCl3) 22.3 (C-5), 27.9 (3×CH3; C-7), 39.4 (C-6), 59.9 (C-2), 68.1 (C-5’), 70.5 (C-
6’), 80.4 (C-4’), 81.6 (Cq, t-Bu), 101.0 (C-2’), 120.8 (C-3 or C-4), 123.8 (C-3 or C-4), 
126.0 (Co, Ph), 128.2 (Cm, Ph), 128.9 (Cp, Ph), 137.6 (Cq, Ph), 170.6 (C=O) ppm. 
HRMS (ESI): calcd for C21H28NO5: 374.1952; found: 374.1962. 
 
5.2.1.2. LACASA-DA Methodology 
i) Synthesis of cycloadduct 4a 
Solution A: a solution of diene 1a (0.100 g; 0.43 mmol) in dry toluene (2.2 mL) 
was added to a solution of Me2Zn (1.2 M) in toluene (359 µL; 0.43 mmol) at 0 ºC, and 
stirred for 5 min.  
Chapter 2.3 
 
 
105 
Solution B: a solution of (S)-BINOL (0.123 g; 0.43 mmol) in dry toluene (2.2 
mL) was added to a solution of MeMgBr (1.4 M) in toluene/THF (307 µL; 0.43 mmol) at 
0 ºC, and stirred for 5 min. 
 Solution A was added to solution B, diluted with dry toluene (3.6 mL), and 
stirred for 5 min. This mixture was cooled to -78 ºC and a solution of t-butyl 2H-azirine-
3-carboxylate (0.061 g; 0.43 mmol) in dry toluene (3 mL) was then added. The reaction 
was stirred at -20 ºC for 24 h. A new portion of t-butyl 2H-azirine-3-carboxylate was 
then added and the reaction was stirred at rt for 5 days. The reaction was quenched 
with NaHCO3 aq. sat. sol. (1 mL), filtered through a pad of Celite®, and the Celite® was 
washed with EtOAc (4 × 10 mL). The filtrates were combined and concentrated under 
reduced pressure to give an orange oil corresponding to a 2:1 mixture of diene starting 
material and the expected product. The crude was submitted to ‘dry-flash’ 
chromatography using a mixture of PE (40-60)-Et2O. The (S)-BINOL was recovered 
from PE-Et2O 1:1 (0.069 g; 56 %) and the product was eluted with PE/Et2O 2:3 to give 
the (R)-isomer as an oil (0.044 g; 28 %). 
 
ii) Synthesis of cycloadduct 4b 
Solution A: a solution of diene 1a (0.100 g; 0.43 mmol) in dry toluene (2.2 mL) 
was added to a solution of Me2Zn (1.2 M) in toluene (359 µL; 0.43 mmol) at 0 ºC, and 
stirred for 5 min.  
Solution B: a solution of (R)-BINOL (0.123 g; 0.43 mmol) in dry toluene (2.2 
mL) was added to a solution of MeMgBr (1.4 M) in toluene/THF (307 µL; 0.43 mmol) at 
0 ºC, and stirred for 5 min.  
Solution A was added to solution B, diluted with dry toluene (3.6 mL), and 
stirred for 5 min. This mixture was cooled to -78 ºC and a solution of t-butyl 2H-azirine-
3-carboxylate (0.061 g; 0.43 mmol) in dry toluene (3 mL) was added. After mixturing 
the reagents, the temperature was allowed to rise gradually to rt. The reaction was 
quenched with NaHCO3 aq. sat. sol. (1 mL), filtered through a pad of Celite®, and the 
Celite® washed with EtOAc (4 × 10 mL). The filtrates were combined and concentrated 
under reduced pressure to give an orange oil, consisting of a 1:1 mixture of starting 
diene and product. The crude was submitted to ‘dry-flash’ chromatography using a 
mixture of PE (40-60)-Et2O. The (R)-BINOL was recovered from PE-Et2O 3:1 (0.076 g; 
62 %) and the product was eluted with PE-Et2O 1:1 to give the (S)-isomer as an oil 
(0.076 g; 47 %). 
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5.2.2. Reaction of D-erythrose diene (1b) and t-butyl 2H-azirine 3-
carboxylate (2) 
5.2.2.1. Thermal Method  
 The t-butyl -azido acrylate (0.340 g; 2.01 mmol) was dissolved in toluene (30 
mL) and refluxed under a nitrogen atmosphere for 90 min. The heating source was 
removed and when the reaction mixture temperature reached 60 ºC, a solution of diene 
1b (0.184 g; 0.386 mmol) in DCM (4 mL) was added. The mixture was maintained at 
60 ºC for 5h. A second portion of azirine was prepared (0.180 g; 1.06 mmol) in dry 
toluene (18 mL) and added to the reaction mixture and stirred further at 60 ºC for 1.5 h. 
The solvent was evaporated until dryness, after which flash chromatography was 
carried out using petroleum ether/ethyl ether 30 % as the eluent. Two isomeric 
compounds were obtained in 78 % overall yield, and separated as oils: (S)-isomer 5b 
(0.063g; 32 %) and (R)-isomer 4b (0.090g; 46 %).  
Isomer (R)-4b: viscous oil. [α]D20 -40.5° (c 1.05, CHCl3). max (neat) 3746, 3682, 3093, 
3067, 3037, 3005, 1727, 1678, 1164, 1135, 1090, 1030, 841 cm-1. 1H NMR (δH, 800 
MHz, CDCl3) 0.10 (3H, s, SiCH3), 0.12 (3H, s, SiCH3), 0.92 (9H, s, SiCCH3), 1.50 (9H, 
s, OCCH3), 2.06 (1H, s, H-7), 2.30 (1H, s, H-7), 2.54 (1H, d, J 17.8 Hz, H-5), 2.64 (1H, 
bs, OH), 2.74 (1H, d, J 17.7 Hz, H-5), 3.66-3.70 (2H, m, H-4’ + H-6’), 4.33-4.37 (2H, m, 
H-6’ + H-2), 4.41 (1H, td, J 9.8, 5.4 Hz, H-5’), 4.58 (1H, br t, J 2.2 Hz, H-3), 5.43 (1H, s, 
H-2’), 7.31-7.38 (3H, m, CH, Ph), 7.42-7.47 (2H, m, CH, Ph) ppm. 13C NMR (δC, 100 
MHz, CDCl3) -4.6 (SiCH3) -4.4 (SiCH3), 18.0 (SiC(CH3)3), 25.6 (SiC(CH3)3), 27.7 (C-5), 
28.0 (C-CH3), 30.9 (C-7), 54.0 (C-2), 38.4 (Cq, t-Bu), 61.3 (C-5’), 71.1 (C-6’), 81.7 
(Cq), 84.9 (C-4’), 99.2 (C-3), 101.3 (C-2’), 126.0 (CH, Ph), 128.1 (CH, Ph), 128.7 (CH, 
Ph), 138.1 (Cq, Ph), 147.3 (C-4), 171.6 (C=O) ppm. HRMS (FAB): calcd for 
C27H42NO6Si: 504.2781; found: 504.2786. 
Isomer (S)-5b: viscous oil. [α]D20 -4.0° (c 1.8, CHCl3). max (neat) 3566, 3554, 3092, 
3068, 3036, 1727 cm−1. 1H NMR (δH, 400 MHz, CDCl3) 0.15 (3H, s, SiCH3), 0.16 (3H, s, 
SiCH3), 0.93 (9H, s, SiC(CH3)3), 1.47 (9H, s, OC(CH3)3), 1.99 (1H, s, H-7), 2.21 (1H, s, 
H-7), 2.56 (1H, dd, J 17.6, 0.7 Hz, H-5), 2.77 (1H, dtd, J 17.6, 2.5, 1.1 Hz, H-5), 3.42 
(1H, dd, J 9.5, 8.8 Hz, H-4’), 3.68 (1H, t, J 10.8, H-6’), 4.00 (1H, ddd, J 10.1, 8.7, 5.2 
Hz, H-2), 4.07 (1H, d, J 9.7 Hz, H-5’), 4.38 (1H, dd, J 10.8, 5.2 Hz, H-6’), 4.84-4.91 (1H, 
m, H-3), 5.52 (1H, s, H-2’), 7.33-7.40 (3H, m, C-H, Ph), 7.45-7.50 (2H, m, C-H, Ph) 
ppm. 13C NMR (δC, 100 MHz, CDCl3) -4.5 (SiCH3), -4.4 (SiCH3), 18.0 (SiC(CH3)3), 25.6 
(SiC(CH3)3), 27.9 (C-CH3), 28.1 (C-5), 28.2 (C-7), 40.9 (Cq, t-Bu), 60.4 (C-5’), 68.0 (C-
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2), 70.4 (C-6’), 81.2 (C-4’), 81.8 (Cq), 95.8 (C-3), 100.7 (C-2’), 125.8 (CH, Ph), 128.2 
(CH, Ph), 128.8 (CH, Ph), 137.6 (Cq, Ph), 148.1 (C-4), 170.4 (C=O) ppm. HRMS 
(FAB): calcd for C27H42NO6Si: 504.2781; found: 504.2779. 
 
5.3. Material and methods 
 Molecular dynamic (MD) simulations were performed with the GROMACS 
package version 4.5.4 using de AMBER03/GAFF force field. The geometry of each 
azirine enantiomer was optimized with a quantum mechanical method at the Hartree-
Fock level with the 6-31G(d) basis set using GAMESS. This optimized geometry and 
the quantum mechanical electrostatic potential was used to calculate the partial atomic 
charges using the RESP fitting method. The azirine molecules were solvated with 500 
chloroform solvent molecules in a cubic box with dimension of 4.4 × 4.4 × 4.4 nm. The 
equations of motion were numerically integrated using a timestep of 2 fs. The 
nonbonded interactions were treated with a cut off of 0.9 nm and updated every 5 
steps. Long-range electrostatic interactions were treated with particle-mesh-ewald 
(PME) using a fourier spacing of 1.2 nm and a PME order of 4. The system was 
simulated in an isothermal and isochoric ensemble using the Berendsen thermostat at 
300 K and relaxation time of 0.1 ps. The pressure coupling was also accomplished with 
the Berendsen barostat with a relaxation time of 0.5 ps and isothermal compressibility 
of 4.5 x 10-5 bar. All bonds were constrained using the LINCS algorithm. An initial 
energy minimization consisting of 5000 steps was performed using the steepest 
descent algorithm. We performed one long MD simulation of 400 ns for each system. 
Conformations were recorded every 1 ps. 
 From these long MD simulations the multidimensional free energy landscape of 
each azirine enantiomer was calculated. The multidimensional free energy landscape 
was calculated using a principal component analysis (PCA) approach based on the 
structural dissimilarity of all pairs of conformations recorded. The protocol for the PCA 
calculations and identification of the lowest free energy conformations used herein was 
the same as described by Sara et al.17  
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1. Abstract 
 1,4-Pentadienol was combined with electrophilic t-butyl 2H-azirine 3-carboxylate 
under a self-assembly LACASA-DA methodology, using BINOL as chiral inductor. 
Cycloadducts were obtained with very high enantioseletivity (>99 % ee), and yields, in 
both enantiomeric forms, by changing the chirality of BINOL. Cycloadducts led to 
polihydroxylated pipecolic acids of two types, after two simple chemical 
transformations. 
 
 
 
 
2. Results and Discussion 
 L-Pipecolic acid 1 (Figure 1) is a natural non proteinogenic -amino acid 
commonly found in plants. Hydroxypipecolic acids can be considered as expanded 
hydroxylated homoprolines or as constrained serine derivatives. As such, replacement 
of natural amino acids in bioactive compounds by this fragment may affect the 
physiological and pathological processes in which they are implicated.1 Also many 
polihydroxylated pipecolic acids have been reported with biological interest: e.g. -
homonojirimycin (2), a potent inhibitor of intestinal -glucosidases;2 a compound 
related to -homonojirimycin, 3, which is a potential immunosuppressive agent;3 and a 
fused aziridine 4, known as an inactivator of glucosidases4 (Figure 1). Therefore much 
effort has been directed towards the development of efficient syntheses of pipecolic 
acid related compounds. Most of the synthetic approaches involve chiral reagents as 
starting materials, but new strategies have emerged employing asymmetric catalysis 
instead.5 
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Figure 1 Pipecolic acid (1) and some related compounds (2-4). 
 
 
 Our group has been engaged in the stereoselective synthesis of 
polihydroxylated piperidines having Diels-Alder cycloaddition (DA) as the key step.6 
E.g. t-butyl 2H-azirine 3-carboxylate 5 was combined with a D-erythrose 1,3-butadiene 
in a LACASA-DA leading to the synthesis of a neuraminic acid precursor.7 In the 
present work the same electrophilic dienophile (5) was combined to the achiral 2,4-
pentadienol (6) aiming the DA cycloadduct, precursor of pipecolic acid related 
compounds. 
 2,4-Pentadienol (6) was reacted to t-butyl 2H-azirine 3-carboxylate (5), obtained 
in situ from t-butyl -azido acrylate at 120 ºC, in a DA cycloaddition.8 The reaction was 
catalysed by a bimetallic complex of Mg and Zn tethering the reagents to (R)- /(S)-
BINOL (Figure 2). The reactions proceeded smoothly at -20 ºC to give the expected 
cycloadducts 7 in moderate yields (47-49 %) (Scheme 1). A minor product was 
obtained in each reaction together with the major compound 7. Their structure was 
identified as being 8, formed by opening the aziridine moiety in compound 7. Major 
features of compounds 8 are 1H NMR spectra showing the presence of two sets of 
doublets at δ 3.46 and 3.66 ppm due to the germinal protons H-6’, instead of the typical 
singlets of methylene aziridine protons at δ ~2 ppm with zero coupling constant 
between them.9 
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Scheme 1 
 
 
 The formation of compounds 8 is explained by the presence of residual water in 
toluene (the solvent of the reaction), which under the acidic reaction conditions 
promote the nucleophilic attack that would be otherwise ineffective. When freshly 
distilled toluene, dried over Na(s), was used in the reaction, the amount of 8 was 
considerably reduced. Fortunately the hydrolysis can be reverted by treatment of 
compound 8 with base giving back cycloadduct 7. This was shown for the reaction 
mixture obtained in the cycloaddition carried out with (S)-BINOL chiral ligand. The 
obtained cycloadduct 7 showed to be levorotatory and the sub-product 8 of this same 
reaction switches the monochromatic light to the dextra. Treatment of compound (+)-8 
with N-methylmorpholine for 3 hours, gives back cycloadduct (-)-7 in quantitative yield. 
The absolute value of optical rotation of the obtained product is exactly the same as for 
cycloadduct (-)-7, which shows that the stereocentres are maintained untouched during 
the ring opening-closing processes (Scheme 2). Being so, the yields of cycloadducts 
can be largely improved from moderate to high (89-93 %). 
 
 
Scheme 2
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 The optical purity of cycloadducts 7, obtained from reactions with the (S)- and 
(R)-BINOL were determined by the 1H NMR analysis of (S)-camphanoate derivatives. A 
single set of singlets appears in spectra for methylene aziridine protons. Also only one 
set of singlets are due for methyl groups of the camphor unit, appearing at δ 0.76, 0.87 
and 0.93 ppm, assuring the presence of a unique enantiomer 7 in each reaction. 
 Cycloadditions followed the typical endo approach of reagents of 2H-azirines to 
1,3-dienes in general, except for furan and derivatives, in which the exo approach is 
preferential.10 Products formed by the endo approach are easily identified by the effect 
of electronic current of the C=C bond at the rear of the structure which creates an 
anisotropic effect over the aziridine methylenic protons, shielding these protons, that 
show up at ca 2 ppm.9  
 Figure 2 depicts the arrangement of all components tethered together in the 
transition state of cycloadditions. According to arrangement A (S)-BINOL induces the 
dienophile to attack the si face of the diene (bottom face). Otherwise (R)-BINOL leaves 
open the re face of the diene (top face) as represented in approach B. 
 
 
Figure 2 Different approaches of 2H-azirine 5 to 2,4-pentadienol (6) in the presence of (S)-
BINOL (A) or (R)-BINOL (B). 
 
 
 In the impossibility of getting appropriate crystals of camphanoate derivatives of 
cycloadducts 7 or 8 for a single crystal X-ray analysis to acknowledge the 
stereocentres configuration of compounds 7/8, a search in the lit. provided information 
of LACASA-DA cycloadditions between 2,4-pentadienol or 1-methoxy-2,4-hexadiene 
and methyl acrylate in the presence of (S)-BINOL. In both cases the dienophile attacks 
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the si face of the diene.7 To improve the evidence in the definition of the absolute 
configuration in products 7/8, it was decided to react an aza-dienophile, to which the 
same kind of interaction with Mg is expected relatively to 2H-azirine, with the aim of 
obtaining a known compound.6,11 For this purpose 2,4-pentadienol (6) and diethyl 
azodicarboxylate (DEAD) was self-assembled on a Lewis acid template incorporating 
(S)-BINOL as chiral ligand. The product, cycloadduct (-)-9, was then transformed to the 
known 5-epi-1-azafagomine (+)-10, by osmilation with formation compound (-)-11 
followed its hydrazinolysis (Scheme 3). The product obtained showed an optical 
rotation value of + 22.7º which is in accordance with optical rotation of homochiral 5-
epi-1-azafagomine 10 in lit.6 
 
Scheme 3
 
 
 Figure 3 shows the coordination and spatial arrangement of 2H-azirine 5 and 
DEAD in the reactive template incorporating (S)-BINOL. It is most likely that the 
absolute stereochemistry of products 7 and 8 will correspond to the approach of the 
azirine to the si face of diene 6 as occurs to DEAD. The reactions with (R)-BINOL gave 
products with the same 1H and 13C NMR spectra as those obtained with (S)-BINOL, but 
with the opposite optical rotation, showing that the azirine is attacking the re face of the 
diene this time. The stereochemistry of the products is opposite to that obtained in the 
reaction with (S)-BINOL. 
 
Chapter 2.4 
 
 
120 
 
Figure 3 Comparison of azirine (5) and DEAD approaches to the si face of 2,4-pentadienol (6).
 
 
 Functionalization of (+)-7 was carried in two steps. First, oxidation occurred 
under OsO4/NMO leading to a 5:1 mixture of stereoisomers; the major isomer (+)-12 
was isolated in 58 % yield by simply washing the crude material with ether. The major 
isomer (+)-12 was hydrolysed by treatment with aq. NaOH 1M at rt to furnish 
compound 13. After a 10 min stirring the reaction was complete. The obtained sodium 
salt was solubilized in water, stirred for another 10 min in the presence of Resin-H+ to 
give the carboxylic acid (+)-14, together with an open chain compound (+)-15. If the 
resin treatment was prolonged for 1h, pure compound (+)-15 was obtained in 35 % 
yield. To avoid the aziridine opening the reaction mixture obtained from sodium 
hydroxide treatment was filtered through a short column of Resin-H+, previously 
washed with water to reduce its acidity. Pure product (+)-14 was obtained in 43 % yield 
by this procedure (Scheme 4). 
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Scheme 4  
Conditions: i) OsO4, NMO, acetone/H2O 8:1, 7h, rt, 66 %; ii) NaOH 1M, 10 min, rt; iii) Resin-H+, 1h, rt, 35 
%; iv) Resin-H+ column, 43 %. 
 
 
 Enantiomers of compounds (+)-14, ent-14, and (+)-15, ent-15, were obtained 
from cycloadduct (-)-7 following the sequence described in Scheme 4 for cycloadduct 
(+)-7. 
 In conclusion, the combination of t-butyl 2H-azirine 3-carboxylate with 2,4-
pentadienol using a bimetallic complex of Zn, Mg tethered with BINOL gave primary 
adducts 7 and its hydrolysis products 8 in high yields and total enantioselectivity. Both 
enantiomers 7 were obtained by changing the chirality of BINOL. It was found that 
compounds 8 can be easily and cleanly transformed into 7 and vice-versa. Osmilation 
of the double bond, followed by t-butyl ester cleavage led to a two set of 
polihydroxylated pipecolic acids, 14 and 15 for each enantiomer. The absolute 
stereochemistry of products was proposed on the basis of similar reactions in lit. and 
by cycloaddition of 2,4-pentadienol to DEAD using (S)-BINOL, in which a known 
product with established configuration at the stereocentres was obtained. 
 
 
3. Experimental section 
3.1. General Methods 
 2H-Azirine 5 was prepared in situ from α-azido t-butyl acrylate.8 All other 
reagents were purchased and used without further purification. Solvents employed in 
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reactions were dried: CH2Cl2 was freshly distilled under CaH2 and toluene was 
submitted to simple distillation to remove the head fraction. Petroleum ether 40-60 ºC 
used in flash chromatography was previously distilled, and all other solvents were used 
as purchased. Glassware was dried prior to use. Compounds were purified by dry flash 
chromatography, using silica 60 <0.063 mm as the stationary phase and water pump 
vacuum. TLC plates (Silica Gel 60 F254, Macherey-Nagel) were visualized either at UV 
lamp or in I2. 1H NMR and 13C NMR were run on a Varian Unity Plus 300, or Brucker 
Avance III 400 or Bruker BioSpin GmbH spectrometers. Infrared spectra were recorded 
on a Bomem MB 104. Samples were run as nujol mulls and oils as thin films. Melting 
points are uncorrected. MS spectra were recorded on a VG Autospec M. spectrometer. 
 
3.2. Synthesis of (2S,6R)-t-butyl 2-(hydroxymethyl)-1-
azabicyclo[4.1.0]hept-3-ene-6-carboxylate (-)-7 and (2R,6S)-t-butyl 2,6-
bis(hydroxymethyl)-1,2,3,6-tetrahydropyridine-2-carboxylate (+)-8 
 Solution A: a solution of Me2Zn 1.2 M in toluene (0.991 mL; 1.19 mmol) was 
added to a solution of penta-2,4-dien-1-ol (0.10 g; 1.19 mmol) in dry toluene (6 mL) at 0 
ºC, and the mixture stirred for 5 min.  
 Solution B: a solution of MeMgBr 1.4 M in toluene/THF (0.849 mL; 2,38 mmol) 
was added to a solution of (S)-BINOL (0.340 g; 1.19 mmol) in dry toluene (6 mL) at 0 
ºC, and mixture stirred for 5 min.  
 Solution A was diluted with dry toluene (10 mL), added to solution B, stirred for 
5 min and then refrigerated at -78 ºC. To this mixture was added a solution of t-butyl 
2H-azirine-3-carboxylate (0.168 g; 1.19 mmol) in dry toluene (10 mL) during 5 min. The 
temperature was allowed to rise gradually to -20 ºC and the reaction mixture was 
transferred into a freezer for 24h and kept stirring. A new portion of t-butyl 2H-azirine-3-
carboxylate (0.168 g; 1.19 mmol) was added, and the reaction stirred for another 7 
days. The reaction was quenched with saturated solution of NaHCO3 (1 mL), filtered 
through a pad of Celite®, and the Celite® washed with EtOAc (2 × 20 mL). The filtrates 
were combined and concentrated under reduced pressure giving an orange oil. The 
crude mixture was purified by “dry-flash” chromatography (silica, petroleum ether/ 
diethyl ether, increasing polarity). (S)-BINOL was recovered with petroleum ether (3): 
ether (1) (0.250 g; 74 %); the minor isomer (+)-8 with petroleum ether (1)/ diethyl ether 
(3) (0.063 g; 22 %), and major isomer (-)-7 with diethyl ether (0.130 g; 49 %) as orange 
oils. 
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Major isomer (-)-7: [α]D20 -54.4° (c 2.0, CHCl3). max (nujol) 3234, 1731, 1659 cm−1. 1H 
NMR (δH, 400 MHz, CDCl3) 1.47 (9H, s, 3 × CH3), 1.93 (1H, s, H-1’), 2.01 (1H, s, H-1’), 
2.58-2.65 (1H, m, H-5), 2.65-2.73 (1H, m, H-5), 3.60 (1H, dd, J 10.8, 8.4 Hz, H-2’), 3.67 
(1H, dd, J 11.2, 4.8 Hz, H-2’), 3.78-3.80 (1H, m, H-2), 5.27-5.31 (1H, dm, J 10.4 Hz, H-
4), 5.73-5.79 (1H, m, H-3) ppm. 13C NMR (δC, 100 MHz, CDCl3) 22.6 (C-5), 27.7 (C-1’), 
27.9 (3 × CH3), 38.5 (C-6), 56.7 (C-2), 65.0 (C-2’), 81.4 (Cq, t-Bu), 121.8 (C-4), 124.4 
(C-3), 171.4 (C=O) ppm. HRMS (ESI): calcd for C12H20NO3: 226.1438; found: 
226.1435. 
Minor isomer (+)-8: [α]D20 +51.4 (c 1.8, CHCl3). max (neat) 3407, 1725, 1642 cm−1. 1H 
NMR (δH, 400 MHz, CDCl3) 1.47 (9H, s, 3 × CH3), 2.13 (1H, dm, J 16.8 Hz, H-3), 2.50-
2.70 (2H, bs, 2 × OH), 2.62 (1H, dddd, J 16.8, 5.8, 2.5, 1.0 Hz, H-3), 3.46 (1H, d, J 9.8 
Hz, H-2’), 3.54 (1H, dd, J 10.8, 4.4 Hz, H-6’), 3.65 (1H, dd, J 11.0, 3.8 Hz, H-6’), 3.66 
(1H, d, J 10.0 Hz, H-2’), 3.91-3.96 (1H, m, H-6), 5.57 (2H, dm, J 10.0 Hz, H-5), 5.79 
(1H, ddt, J 10.2, 5.8, 2.2 Hz, H-4) ppm. 13C NMR (δC, 100 MHz, CDCl3) 27.9 (3 × CH3), 
32.4 (C-3), 40.6 (C-2’), 53.6 (C-6), 61.1 (C-2), 65.3 (C-6’), 82.3 (Cq, t-Bu), 124.1 (C-4), 
126.8 (C-5), 171.6 (C=O) ppm. HRMS (ESI): calcd for C12H22NO4: 244.1549; found: 
244.1520. 
 
3.3. Synthesis of (2R,6S)-t-butyl 2-(hydroxymethyl)-1-
azabicyclo[4.1.0]hept-3-ene-6-carboxylate (+)-7 and (2S,6R)-t-butyl 2,6-
bis(hydroxymethyl)-1,2,3,6-tetrahydropyridine-2-carboxylate (-)-8 
 Solution A: a solution of Me2Zn 1.2 M in toluene (0.991 mL; 1.19 mmol) was 
added to a solution of penta-2,4-dien-1-ol (0.10 g; 1.19 mmol) in dry toluene (6 mL) at 0 
ºC, and stirred for 5 min.  
 Solution B: a solution of MeMgBr 1.4 M in toluene/THF (0.849 mL; 2.38 mmol) 
was added to a solution of (R)-BINOL (0.340 g; 1.19 mmol) in dry toluene (6 mL) at 0 
ºC, and stirred for 5 min.  
 Solution A was diluted with dry toluene (10 mL), added to solution B, stirred for 
5 min, and then refrigerated at -78 ºC. To this mixture was added a solution of t-butyl 
2H-azirine-3-carboxylate (0.168 g; 1.19 mmol) in dry toluene (10 mL) during 5 min. The 
temperature was allowed to rise gradually to -20 ºC and the reaction mixture was 
transferred into a freezer for 24h and kept stirring. A new portion of t-butyl 2H-azirine-3-
carboxylate (0.168 g; 1.19 mmol) was added, and the reaction stirred for another 7 
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days. The reaction was quenched with saturated solution of NaHCO3 (1 mL), filtered 
through a pad of Celite®, and the Celite® washed with EtOAc (2 × 20 mL). The filtrates 
were combined and concentrated under reduced pressure giving an orange oil. The 
crude oil was purified by “dry-flash” chromatography (silica, petroleum ether / diethyl 
ether). (R)-BINOL was recovered with petroleum ether (3) : ether (1) (0.246 g; 72 %); 
the minor isomer (-)-8 with petroleum ether (1) : diethyl ether (3) (0.081 g; 28 %) and 
major isomer (+)-7 with diethyl ether (0.127 g; 47 %) as orange oils. 
Major isomer (+)-7: [α]D20 +78.0° (c 0.75, CHCl3)  
Minor isomer (-)-8: [α]D20 -45.6° (c 1.5, CHCl3)  
 
3.4. Synthesis of camphanoate derivative of compound (-)-7 
 To a solution of (-)-7 (0.011 g; 0.045 mmol) in dry CH2Cl2 (6 mL) was added 
DMAP (4 mg), triethylamine (98 µL) and (S)-camphanic acid chloride (22 mg; 0.09 
mmol). The reaction was stirred at rt for 40 min. The solvent was removed by reduced 
pressure; the residuum was dissolved in ethyl acetate (10 mL), filtered through a pad of 
silica and washed with ethyl acetate (2 × 10 mL). The filtrate was concentrated, giving 
a yellow oil (0.018 g; 96%), which proved by 1H NMR to be an unique diastereomer.  
1H NMR (δH, 400 MHz, C6D6) 0.75 (3H, s, CH3), 0.86 (3H, s, CH3), 0.92 (3H, s, CH3), 
1.26 (2H, dt, J 10.0, 4.8 Hz, H-8’), 1.34 (9H, s, 3×CH3), 1.72 (1H, ddd, J 13.6, 9.0, 5.0 
Hz, H-9’), 1.81 (1H, s, H-1’), 2.07 (1H, s, H-1’), 2.10 (1H, ddd, J 13.4, 10.2, 4.9 Hz, H-
9’), 2.31 (1H, dd, J 18.4, 6.5 Hz, H-5), 2.74 (1H, dtdd, J 18.4, 3.3, 2.3, 1.3 Hz, H-5), 
3.65 (1H, bs, H-2), 3.87 (1H, dd, J 11.2, 4.4 Hz, H-2’), 4.27 (1H, dt, J 12.7, 6.4 Hz, H-
2’), 4.94 (1H, dm, J 10.4 Hz, H-3), 5.36 (1H, dddd, J 10.3, 6.6, 3.0, 2.2 Hz, H-4) ppm. 
 
3.5. Synthesis of camphanoate derivative of compound (+)-7 
 To a solution of (+)-7 (0.025 g; 0.11 mmol) in dry CH2Cl2 (13.5 mL) was added 
DMAP (9 mg), triethylamine (178 µL) and (S)-camphanic acid chloride (50 mg; 0.22 
mmol). The reaction was stirred at rt for 30 min. The solvent was removed at reduced 
pressure and the residuum was dissolved in ethyl acetate (10 mL), filtered through a 
short pad of silica, and washed with ethyl acetate (2 × 10 mL). Filtrate was 
concentrated, giving a yellow oil (0.019 g; 41 %), which proved by 1H NMR to be a 
single diastereomer.  
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1H NMR (δH, 400 MHz, C6D6) 0.76 (3H, s, CH3), 0.87 (3H, s, CH3), 0.91 (3H, s, CH3), 
1.26 (2H, dt, J 10.0, 4.8 Hz, H-8’), 1.33 (9H, s, 3×CH3), 1.72 (1H, ddd, J 13.6, 9.0, 5.0 
Hz, H-9’), 1.82 (1H, s, H-1’), 2.05 (1H, s, H-1’), 2.10 (1H, ddd, J 13.4, 10.2, 4.9 Hz, H-
9’), 2.31 (1H, dd, J 18.4, 6.5 Hz, H-5), 2.74 (1H, dtdd, J 18.4, 3.3, 2.3, 1.3 Hz, H-5), 
3.66 (1H, bs, H-2), 3.87 (1H, dd, J 11.2, 4.4 Hz, H-2’), 4.28 (1H, dd, J 11.1, 6.9 Hz, H-
2’), 4.94 (1H, dm, J 10.4 Hz, H-3), 5.36 (1H, dddd, J 10.3, 6.6, 3.0, 2.2 Hz, H-4) ppm. 
 
3.6. Conversion of (+)-8 into (-)-7 
 To a solution of a 3:1 mixture of (+)-8 and (-)-7 (0.122 g; 0.50 mmol) in acetone 
(1.6 mL) and water (0.2 mL) was added N-methylmorpholine (81 µL; 0.75 mmol), and 
the reaction mixture stirred for 3h at rt, then diluted with CH2Cl2 (10 mL) and washed 
with water (2 × 10 mL). The organic layer was dried over MgSO4, filtered and 
concentrated under reduced pressure, giving compound (-)-7 (0.112 g; 99 %). 
 
3.7. Synthesis of (S)-diethyl 3-(hydroxymethyl)pyridazine-1,2(3H,6H)-
dicarboxylate (-)-9 
 Solution A: a solution of Me2Zn 1.2 M in toluene (991 µL; 1.19 mmol) was 
added to a solution of penta-2,4-dien-1-ol (0.100 g; 1.19 mmol) in dry toluene (6 mL) at 
0 ºC, and stirred for 5 min.  
 Solution B: a solution of MeMgBr 1.4 M in toluene/THF (849 µL; 1.19 mmol) 
was added to a solution of (S)-BINOL (0.340 g; 1.19 mmol) in dry toluene (6 mL) at 0 
ºC, and stirred for 5 min.  
 Solution A was diluted with dry toluene (10 mL), added to solution B, stirred for 
5 min, and then refrigerated at -78 ºC. To this mixture was added a solution of diethyl 
azodicarboxylate (543 µL; 1.19 mmol) in dry toluene (10 mL). The temperature was 
allowed to rise gradually to rt and the reaction mixture was stirred for 18h. The reaction 
was quenched with saturated solution of NaHCO3 (1 mL), filtered through a pad of 
Celite®, and the Celite® washed with EtOAc (3 × 20 mL). The filtrates were combined 
and concentrated under reduced pressure giving a yellow oil. The crude oil was purified 
by “dry-flash” chromatography (silica, petroleum ether / diethyl ether). (S)-BINOL was 
recovered with petroleum ether (1) : ether (1) (0.200 g; 69 %) and product (-)-9 with 
diethyl ether (0.225 g; 73 %) as a yellow oil. 
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[α]D20 -23.4º (c 1.25, CHCl3). max (neat) 3483, 1707 cm−1. 1H NMR (δH, 400 MHz, 
CDCl3)* 1.23-1.30 (12H, m, 4 × CH3, A+B), 2.58 (1H, bs, OH), 3.35 (1H, dd, J 12.3, 9.5 
Hz, H-3’, A), 3.45 (1H, dd, J 12.0, 9.8 Hz, H-3’, B), 3.56-3.69 (2H, m, 2 ×H-3’, A+B), 
3.77 (1H, dd, J 13.5, 4.3 Hz, H-6, A), 3.91 (1H, bs, H-6, B), 4.11-4.26 (8H, m, 4 × CH2, 
A+B), 4.30 (1H, tdd, J 6.0, 3.9, 2.2 Hz, H-6, B), 4.34-4.44 (1H, m, H-6, A), 4.72 (2H, bs, 
H-3, A+B), 5.66-5.88 (4H, m, H-4 + H-5, A+B) ppm. 13C NMR (δC, 100 MHz, CDCl3)** 
14.3 (CH3, A), 14.4 (CH3, B), 42.2 (C-6, A), 43.6 (C-6, B), 55.9 (C-3, A), 56.9 (C-3, B), 
61.9 (C-3’, A+B), 62.6, 62.7, 62.8, 62.9 (CH2, A+B), 123.4, 124.2, 124,6, 125.2 (C-4 or 
C-5, A+B), 154.9, 155.7, 156.2, 156.3 (C=O, A+B) ppm. HRMS (ESI): calcd for 
C11H18N2NaO5: 281.1108; found: 281.1109. 
* 1H NMR analysis showed a 1:1 mixture of rotamers A and B, due to inversion of the nitrogen 
atoms lone pair within the six membered ring. 
** 13C NMR also showed peak duplication. 
 
3.8. Synthesis of (3R,4R,5S)-diethyl 4,5-dihydroxy-3-
(hydroxymethyl)piperazine-1,2-dicarboxylate (-)-11 
 To a solution of (-)-9 (0.115 g; 0.45 mmol) in acetone (0.5 mL) and water (0.25 
mL) was added N-methylmorpholine N-oxide (NMO) (0.079 g; 0.67 mmol) and solution 
of OsO4 4 % in water (48.6 µL; 0.017 eq.). The reaction mixture was stirred for 5 days 
at rt. The reaction was quenched with an aqueous solution of Na2S2O3 5 % (10 mL) 
and the mixture was stirred for 15 min. Then, the solution was concentrated under 
reduced pressure; the residuum was dissolved in EtOAc and filtered through a short 
column of silica. Concentration of filtrate gave compound (-)-11 as a colourless oil 
(0.079 g; 60 %). 
[α]D20 -17.0º (c 3.65, MeOH). max (neat) 3419, 2983, 2937, 1698 cm−1. 1H NMR (δH, 
400 MHz, CDCl3)* 1.23-1.32 (12H, m, 4 × CH3, A+B), 3.12 (1H, bd, J 10.8 Hz, H-6, A), 
3.21 (1H, bd, J 10.8 Hz, H-6, B), 3.50 (2H, t, J 11.6 Hz, H-3’, A), 3.62 (1H, d, J 8.0 Hz, 
H-3’, B), 3.65-3.95 (4H, bs, H-4 + H-5, A+B), 4.01 (2H, dd, J 13.2, 5.6 Hz, H-6, A), 
4.10-4.25 (9H, m, H-6, B + 4×CH2, A+B), 4.52-4.64 (2H, bs, H-3, A+B) ppm. 13C NMR 
(δC, 100 MHz, CDCl3)** 14.3, 14.4 (CH3, A+B), 44.0, 45.7 (C-6, A+B), 58.4, 59.0 (C-3, 
A+B), 61.9, 62.8 (C-3’, A+B), 63.0, 63.1 (CH2, A or B), 63.2, 63.3 (CH2, A or B), 64.0, 
64.3 (C-4 or C-5, A+B), 66.4, 66.7 (C-4 or C-5, A+B), 1555.2, 156.5 (C=O, A+B), 157.1, 
157.3 (C=O, A+B) ppm. HRMS (ESI): calcd for C11H20N2NaO7: 315.1163; found: 
315.1163. 
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* 1H NMR analysis showed a 1:1 mixture of rotamers A and B, due to inversion of the nitrogen 
atoms lone pair within the six membered ring. 
** 13C NMR also showed peak duplication. 
3.9. Synthesis of (3R,4R,5S)-3-(hydroxymethyl)piperazine-4,5-diol (+)-10 
 A solution of (-)-11 (0.060 g; 0.21 mmol) in NH2NH2.H2O (3 mL) was stirred in 
an oil bath during 18h, at 100 ºC. The mixture was concentrated under reduced 
pressure and the residuum was submitted to a “dry-flash” chromatography (silica; 
ethanol / NH4OH 25 %). The product was eluted with a 14:1 mixture of ethanol / 
NH4OH 25 % as a colourless oil ((+)-10; 0.026 g; 86 %). 
[α]D20 +22.7º (c 1.6, H2O) 
The spectroscopic data of the racemic mixture was reported before.11 
 
3.10. Synthesis of (2S,3S,4R,6S)-t-butyl 3,4-dihydroxy-2-(hydroxymethyl)-1-
azabicyclo[4.1.0]heptane-6-carboxylate (+)-12 
 To a solution of (+)-7 (0.075 g; 0.33 mmol) in acetone (1.60 mL) and water (0.20 
mL) was added NMO (0.057 g; 0.49 mmol) and solution of OsO4 4 % in water (35 µL; 
0.06 mmol), and stirred at rt for 7h. The reaction was quenched with aqueous solution 
of Na2S2O3 5 % (7.40 mL), and stirred for 10 minutes. The solvent was removed by 
reduced pressure; the residuum obtained was washed ethanol (3 × 20 mL), filtered 
through a short column of silica and concentrated yielding a brown solid which by 1H 
NMR spectrum proved to be a 5:1 mixture of isomers. The mixture was washed with 
diethyl ether and filtrated under vacuum, giving the major isomer (+)-12 as beige solid 
(0.057 g; 66 %). 
[α]D20 +73.3° (c 1, THF). mp 161-163 ºC. max (nujol) 3334, 3187, 1726 cm−1. 1H NMR 
(δH, 400 MHz, THF-d4) 1.40 (9H, s, 3×CH3), 1.77 (1H, d, J 1.6 Hz, H-1’), 1.93 (1H, dd, J 
14.8, 4.0 Hz, H-5), 1.97 (1H, d, J 1.2 Hz, H-1’), 2.83 (1H, dd, J 14.8, 4.0 Hz, H-5), 3.21-
3.28 (1H, m, H-3 or H-4), 3.28-3.34 (1H, m, H-3 or H-4), 3.65 (1H, dd, J 5.9, 3.6 Hz, H-
2), 3.69 (1H, bd, J 3.2 Hz, OH), 3.73 (1H, bd, J 5.6 Hz, OH), 3.74-3.82 (3H, m, 2×H-
2’+OH) ppm. 13C NMR (δC, 100 MHz, THF-d4) 28.0 (3×CH3), 30.3 (C-5), 35.3 (C-1’), 
36.0 (C-6), 57.1 (C-3 or C-4), 64.3 (C-2’), 66.7 (C-2), 67.6 (C-3 or C-4), 80.1 (Cq, t-Bu), 
172.5 (C=O) ppm. HRMS (ESI): calcd for C12H22NO5: 260.1420; found: 260.1429. 
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3.11. Synthesis of (2S,3S,4R,6S)-3,4-dihydroxy-2-(hydroxymethyl)-1-
azabicyclo[4.1.0]heptane-6-carboxylic acid (+)-14 
 To a solution of (+)-12 (0.009 g; 0.035 mmol) in 1,4-dioxane (2 mL) was added 
NaOH (1M, 3 mL) and stirred at rt for 10 min. The reaction mixture was filtrated through 
a column of resin-H+ (Dowex 50 WX8 16-40 Mesh) and filtrate was concentrated by 
reduced pressure, giving the product as yellow oil ((+)-14; 0.003 g; 43 %). 
[α]D20 +52.8° (c 0.6, MeOH). max (neat) 3422, 1653 cm−1. 1H NMR (δH, 400 MHz, D2O) 
1.86 (1H, s, H-1’), 1.95 (1H, s, H-1’), 2.29 (1H, dd, J 15.2, 3.6 Hz, H-3), 2.63 (1H, dd, J 
15.2, 4.4 Hz, H-3), 3.33-3.41 (1H, m, H-6), 3.50 (1H, dd, J 9.0, 2.2 Hz, H-4 or H-5), 
3.81 (1H, dd, J 12.0, 6.4 Hz, H-6’), 3.88-3.93 (2H, m, H-6’ + H-4 or H-5) ppm. 13C NMR 
(δC, 100 MHz, D2O) 30.7 (C-3), 33.8 (C-1’), 38.8 (C-2), 55.6 (C-6), 62.1 (C-6’), 65.8 (C-
4 or C-5), 66.1 (C-4 or C-5), 179.9 (C=O) ppm. HRMS (ESI): calcd for C8H14NO5: 
204.0794; found: 204.0801. 
 
3.12. Synthesis of (2S,4R,5S,6S)-4,5-dihydroxy-2,6-
bis(hydroxymethyl)piperidine-2-carboxylic acid (+)-15 
 To a solution of (+)-12 (0.010 g; 0.04 mmol) in 1,4-dioxane (2 mL) was added 
NaOH (1M; 3 mL) and the mixture was stirred at rt for 10 min. Resin-H+ (Dowex 50 
WX8 16-40 Mesh) was added and the mixture stirred for 1h. The resin was filtered off 
and filtrate was concentrated by reduced pressure, giving a brown oil ((+)-15; 0.003 g; 
35 %). 
[α]D20 +44.4° (c 0.6, MeOH). max (neat) 3435, 1646, 1212 cm−1. 1H NMR (δH, 400 MHz, 
D2O) 2.19 (1H, dd, J 15.2, 2.4 Hz, H-3), 2.74 (1H, dd, J 15.2, 4.0 Hz, H-3), 3.64 (2H, s, 
H-2’), 3.88 (1H, dd, J 11.0, 2.6 Hz, H-5), 3.91 (1H, dd, J 12.2, 6.2 Hz, H-6’ ), 3.99-4.04 
(1H, m, H-6), 4.10 (1H, dd, J 12.4, 3.2 Hz, H-6’ ), 4.18-4.22 (1H, m, H-4) ppm. 13C NMR 
(δC 100 MHz, D2O) 33.8 (C-3), 38.1 (C-2’), 51.8 (C-6), 55.4 (C-6’), 60.9 (C-2), 63.1 (C-
4), 63.3 (C-5), 169.0 (C=O) ppm. HRMS (ESI): calcd for C8H16NO6: 222.0899; found: 
222.0902. 
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 In this chapter, the title compounds achieved during the work presented in this 
thesis were summarized for an easy overview of results. The corresponding precursors 
were not included. The number of the subchapter was added to the number used in 
each article, in order to avoid confusion between different compounds with the same 
number but belonging to different subchapters: for example, compound 5a in 
subchapter 2.2 is now 2.2-5a. 
 The compounds for which biological activity studies were carried out, the values 
obtained were also presented. 
 In the case of facial selectivity studies, a summary of results were presented in 
tables for an easy comparison of the reaction conditions used either for thermal and 
catalysed reactions. 
 
 Chapter 2.1 “Advances in the Synthesis of Homochiral (-)-1-Azafagomine and 
(+)-5-epi-1-Azafagomine. 1-N-Phenyl Carboxamide Derivatives of both Enantiomers of 
1-Azafagomine: Leads for the Synthesis of Active -Glycosidase Inhibitors.” J. Org. 
Chem. 2011, 76, 9584-9592. 
 
Table 21 Ki Values (µM) for the inhibition of - and -glucosidases for compounds 2.1-22 and 
other relative azasugars. 
Compound Structure 
-glucosidase (baker’s 
yeast) 
-glucosidase 
(almonds) 
2.1-(-)-2 
 
6.9a 0.32a 
2.1-(+)-3 
 
>1000b 137b 
2.1-(-)-22 
 
3.36c 14.7c 
___d,e
 
67.4d 
 
2.1-(+)-22 
 
10.6c 25.2c 
___d,e 90.0d 
a pH 6.8. b Values obtained for the racemic mixture. c pH 7.0. d pH 5.0. e Enzyme inactive. 
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 Chapter 2.2 “Diastereoselectivity in Diels-Alder Cycloadditions of Erythrose 
Benzylidene-acetal 1,3-Butadienes with Maleimides” Synlett 2012, 23, 1765-1768. 
 
Table 22 Comparison of the facial selectivities achieved in thermal and catalysed cycloadditions 
of D-erythrose benzylidene-acetal 1,3-butadienes with maleimides. 
 
Product Thermal reactiona 
Catalysed reactionb 
using (R)-BINOL using (S)-BINOL 
2.2-5a/2.2-6a 1(R):1(S) 1(R):2.5(S) ___ 
2.2-5b/2.2-6b 3(R):1(S) (R) (R) 
2.2-5c/2.2-6c 2(R):1(S) ___ ___ 
2.2-5d/2.2-6d 3(R):1(S) ___ ___ 
a Reactions performed at rt. b LACASA-DA methodology. 
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 Chapter 2.3 “Asymmetric Diels-Alder Cycloadditions of D-Erythrose 1,3-
Butadienes to Achiral t-Butyl 2H-Azirine 3-Carboxylate” Tetrahedron: Asymmetry 2013, 
24, 1063-1068. 
 
Table 23 Comparison of the facial selectivities achieved in thermal and catalysed cycloadditions 
of D-erythrose benzylidene-acetal 1,3-butadienes and t-butyl 2H-azirine 3-carboxylate. 
 
Product Thermal reactiona 
Catalysed reactionb 
using (R)-BINOL using (S)-BINOL 
2.3-4a/2.3-5a 2.5(R):1(S) (S) (R) 
2.3-4b/2.3-5b 1.4(R):1(S) ___ ___ 
a Reactions performed at rt. b LACASA-DA methodology. 
 
 
 Chapter 2.4 “Enantioselective Diels-Alder Cycloadditions in the Synthesis of 
Two Enantiomeric Sets of Homochiral Polihydroxylated Pipecolic Acid Derivatives.”, 
submitted to Org. Lett. 2013. 
 
 
Scheme 30 Synthesis of two enantiomeric sets of homochiral polihydroxylated pipecolic acid 
derivatives. 
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 A 1,3-butadiene bearing a 2,3,4,6-tetraacetylglucosyl unit at position 1 was 
reacted by PTAD to give a homochiral cycloadduct, that was used as precursor of 
known iminosugars and its derivatives. This strategy allowed to obtaining 1-
azafagomine in both enantiomeric forms, and for the first time (+)-5-epi-1-azafagomine. 
FGT of the cycloadduct afforded two new derivatives of 1-azafagomine: the N-phenyl 
carboxamides. These compounds were evaluated as glucosidase inhibitors; (-)-1-
azafagomine derivative had shown the best inhibitory activity against baker’s yeast -
glucosidase (Ki = 3.39 µM) (Subchapter 2.1). 
 Combination of a D-erythrose diene with maleimides and an achiral 2H-azirine 
3-carboxylate using a LACASA-DA methodology proved to be very efficient, giving in 
most cases total facial selectivity. In contrast thermal reactions produced a 3:1 ratio of 
diastereomers resulting from facial selectivity. A matched double asymmetric induction 
was observed in the catalysed reaction (Subchapters 2.2 and 2.3). 
 Combination of achiral reagents: 2,4-pentadienol (diene), 2H azirine and DEAD 
(dienophiles), in a LACASA-DA cycloaddition afforded the corresponding cycloadducts 
with total enantioselectivity. Cycloadducts were produced in both enantiomeric forms. 
In the case of the aziridine-fused cycloadduct, FGT led to the synthesis of 
polihydroxylated pipecolic acid derivatives (Subchapter 2.4).  
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1. Conclusions 
 
 The focus of this thesis has been put on the stereoselective synthesis of 
iminosugars with potential biological activity. Diels-Alder cycloaddition is the key step in 
every case. 
 The work started with a diastereoselective DA reaction. The inhibitory activity of 
the products obtained was tested in its - and -glucosidases, and the results were 
compared to analogues reported in lit. 
 The method demonstrated to be very efficient in terms of facial discrimination, 
but with a relatively long chain of reactions. A much more simplified and versatile 
process was established for the same compounds by an enantioselective methodology 
attaching the reagents to a Zn/Mg complex with BINOL. Homochiral products were 
obtained in both enantiomeric forms by changing the BINOL chirality. 
 
 The highlights of the obtained results are summarized next: 
 
- chapter 2.1 
 
 A new expeditious preparation of homochiral (-)-1-azafagomine and (+)-5-epi-1-
azafagomine was presented. The key step of the methodology employed consisted in a 
diastereoselective Diels-Alder cycloaddition of a diene bearing a 2,3,4,6-tetraacetyl 
glucosyl chiral auxiliary at position 1 with PTAD. New homochiral derivatives of both 
enantiomeric forms of 1-azafagomine: 1-N-phenyl carboxamide were synthetized and 
tested as glucosidase inhibitors face to - and -glucosidases. Both showed very good 
enzymatic inhibition toward baker’s yeast -glucosidase, one is twice more potent than 
(-)-1-azafagomine. Molecular modelling studies were performed in Saccharomyces 
cerevisae enzyme used for homology modelling, to understand the recognition 
mechanism of 1-N-phenyl carboxamide derivatives by baker’s yeast-glucosidase. 
The accommodation of the aromatic ring present in the 1-N-phenyl carboxamide moiety 
into a hydrophobic pocket in the enzyme’s active site seems to be responsible for the 
improved inhibition observed relatively to the underivatized 1-azafagomine 
enantiomers. 
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- chapter 2.2 
 
 Maleimides were combined with D-erythrose benzylidene-acetal 1,3-butadienes 
in order to study the facial selectivity of the Diels-Alder cycloadditions. In thermal 
cycloadditions, the best result obtained was a 1:3 ratio of isomer products. It was found 
possible to reverse the selectivity to 2:1 by lowering the reaction temperature to 5º C. 
Tethering NH-maleimide, D-erythrose benzylidene-acetal 1,3-butadiene bearing the 
hydroxyl group unprotected to the chiral BINOL bimetallic Lewis acid catalyst 
(LACASA-DA reaction), allowed the synthesis of pure (S)-isomers in moderate yields, 
either in the presence of (R)- or (S)-BINOL.  
 
- chapter 2.3 
 
 Two D-erythrose benzylidene-acetal 1,3-butadienes were reacted with 
electrophilic t-butyl 2H-azirine 3-carboxylate. Thermal cycloaddition occurred at 60 ºC 
with moderate facial selectivity, giving as major product the (R)-isomer. The moderate 
selectivity was explained by the antagonism of thermodynamics and kinetics in the 
reaction mechanism. Computational free energy perturbation methods together with 1H 
NMR data led to the identification of the isomers formed. It was also shown that the 
(S)-product was thermodynamically preferred to the (R)-product. Pure (R)- and (S)-
isomers were obtained by LACASA-DA methodology using Zn/Mg bimetallic complexes 
and BINOL as an extra chiral inductor. 
 
- chapter 2.4 
 
 A bimetallic complex of Zn, Mg tethering BINOL, t-butyl 2H-azirine 3-
carboxylate and 2,4-pentadienol led to a Diels-Alder cycloaddition with complete facial 
selectivity. Cycloadducts were obtained in high yields in both enantiomeric forms. The 
BINOL chirality is the factor responsible for the selectivity discrimination in each case. 
Cycloadduct’s hydrolysis easily occurs under cycloaddition conditions, but proved to be 
reversible. The aziridine and the open-ring aziridine product led to two types of final 
products. Two simple chemical transformations furnished final polihydroxylated 
pipecolic acids. The absolute stereochemistry of products was proposed on the basis 
of similar reactions described in lit. and by cycloaddition of 2,4-pentadienol to DEAD, 
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using (S)-BINOL, in which a known product with established configuration at the 
stereocentres is obtained. 
 
2. Future Prospects 
 
 1) In an attempt to obtain piperidine iminosugars, 2,4-pentadienol was 
combined with a glyoxylate imine in a LACASA-DA cycloaddition. This system showed 
to be unreactive. To improve the reactivity the diene was substituted by a nucleophilic 
diene (Danishefsky’s diene) and a boron catalyst was used instead of Zn/Mg complex. 
The catalyst was obtained from BINOL and B(OPh)3. 1H and 13C NMR spectra of 
cycloadduct obtained showed that the diene skeleton was not included in the molecule. 
The full identification of this compound is still ongoing. 
 2) LACASA-DA methodology allows the synthesis of the cycloadducts 
precursors of important molecules, such as neuraminic acid and D-swainsonine 
analogues. The transformation of these cycloadducts into the final products is to be 
pursued. The (R)-cycloadduct (2.3-4a) obtained by LACASA-DA cycloaddition of D-
erythrose 1,3-butadiene and t-butyl 2H-azirine 3-carboxylate, could be transformed into 
epimeric neuraminic acid analogue by trivial functional group transformations (Scheme 
31). 
 
 
Scheme 31 Conversion of cycloadduct 2.3-4a in neuraminic acid analogue. 
 
 
 Disubstituted swainsonine analogues in position 5 will be accessed from 
cycloadduct 2.3-4a by FGT (Scheme 32). 
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Scheme 32 FGT of cycloadduct to D-swainsonine analogue. 
 
 
 Other final compounds could be achieved from imines and azodicarboxylates 
starting materials (see Figure 18). 
 
 
 
 
 
Figure 18 Structures of D-swainsonine and aza-D-swainsonine. 
  
 
